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Abstract 
Heterologous protein expression in E. coli can lead to the formation of dense insoluble 
aggregates named inclusion bodies (IB).  The refolding of protein derived from IB is 
often characterised by low yields of active product.  Process optimisation is often 
achieved empirically and requires significant resource and time efforts.   Microscale 
experimentation may provide a valuable alternative by enabling representative process 
studies to be conducted early on in process development, using minimal quantities of 
product, parallel experimentation and automated liquid handling procedures.   
 
An automated robotic platform has been used to develop a dilution refold microscale 
process-screening tool with a set of hierarchical assays to rapidly determine optimal 
refolding conditions.  The hierarchical orthogonal assays enable the simplest, cheapest 
and most generic high-throughput assays to first screen for a smaller subset of 
potentially high-yielding conditions.  Absorbance can be used as an initial filter to 
measure particulate formation and fluorescence boundaries can then be used to select 
the conditions with the most native-like tertiary structure.  The subset can then be 
analysed for native protein yield by slower, more expensive or protein specific assays, 
thus saving resources whilst maximising information output, alleviating the analytical 
bottleneck. This approach has been demonstrated in this work using lysozyme, with 
fluorescence boundaries to select 30% of highest yielding samples, and also with 
DHFR.   
 
An automated whole bioprocess sequence comprising fermentation, cell harvest and 
lysis, inclusion body harvest, denaturation and refolding has been developed at the 
microscale to study the effect of fermentation conditions on inclusion body yield and 
quality.  The approach has been applied to dihydrofolate reductase (DHFR) and insulin, 
allowing a more thorough understanding of the effect of fermentation feeding, media 
and induction strategies on protein refolding yield and purity.  This approach allowed 
yields of active insulin of increased from 10% to 68%.  The results obtained from this 
approach have been compared to larger scales of operation, illustrating the challenges of 
scale-up.  The process sequence, integrated with rapid analytical assays, provides a 
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powerful tool for understanding the interaction between fermentation conditions and 
downstream processing yields, allowing a whole process approach to optimisation.    
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1 Introduction 
1.1 The context of the research 
Biopharmaceuticals are products consisting of (glyco)proteins, which include 
recombinant therapeutic proteins, monoclonal antibodies and nucleic acid based 
medicinal products (Crommelin et al., 2003).  They now represent one in four of new 
molecular entities reaching the market, generating €30 billion in sales annually.   
Approximately 160 biopharmaceuticals have been approved for clinical use (Walsh, 
2005) and some of these have revolutionized the traditional treatment of many diseases 
(Schellekens, 2002).   These biological products introduce new challenges due to their 
complex conformational structure that is easily disrupted in comparison to traditional 
low molecular weight chemicals (Crommelin et al., 2003).  Consequently, their 
performance relies on strict production protocols in both upstream and downstream 
processing, as a number of factors are thought to influence biopharmaceuticals 
immunogenicity (Schellekens, 2002).  The manufacturing process has to be designed to 
consistently deliver a product with the necessary quality attributes.  This requires 
extensive process characterisation during process development, which usually involves 
evaluating a wide range of process parameters (Rathore et al. 2007).  
 
Microscale processing techniques involve the study of unit operations at the microlitre 
scale (20-2000 μl) using microwell or microfluidic formats (Micheletti and Lye, 2006) 
to predict the performance of individual bioprocess unit operations at larger scale.   It 
offers the potential to speed up process development, reduce development costs and 
deliver new drugs to the market quicker.  In particular the study of bioprocess unit 
operations in microwell plate formats and the use of automation can significantly 
enhance experimental throughput and facilitate the parallel evaluation of a large number 
of process conditions (Jackson et al., 2006; Nealon et al., 2006). The majority of 
microscale studies have focused on microbial fermentation, whilst comparatively little 
work has addressed downstream processing operations. This potential bottleneck 
requires considerable attention if significant step-wise process enhancements are to be 
gained. In particular the impact of fermentation conditions on whole process 
performance must be understood in order to prevent downstream processing from 
becoming rate limiting (Micheletti and Lye, 2006). The refolding of recombinant 
1  Introduction  G. Ordidge 
 
26 
protein from inclusion bodies (IB) represents a specific example that could greatly 
benefit from this approach. During heterologous expression in a host organism, 
inclusion bodies can form which contain a high concentration of very pure therapeutic 
protein.  The inclusion bodies represent a high yielding system with an easily isolated 
high purity product (albeit in an aggregated form that requires refolding).  However 
protein refolding yields at industrially relevant concentrations are restricted by 
aggregation of protein upon the initiation of dilution refolding. A number of studies 
have investigated chemical (Buswell and Middelberg, 2002; Mannall et al., 2007) as 
well as physical (Mannall et al., 2006) factors affecting the dilution refolding in small 
(20-200ml) bioreactors. However, for the majority of proteins a large number of refold 
conditions usually need to be tested in order to optimize this processing step. The use of 
microwell plates as a format in which to perform protein refold experiments has been 
preliminary investigated and initial scalability between microwell and bench scale 
operation has been demonstrated (Mannall et al., 2009).  Microwell refolding allowed a 
significant amount of information to be gained in a short period of time using a small 
amount of the valuable IB-derived protein. In this project the automated microwell 
approach will be developed for the rapid optimization of the protein refolding step by: 
1) adopting a whole process approach to optimization which investigates the effect of 
fermentation conditions on subsequent refolding yields and product quality 2) 
establishing the automation of the refolding step, both in terms of liquid handling 
operations and associated analytical methods, to speed up the investigation of multiple 
variables under different mixing conditions. 
1.1.1.1.1 Literature survey 
The following review is concerned with the current understanding of inclusion bodies as 
a result of over expression in Escherichia coli (E. coli).  Protein folding is discussed in 
general terms for the refolding step and also in the in vivo context, describing the factors 
involved with IB formation.  Particular attention is paid to the key factors and 
fermentation conditions leading to IB formation over soluble protein.  The role of 
inclusion bodies in industry is also discussed, along with the use of microscale 
bioprocessing methods and how these could be used to speed up development.  Lastly, 
some background information is provided on the protein systems studied.   
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1.1.2 Escherichia coli as an expression system 
Advances in molecular biology and directed evolution techniques, coupled with the 
human genome project, have led to an increasing interest in the efficient production of 
genetically engineered proteins.  The most widely used prokaryote for genetic 
manipulations and industrial production is the enteric bacterium Escherichia coli (E. 
coli) (Ferrer-Miralles et al., 2009).  E. coli is a highly versatile host organism and it has 
been extensively used to achieve protein expression rapidly and economically.  Its long 
history as a model system means that extensive knowledge of its genetics is currently 
available.  There is a diverse range of tools for chromosome engineering, gene cloning 
and expression vectors, allowing the creation of mutant strains (Baneyx and Mujacic, 
2004).  Additionally E. coli metabolism is well studied, which has allowed studies on 
the optimisation of media and culture conditions due to its relatively simple nutritional 
requirements (Kolaj et al., 2009).  E. coli grows on inexpensive carbon sources and its 
ability to rapidly accumulate biomass make it amenable for high cell density 
fermentation and scale-up (Ferrer-Miralles et al., 2009).  E. coli is typically selected for 
expression if the heterologous protein does not require post-translational modifications 
and is produced in soluble form.  However over expression of the protein can occur, 
resulting in a protein with an incorrect conformation.  The misfolded protein can then 
form insoluble aggregates called inclusion bodies (Ferrer-Miralles et al., 2009).  
Additionally product loss due to membrane leakiness and cell lysis have been reported, 
leading to further yield reductions (Kolaj et al., 2009).  However E. coli continues to be 
an important host system with new strains being developed that allow post translational 
modifications (Wacker et al., 2002), improved strategies for soluble expression using 
folding chaperones (Marco, 2007), and progress towards disulphide bond formation and 
extracellular excretion (Makrides, 1996). 
1.1.3 Protein structure and folding 
1.1.3.1 General overview 
Proteins are constructed from a repertoire of 20 amino acids, linked by peptide bonds. 
The folding of a chain of amino acids to form the native conformation is a complex 
process with four levels of structure involved.  The sequence of amino acids forms the 
primary structure of the protein and confers the three dimensional structure of a protein, 
as demonstrated by Anfinsen (1973) with the spontaneous refolding of denatured 
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ribonuclease.  The polypeptide chain folds to give a secondary structure as a result of 
the formation of hydrogen bonds that give regular structures such as an alpha helix, a 
beta sheet, turns and loops.  These secondary structure domains come together, giving 
the overall conformation of the polypeptide protein its tertiary structure.  The 
polypeptide folds so that the hydrophobic side chains are buried in the centre and the 
polar charged chains are on the surface of the protein.  The compact globular structure is 
stabilized by non-specific hydrophobic interactions between non-polar side chains, 
specific hydrogen bonds between polar side chains and salt bridges (Dill et al., 2008).  
The tertiary structure also includes the formation of disulphide bonds, which involves 
the oxidation of a pair of cysteine residues to give a pair of cystines (Figure 1.1).  As 
these interactions are weak the polypeptide maintains some flexibility, which is 
important for the function and regulation of the protein.  For multimeric proteins a 
further stage requiring the formation of quaternary structure is required, where subunits 
interact to form the final structure (Berg et al., 2002).   
 
Figure 1.1  Formation of a disulphide bond, taken from Berg et al. (2002). 
1.1.3.2 Folding- a search for a low energy conformation  
Folding is known as an “all or nothing” process as half-folded protein is 
thermodynamically unstable and only exists transiently (Berg et al., 2002).  The folding 
of proteins is highly co-operative due to their thermodynamic properties.  In order for 
proteins to find their native confirmation they utilise cumulative selection, rather than a 
random search method.  This is because partly folded intermediates are retained and 
interactions with other local regions result in them adopting their preferred structure, 
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progressively stabilising the structure.  A partially folded polypeptide chain is flexible 
and fluctuations in the conformation allow amino acids far apart in sequence to come 
into contact.  Native-like interactions are more on average more stable, and 
consequently are favoured over less stable non-native interactions, and therefore 
retained.  This search mechanism drives the search in the direction of the lowest energy 
structure, the native state, and ensures that only a very small fraction of the possible 
conformations needs to be sampled (Dobson, 2004b). 
1.1.3.3 Mechanisms of folding 
Studies using site-directed mutagenesis to map the free energy of a polypeptide chain as 
a function of its conformational properties suggest that the fundamental method of 
folding for small molecules involves “nucleation-condensation”.  This is the formation 
of a folding nucleus consisting of a few key residues around which the rest of the 
structure condenses (Fersht, 2000).  It has been observed that a key feature of the 
transition state in some proteins is that it has the same overall topology of the native 
fold.  Despite having a highly disordered structure, the interactions of the key core 
residues force the polypeptide chain to adopt a native-like architecture.  The creation of 
the correct topology in the transition state invariably leads to the creation of the native 
structure during the final stages of folding.  
 
Larger proteins (greater than 100 residues) on the other hand fold by a slightly different 
mechanism.  This generally involves passing through one or more partially folded 
intermediates before the native state is reached.  Studies of these intermediates using 
near-UV CD, far-UV CD and NMR suggest that larger proteins fold in modules.  This 
means that they largely fold independently to form segments or domains (Panchenko et 
al., 1996; Ellis and Minton, 2003; Khan et al., 2003).     As with smaller proteins, the 
native-like fold within these local regions forms from the interaction of key residues.  
Once this structured domain is created, other key residues interact with independent 
regions of structure to assemble into the correct overall fold. 
1.1.3.4 Timescale of folding 
The secondary structure affects the rate of protein folding.  It has been observed that 
individual α-helices can fold in 100 ns and β-turns in circa 1 μs (Eaton et al.; Snow et 
al., 2002).  Small helical bundles have been observed to fold in less than 50 μs, and the 
1  Introduction  G. Ordidge 
 
30 
“speed limit” for simpler proteins has been estimated a tenth of this time (Mayor et al., 
2003; Yang and Gruebele, 2003).  However proteins that contain an extensive β –
structure take several orders of magnitude longer to fold.  The stability also influences 
the folding rate of small proteins due to the contact order, the average space in terms of 
sequence between residues in contact in the native structure.  The process of a stochastic 
search is more efficient if the nucleus forming residues are close together in sequence, 
and hence folding occurs faster.  However, the most important factor affecting the 
folding is thought to be the sequence of amino acids and the pattern of hydrophilic and 
hydrophobic residues.   
1.1.3.5 Folding in vivo 
The interior of a cell is a crowded environment where the concentration of 
macromolecules is approximately 300-400 mg.ml
-1
 (Ellis and Minton, 2003).  One 
protein chain is released from the ribosome every 35 seconds (Lorimer, 1996).  This 
represents two main challenges for in vivo folding.  Firstly undesirable interactions with 
other cell components in the crowded interior must be avoided as it will prevent the 
formation of a folded structure.  Chaperones and enzymes are used to prevent 
aggregation or misfolding.  Chaperones favour the formation of on-pathway folding 
species by shielding interactive surfaces of partially folded protein (Baneyx and 
Mujacic, 2004).    The second challenge is the slow steps involved in protein folding.  
These rate limiting steps are overcome by folding catalysts such as peptidyl proline 
isomerase and protein disulphide isomerase, which accelerate peptide and disulphide 
bond formation respectively. 
 
In conclusion, proteins are not searching randomly for the correct native conformation, 
but are driven by a decrease in free energy.  Fluctuations in the polypeptide allow amino 
acids distant in sequence to interact, and when these interactions are native-like, they 
are more likely to be retained.  Once the key residues of the folding nucleus have 
formed the correct interactions, the polypeptide chain is forced to form a native-like 
overall fold and the transition state is formed.  This state then leads to the creation of the 
native state, as the highly disordered structure folds and condenses around the folding 
nucleus. 
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1.1.4 Inclusion Bodies 
1.1.4.1 Structure 
Inclusion bodies (IBs) are commonly found in the cytoplasm of bacteria, but they have 
also been reported to form in the periplasmic space (Georgiou et al., 1986; Bowden and 
Georgiou, 1990).  They consist of refractile, dense aggregates of insoluble misfolded 
protein that are  less than 2µm  long  (Carrió et al., 2006).  Despite their dense nature, 
analysis has shown that they have a porous structures with a high level of hydration 
(Taylor et al., 1986a).   Proteolytic digestion studies have shown inclusion bodies are 
non-homogeneous structures where more than one protein species may coexist with 
different protease susceptibility (Carrió et al., 2000).  Scanning electron microscopy and 
kinetic analysis studies of tryptic digests have revealed the formation of clustered sub-
unit structures (Carrió et al., 2000),  possibly resulting from the IB construction process.  
A high level of secondary structure and native-like structure can also exist in inclusion 
bodies (Oberg et al., 1994). .  Inclusion bodies share some of the properties of amyloid 
fibrils, such as the presence of additional β-structure not observed in the native state 
(Villaverde and Carrió, 2003).  A decrease in alpha-helix content of the protein, and an 
increase in beta-sheet conformation, has also been reported in IB when compared to the 
native protein structure (Przybycien et al., 1994).  These elements of native-like 
structure, in conjunction with the high porosity of inclusion bodies could help explain 
the enzyme activity observed in some cases of IB forming enzymes, although 
contamination with active native during purification cannot be completely ruled out 
(Carrió and Villaverde, 2002).  Different morphologies have also been reported, with 
some inclusion bodies forming rod shaped particles (Carrió et al., 2000), whilst others 
having an ovoid shape (Bowden and Georgiou, 1990).  In addition, the topology may 
vary from rough to smooth (Bowden and Georgiou, 1990); however this may result 
from the different recombinant protein studied. 
1.1.4.2 Composition  
The major component of inclusion bodies in recombinant E. coli cells is the target 
protein.  The amount of protein varies, but it is thought to be in the range of 50 to 95% 
of the total protein (Valax and Georgiou, 1993).  Additionally other contaminants are 
also present such as protein and phospholipids.  Some of these contaminants are derived 
from an incomplete purification process and the unspecific co-precipitation of unrelated 
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polypeptides (Carrió and Villaverde, 2002).  Other contaminants can be incorporated in 
vivo during the growth of the inclusion body, such as folding chaperones.  The small 
heat shock proteins IbpA and IbpB are involved in protein folding and cell survival 
under thermal stress and are common components of IBs.  Other chaperones, DnaK and 
GroEL have also been reported to be present in inclusion bodies (Allen et al., 1992) as 
well as ribosomal components and translation factors (Kane and Hartley, 1988).  
However it is not yet understood if these chaperones are trapped during the growth of 
the inclusion body or if they play a role in the construction and deconstruction process.   
 
Figure 1.2  Scanning electron micrograph of purified VP1LAC inclusion bodies, taken from Carrió et al., 
(2000). 
1.1.4.3 Factors causing IB formation 
Inclusion bodies are thought to form from the aggregation of partially folded 
intermediates as a result of the competition between folding and aggregation. A 
relatively high concentration of unfolded protein in the cell during the production of 
recombinant protein results in a “crowding effect” where intrachain interactions 
compete with intermolecular interactions.  However not all non-secreted proteins form 
inclusion bodies.  Some factors contributing to their formation (Fahnert et al., 2004b) 
are:   
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 Post-translational folding: When a eukaryotic protein is produced in a 
prokaryotic host instead of folding happening co-translationally, as in 
eukaryotes, it occurs post-translationally.   
 Glycosylation: In a prokaryotic host, glycosylation is absent.  Glycosylation 
often improves solubility and it is necessary for the folding of some proteins.   
 Disulphide bond formation: The cytoplasm of prokaryotes, where disulphide 
bonds form in the host, is reducing.  In eukaryotes disulphide bonds form in the 
oxidising environment of the endoplasmic reticulum (ER) which is a more 
favourable environment. 
 Number of cysteine residues: Mammalian proteins that are cysteine rich are 
reported to be more difficult to express in E. coli in their soluble form.  
 
The formation of inclusion bodies appears to be structure and therefore sequence 
dependent.  Sequence modifications have been used to increase solubility during 
production or improve in vitro refolding yields (Rinas et al., 1992).  In order to reduce 
aggregation of over expressed recombinant protein and combat inclusion body 
formation many parameters have been explored such as gene dosage, promoter strength, 
mRNA stability, codon usage, culture temperature, protein and genetic engineering and 
over expression of folding modulators to obtain soluble expression protein in E. coli  
(Martínez-Alonso et al., 2009).   
1.1.5 Misfolding and Aggregation 
A polypeptide chain can adopt a range of different states, as illustrated in Figure 1.3.  
The state adopted depends on the relative thermodynamic stabilities of these different 
states and the kinetics that govern their conversion between states (Dobson, 2004b).  
For example, concentration is a critical parameter in the formation of aggregates or 
oligomers.  The conformations accessible are also regulated by the action of molecular 
chaperones and degradation mechanisms (Dobson, 2004a).  Biological systems exploit 
the many states available in order to generate specificity and control the cellular 
environment.  The outcome of in vivo folding is determined by the rate of protein 
synthesis, growth conditions,  interactions with cellular components, and the folding 
pathway for that particular protein (Valax and Georgiou, 1993).   
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Misfolding has been described as “processes that result in a protein acquiring a 
sufficient number of persistent non-native interactions to affect its overall architecture 
and/or its properties in a biologically significant manner” (Dobson, 2004b), for example 
an intermediate with non-native topology.   Misfolding may result from the newly 
synthesized chain failing to fold to the native conformation, premature termination of 
translation or loss of structure due to environmental stress (Baneyx and Mujacic, 2004).  
Heterologous protein expression can lead to misfolding as, in addition to these factors, 
the use of strong promoters and high inducer concentrations results a in high protein 
concentration in vivo.  The inability of E. coli to provide the post translational 
modifications required for the folding of some proteins, such as the formation of 
disulphide bonds, introduces further challenges.    
 
Synthesis Unfolded Intermediate Native
Aggregate
 
Figure 1.3  A schematic showing the accessible states for a polypeptide chain following its synthesis.  
The population of these states and the interconversions are determined by the thermodynamic and kinetic 
stabilities.  This is highly regulated by controlling the environment in the cell, and through the action of 
molecular chaperones, proteolytic enzymes and other factors. 
 
Misfolding is not uncommon for host cell proteins, and consequently cells have evolved 
mechanisms that favour de novo protein synthesis, refold partially folded protein, 
dissolve aggregates and dispose of irremediably damaged protein (Baneyx and Mujacic, 
2004).  Protein folding in vivo is aided by molecular chaperones and foldases.  
Chaperones help the protein to escape metastable and misfolded states that occur during 
the folding process (Vendruscolo and Dobson, 2005).  They interact transiently with 
unfolded and partially folded intermediates, and shelter the exposed hydrophobic 
patches to prevent them interacting inappropriately (Kopito, 2000).  Folding chaperones 
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can be divided into three functional classes.  Firstly there are folding chaperones which 
use conformational changes driven by ATP to refold or unfold the protein; in this 
category are DnaK-DnaJ-GrpE (Hsp70-Hsp40) and GroEL-GroES (Hsp60- Hsp10) 
systems.  Secondly there are holding proteins, small heat shock protein (IpbAB), which 
act as a holding system passively stabilizing partially folded protein until folding 
chaperones become available.  The third class are disaggregating chaperones, such as 
ClpB in E. coli, which undergo ATP fuelled conformational changes to solubilise 
aggregates and transfer partially folded protein to folding chaperones for refolding 
(Baneyx, 2004).  Foldases on the other hand are enzymes which catalyse rate limiting 
reactions in the folding pathway, such as the cis trans isomerisation of peptidyl-prolyl 
bonds by peptidyl-prolyl isomerases and the formation and isomerisation of disulphide 
bonds by oxidoreductases (Baneyx, 1999; Miot and Betton, 2004).  The final 
components of these systems are proteases, which degrade irreparably damaged 
proteins.  Aggregation in vivo is controlled by the chaperones DnaK and GroEL.  
Studies also indicate that ClpB may play a large or moderate role as it binds 
preferentially to the hydrophobic surface of aggregated proteins (Ventura, 2005).   
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Figure 1.4  Chaperones involved in protein folding and disaggregation in E.coli.  The DnaK system 
(DnaK, DnaJ, GrpE) and the chaperonins (GroESL) may assist the protein intermediates to reach their 
native structure. The small heat-shock proteins IbpAB  bind misfolded proteins during aggregation and 
ClpB triggers the disaggregation process, in combination with there DnaK system, allowing refolding.  
Taken from Baneyx and Mujacic, (2004). 
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1.1.5.1 The role of inclusion bodies 
Protein aggregates do not usually accumulate in an unstressed cell due to the quality 
control mechanisms present.  However when a cell is being used for the recombinant 
expression of protein, the over expression of the plasmid encoding genes acts as a form 
of artificial stress and redirects the metabolism of the cell towards the production of the 
specific target protein.  This triggers a variety stress responses (stringent, SOS, heat 
shock) and the transcription of other sets of stress genes (Villaverde and Carrió, 2003), 
leading to protein accumulating as inactive and insoluble aggregates (IBs), instead of 
remaining as soluble active protein.  This mechanism may have evolved to reduce the 
potential toxicity of polypeptides with partially exposed hydrophobic patches which 
could interact with cellular machinery, thereby playing a cellular protective role 
(Ventura, 2005).  Inclusion bodies could also act as a transient store of incorrectly 
folded polypeptides during stress conditions, which can later be further processed by 
refolding or proteolysis (Villaverde and Carrió, 2003).  Carrió and Villaverde (2001) 
showed that inclusion bodies are not inert protein aggregates but transient deposits, 
resulting from an imbalance between in vivo protein aggregation and solubilisation.  
When protein synthesis is arrested, the equilibrium is displaced back towards protein 
refolding.  
1.1.5.2 The mechanism  
A range of proteins are incorporated into inclusion bodies; small, large, multimeric or 
monomeric.  The amount of secondary structure and disordered structure varies between 
proteins.  Studies using attenuated total reflectance FTIR have shown an increase in β-
structure in inclusion bodies, relative to the native conformation (Ventura, 2005).  Other 
FTIR studies have also suggested that β-sheet like interactions are involved in 
aggregation and inclusion bodies contain newly formed β-sheet which are tightly 
packed by hydrogen bonds providing stability (Carrió et al., 2005). 
 
Inclusion body formation was initially considered a non-specific process resulting from 
non-native interactions between hydrophobic patches on the surface of unfolded or 
partially unfolded conformations such as folding intermediates.  However recent work 
suggests aggregation in bacterial inclusion bodies is a specific event (Ventura, 2005).  
There are usually only one or two inclusion bodies per cell.  This low number suggest 
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inclusion bodies grow in a nucleation-like mechanism from a reduced number of 
“founder” aggregates (Ventura, 2005).  The specificity of protein aggregation during 
refolding has been investigated by refolding mixtures of P22 tail spike and coat 
polypeptide chains.  When the partially folded intermediates of the two are mixed 
together in vitro, they independently self-associate and no co-aggregation occurs, 
despite them both forming inclusion bodies when expressed individually with bacteria 
(Speed et al., 1996).  
1.1.5.3 Fermentation conditions influencing IB formation 
A number of process parameters influence inclusion body formation.  They include 
media composition, growth temperature, the production rate (which results from a 
multitude of factors such as gene dosage, codon usage, promoter strength, mRNA 
stability) and the availability of heat shock chaperones in the cell (Strandberg and 
Enfors, 1991; Carrió and Villaverde, 2002; Ventura and Villaverde, 2006).  During 
fermentation several conditions can be manipulated in order to promote solubility, but 
the operational range of these process variables are limited as a means to provide a 
completely soluble product. The following cultivation conditions increase the likelihood 
of inclusion body formation (Schein and Noteborn, 1988; Wang et al., 1999; Choi et al., 
2000; Fahnert et al., 2004b): 
 
 High temperatures  
 High cell density  
 High concentration of inducer  
 Short induction time (2-5hrs) 
 Complex media 
 
The above conditions influence the aggregation kinetics by varying the protein 
concentration in the cell, synthesis rate or, in the case of high temperatures, by crossing 
the thermodynamic threshold needed for intermolecular interactions.  In addition to the 
cultivation conditions, other factors such as a strong promoter or large plasmid copy 
number result in an increased protein synthesis rate which overwhelms cellular folding 
machinery resulting in aggregation (Fahnert et al., 2004a).  Some methods are available 
to reduce aggregation in order to optimise the production of a soluble active protein 
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Such methods include cultivation at low temperatures, limited induction times, fusion to 
solubilising partners, co-expression of chaperones and foldases.  
1.1.6 Inclusion bodies in industry 
Protein synthesis in a recombinant host allows the production of high concentrations of 
target protein in a short space of time.  However proteins can fail to reach the native 
conformation due to the corresponding increase in aggregation, the availability of 
chaperones and the necessity for post translational modifications.  This leads to the 
protein either being deposited into inclusion bodies or degraded (Baneyx and Mujacic, 
2004).   
1.1.6.1 The advantages of inclusion body production 
The numerous factors involved with in vivo folding means the optimisation of soluble 
protein expression is usually a time consuming and unpredictable process, and 
consequently soluble expression may be difficult to achieve.  Additionally there are 
considerable advantages to expressing protein as insoluble inclusion bodies that make 
their formation desirable for some products. 
 
1. The expression levels are often high, resulting in a large amount of protein 
present.  Yields of around 30% of the total cellular protein content and 
approximately 8.5 g.L
-1 
have been reported in an E. coli with transient over 
expression and a high cell density (Li et al., 2004). 
2. Inclusion bodies are a highly enriched source of protein product, with 40-50% of 
the target protein present (Buswell et al., 2002).  
3. Proteins are protected from proteolytic degradation as they are trapped in 
insoluble aggregates.  This increased protein stability results in less product loss 
via degradation by host cell enzymes. 
4. Inclusion bodies can be easily separated from soluble and insoluble 
contaminants using centrifugation due to their density difference (Buswell et al., 
2002).  This reduces the number of purification steps required, increasing the 
overall yield.  Additionally, inclusion bodies can also be easily separated from 
soluble contaminants using filtration or size exclusion chromatography.   
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5. If the expressed protein is toxic or lethal to the cell, the formation of inactive 
inclusion bodies protects the cells from this affect, increasing viability and the 
yield of the target protein. 
6. The optimisation of a refolding step (to convert the insoluble inactive inclusion 
to soluble native protein) involves a limited number of parameters, whereas 
optimisation in vivo to achieve soluble product can be far more complicated 
(Fahnert et al., 2004b). 
 
Production in inclusion bodies does have some disadvantages however, the major one 
being the efficiency of the refolding step.  A low yield in this unit operation due to 
aggregation problems impacts heavily on the overall achievable yield.  Consequently it 
is often the efficiency of refolding step that determines overall economic viability 
(Buswell et al., 2002).  
1.1.6.2 Inclusion Body Process 
After expression of the target protein product as inclusion bodies in E. coli, the cells are 
harvested from the fermentation broth using centrifugation and resuspended in buffer.  
The cells are then mechanically lysed using high pressure homogenisation to release the 
inclusion bodies and generate micronized cell debris.  The inclusion bodies then require 
isolation from the cell components using centrifugation or filtration.  One of the 
advantages of inclusion bodies over soluble expression is the simple primary recovery 
step to separate the dense inclusion bodies from the lighter cell membrane components 
and soluble contaminants.  A washing step is typically performed to remove impurities 
associated with the surface of the inclusion bodies.   The inclusion bodies are then 
solubilised in high concentrations of chaotropes such as urea or guanidine to unfold the 
protein.  A reducing agent is also added to break any disulphide bonds to allow 
denaturation.  A refolding step follows to obtain active folded product, which is then 
further purified before formulation.   
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Cell harvest
Cell lysis
IB harvest
Fermentation
Centrifugation Microf iltration
Mechanical lysis Chemical lysis
Centrifugation Microf iltration
Washing
Solubilisation
Refolding
Multiple cycles
 
Figure 1.5  The sequence of operations involved in an inclusion body process 
1.1.6.3 Washing   
A washing step can reduce the number of steps in purification and increase refolding 
yields.  It has been reported that a purity of up to 90% can be achieved by using an 
optimal washing procedure (Panda, 2003).  Contaminants present in the refolding step 
can significantly reduce the refolding yield.  Inclusion bodies can contain other proteins 
such as RNA polymerase subunits, outer membrane proteins, 16S and 23S RNA, 
plasmid DNA and other enzymes (Fischer et al., 1993).  Plasmid DNA, 
lipopolysaccharide and protein have been shown to increase aggregation during the 
renaturation of hen egg-white lysozyme and hence decrease yield (Middelberg, 2002).  
The most common method for washing involves using EDTA and low concentrations of 
denaturant (1-4M urea), sucrose or detergents such as Triton X-100, deoxycholate and 
octylglucoside to reduce the level of contaminants (Clark, 2001).  However, this step 
increases the cost and complexity of the process (Middelberg, 2002).  Centrifugation or 
microfiltration can then be used after addition, although centrifugation results in a 
higher protein purity (Clark, 2001).   
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1.1.6.4 Solubilisation and denaturation 
Inclusion bodies are generally soluble in high concentrations of chaotrophic solvents at 
a concentration of 6-8 M to give a protein concentration of 1-10 mg.ml
-1
 (Clark, 2001).  
This can sometimes be difficult at a larger scale if the moisture content of the inclusion 
body paste is high, leading to a lower effective concentration of your chaotroph 
(Buswell et al., 2002).  Another component of the solubilisation buffer is a reducing 
agent such as DTT or β-mercaptoethanol, which maintains the cysteine residues in a 
reduced state thus preventing non-native disulphide bond formation.  It has also been 
shown to improve the solubilisation yield. Chelating agents such as EDTA are often 
used to prevent metal-catalysed air oxidation of cysteine residues (Panda, 2003).  In 
order to make this step efficient and economically viable, the minimum concentration of 
denaturant required to solubilise the protein, allowing it to recover its full activity in the 
following step, must be determined.  Alternative methods to solubilise inclusion bodies 
such as extremes of pH and detergents are also available.  However, the use of extreme 
pH may not be applicable for most pharmaceutical protein as prolonged exposure can 
lead to irreversible chemical modifications.  Detergents such as sodium dodecyl 
sulphate (SDS) can be used, but the main drawback is that the detergent may interfere 
with downstream chromatographic steps (Clark, 2001). 
 
Figure 1.6  Methods for solubilization and renaturation, taken from Clark, (2001) 
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1.1.6.5 Refolding 
The refolding step involves renaturation of the solubilised recombinant proteins.  This is 
achieved by the removal or dilution of the denaturing agent, producing a chemical 
environment that favours folding (Buswell et al., 2002).  The buffer must also contain 
reducing and oxidising agents to aid disulphide bond shuffling.  The oxidising agent is 
required for the formation of disulphide bonds and can be achieved by air oxidation, or 
the addition of a mixture of reduced and oxidised thiol species.  The most commonly 
used thiol reagents are reduced/oxidised glutathione (GSH/GSSH), DTT/GSSH, 
cysteine/cystine and cysteamine/cystamine to give a total concentration of between 5 
and 15mM and a ratio of reduced to oxidised species of 1:1 to 5:1 (Panda, 2003).  The 
use of these reagents improves the solubility of the protein during refolding and reduces 
the formation of incorrect disulphides bonds as the protein can undergo disulphide bond 
shuffling.  Low molecular weight additives can also be added to reduce aggregation and 
improve yields such as acetone, urea, detergents, sugars, short-chain alcohols and PEG.  
The most commonly used additives are L-arginine, low concentrations of urea or 
guanidine hydrochloride and detergents.  The mechanism of how arginine reduces 
aggregation is not precisely understood, but it is thought that its guanidino structure aids 
the solubilisation of the folding intermediates without destabilizing them. 
1.1.6.5.1 Refolding techniques 
The refolding of denatured inclusion bodies to form soluble bioactive product is a major 
hurdle in the production of inclusion body derived therapeutic proteins (De Bernardez 
Clark et al., 1998; Buswell and Middelberg, 2003).  The yields from dilution refolding 
are often low due to protein misfolding and aggregation of partially folded 
intermediates (Goldberg et al., 1991; Buswell and Middelberg, 2002).  Refolding 
follows first order kinetics, whereas aggregation follows second or higher order 
kinetics.  This results in competing kinetic reactions and, consequently, at high initial 
protein concentrations the rate of aggregation is higher than the rate of folding.  
Therefore protein refolding is favoured at a lower denatured protein concentration 
(Kiefhaber et al., 1991).  Low protein concentrations of 10-100 µg.ml
-1
 are typically 
used to minimise aggregation ((Rudolph and Lilie, 1996; Buswell and Middelberg, 
2002).  However they require large mixing vessels, high volumes of refolding buffer 
and a subsequent ultrafiltration step to concentrate the final protein solution for 
downstream processing (Panda, 2003; Vallejo and Rinas, 2004).  Disulphide bond 
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formation is the rate-limiting step in refolding as non-native disulphide bonds must be 
continuously broken by re-oxidation to allow the correct pairings to form.  This 
disulphide bond shuffling can be achieved by controlled air oxidation, or using redox 
shuffling systems such as mixed disulphides (Fischer et al., 1993).  Air oxidation is 
simple and inexpensive, but is typically characterised by low refolding rates and yields 
(Rudolph and Lilie, 1996).  It is less favoured in industry as it does not allow precise 
control of the process (Fischer et al., 1993).  Air oxidation is usually achieved by 
aeration or static exposure of the vessel to air or oxygen.  The dissolved oxygen can 
then oxidise the reduced thiol compound forming a disulphide bond, leading to the 
creation of a redox pair that causes disulphide-bond shuffling.  This system is limited by 
the slow mass transfer rate of oxygen and increasing agitation rates to overcome this can 
result in increased shear and interfacial stress which may lead to aggregation (Clark, 
2001).  Redox shuffling systems, while more expensive, often result in higher rates and 
yields by accelerating the rate of shuffling (De Bernardez Clark 1998, Hevehan De 
Bernardez Clark 1997).  Typically they consist of low molecular weight thiols in both 
reduced and oxidised forms, with reduced thiol at around 1-3 mM and a reduced to 
oxidised thiol ratio between 5:1 and 10:1 (Rudolph and Lilie, 1996).   
 
There are three main methods for refolding: 
1. Dilution 
This involves diluting the solubilised protein directly into a renaturation buffer.  
Dilution refolding is extensively used in industry due to its simplicity.  The 
disadvantage of this method is that it is time consuming and requires large buffer 
volumes.  Therefore it is less than optimal at a large scale as an added concentration 
step will be needed afterwards and, in comparison to other methods, the yield of native 
protein is lower (Li et al., 2004).  Since the overall cost of the process usually increases 
with the use of more sophisticated equipment, simple dilution refolding can be 
economic as it only requires a stirred tank vessel (Buswell et al., 2002).  In order for the 
dilution refolding to be successful, the rate of denatured protein to the renaturation 
buffer must be controlled and good mixing provided to maintain a low protein 
concentration and prevent aggregation (Clark, 2001).  A variation of this method is 
represented by “pulse renaturation”, where aliquots of denatured protein are added to 
buffer in a step-wise fashion, or semi continuously in fed-batch mode.  This can result 
in yields 10% higher (Katoh and Katoh, 2000).  This method was chosen for further 
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study in this thesis as it is the preferred method in industry, the most common method in 
literature (Buckle et al., 2005) and the method can be achieved at the microscale (see 
Section 1.1.7.3). 
 
2. Solvent exchange by dialysis, diafiltration or size exclusion chromatography. 
Dialysis and diafiltration can be performed using an ultrafiltration membrane to reduce 
the denaturant concentration of the solubilised inclusion bodies to a low concentration, 
causing the protein to spontaneously fold.  However, renaturation yields can be affected 
by protein binding to the membrane (fouling), which also reduces the lifetime of the 
membrane (Li et al., 2004).  This effect can be minimized by using highly hydrophilic 
membranes that reduce binding, such as cellulose acetate.  Unfolded protein can also be 
lost in significant amounts through transmission across the membrane.  This can be 
overcome by dialysing against a lower concentration of denaturing buffer, so that the 
protein forms a molten-globule state or native configuration (Clark, 2001).  Size-
exclusion chromatography (SEC) is another buffer-exchanging method that aims to 
inhibit aggregation by restricting diffusion of partially folded intermediates.  A method 
comparison study conducted by Fahey et al., (2000) showed SEC results in higher 
yields when the dilution factor is below 40.  Conversely, a study by Werner et al., 
(1994) using lysozyme showed that SEC offered no advantage over traditional dilution 
in terms of yield.  SEC method does, however, offer advantages in terms of purification 
because the material leaving the column is fractionated by size and hence the protein is 
free from contaminants and aggregates.  The disadvantages of SEC are that the yield of 
folded protein decreases with higher protein concentrations, higher sample volumes and 
lower flow rates.  Problems can occur with sample application, as the sudden change in 
conditions leads to a rapid structural collapse which can cause aggregation.  However 
this can be overcome by adding the protein under denaturing conditions and flowing 
renaturation buffer through the column (Clark, 2001).  The application of these buffer 
exchanging methods in the microscale format are more complex than simple dilution 
refolding, however some work has already addressed the use of microfiltration for 
inclusion body refolding (Davies, R., 2009). 
 
3.  Reversible adsorption onto a solid support. 
This method involves binding the denatured protein transiently to a solid support.  This 
minimizes intermolecular interactions that lead to aggregation by isolating the 
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molecules spatially and preventing the partially folded intermediates from diffusing and 
aggregating (Li et al., 2004).  In order to allow the structure further freedom for folding, 
a fusion partner can be added such as a His-tag or cellulose binding domain, which is 
able to bind at denaturing conditions.  The protein can then be purified by washing the 
bound protein before eluting (Clark, 2001).  However a commercially viable refolding 
step involves minimising the number of steps and reducing the cost (and amounts) of 
chemicals required (Li et al., 2004) and consequently dilution refolding fulfils these 
criteria better.  Further work is required to fine tune the on-column refolding process for 
industrial applications (Jungbauer et al., 2004).  
1.1.7  Microscale Bioprocessing Techniques 
The cost of bringing a drug to the market is currently estimated to be between $500 and 
$2000 million (depending on the therapy and developing firm), with an average cost of 
$868 million (Adams and Brantner, 2006) .  The time needed to develop a drug from the 
discovery stage to its release on the market is on average 10 years (Dickson and 
Gagnon, 2004).  Before clinical trials, the final manufacturing process has to be 
determined due to regulatory requirements.  Therefore techniques aiming to increase the 
speed at which drugs are delivered to the market are really desirable at bioprocess 
development stage.  Decreasing the time and cost required to develop a robust 
manufacturing process would have clear advantages.  For a blockbuster drug, every day 
lost on the market represents a loss of sales of $4-5 million (Frantz, 2004).  
 
The microscale approach involves the study of unit operations at the microlitre scale 
(20-2000 μl) using microwell or microfluidic formats (Micheletti and Lye, 2006).  This 
methodology can be used to predict the performance of individual bioprocess unit 
operations at larger scale.  It offers a potential solution to lengthy development 
timelines, providing the means to investigate operating variables with small quantities 
of material early on in process development.  The process conditions can then be 
optimised to develop a robust manufacturing process with a lower cost of goods.  
Miniaturization has already been successful for increasing productivity during early 
drug discovery, increasing throughput and allowing parallel experimentation, whilst 
decreasing processing time, reagent volumes and waste (Kapur et al., 1999; Sundberg, 
2000).  Miniaturization is being increasingly applied to bioprocess development 
activities such as microbial fermentation (Duetz et al., 2000; Elmahdi et al., 2003; 
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Duetz, 2007), mammalian cell culture (Micheletti et al., 2006), biocatalysis (Lye et al., 
2003; Ferreira-Torres et al., 2005; Baboo et al., 2012), ultra scale down (USD) 
centrifugation (Tustian et al., 2007), microfiltration (Jackson et al., 2006; Rayat, 2011), 
cell lysis (Wenger et al., 2008), protein refolding (Vincentelli et al., 2004; Dechavanne 
et al., 2011) and chromatography (Wenger et al., 2007).  Ultimately, linking different 
microscale unit operation could lead to the creation of a whole bioprocess to study the 
complex interactions between process variables and operating conditions. 
  
The microwell format is readily compatible with automation, improving efficiency and 
throughput further (Major, 1998).  This allows automated mixing, addition and removal 
of liquids (liquid handling), as well as robotic arm movements, which transport each 
plate between different devices and analytical equipment such as plate readers and 
HPLC systems.  Automation offers the advantages of liquid handling precision and 
accuracy, enhancing reproducibility between experiments due to improved consistency.  
It also allows walk away and 24 hour operation, resulting in higher workloads, thus 
boosting productivity.  However these higher workloads result in a large number of 
samples requiring analysis by techniques such as HPLC, and consequently fast analytics 
need to be developed in tandem to enable the high throughput study of conditions. 
1.1.7.1 Scale-up 
It is important that studies performed at the microscale translate to the larger scales of 
operation at which industrial manufacture occurs for the majority of biotherapeutics.  
Therefore results gained at the microscale need to be scaled up, and offer either insight 
into scaling issues or act as direct mimics of the large scale.  The characterisation of 
microwell systems in terms of oxygen transfer (Hermann et al., 2003; Doig et al., 
2005a; Puskeiler et al., 2005),  mixing times (Nealon et al., 2006; Tissot et al., 2010) 
and engineering environment (Zhang et al., 2008) aids this objective by providing 
fundamental characteristics that can be matched at the large scale, allowing direct scale-
up of results.  This is particularly important for microwell fermentation studies, where 
sufficient dissolved oxygen is required to meeting the oxygen demands of aerobically 
growing microbial cells and oxygen limited conditions would give suboptimal results.  
For this reason, the volumetric mass transfer coefficient is often chosen as an 
appropriate scaling parameter for aerobic fermentations (Ferreira-Torres et al., 2005; 
Micheletti et al., 2006; Islam et al., 2008).   
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1.1.7.2 Cell lysis at microscale using Adaptive focused acoustics 
(AFA) 
At the industrial scale, high pressure homogenisation is used to lyse E. coli cells with 
multiple passes at a high pressure (Balasundaram et al., 2009).  Bench-top equivalents 
exist for laboratory scale experiments with volume requirements of 10-100 ml.  When 
the volumes involved are less than 10 ml, sonication or chemical lysis are used, but they 
are not representative of the large scale due to the different contamination profiles 
resulting from the reduced efficiency of cell rupture (Wenger et al., 2008).  A new 
technology has been developed for small volumes of 50 μl to several 100 μls using 
adaptive focused acoustics (AFA), which allows the automated treatment of multiple 
samples.  It operates at a higher frequency range than a conventional sonicator (Figure 
1.7), resulting in shorter wavelengths than can be more easily scaled down to small 
volumes (Wenger et al., 2008).  The high frequency of the burst of ultrasonic acoustic 
energy results in a wavelength of a few millimetres that can be focused on a discrete 
zone in a sample vial immersed in a water bath.   
 
Figure 1.7  Operating frequency of the adaptive focused acoustics of the Covaris device compared to a 
sonicator.   
 
It also has an isothermal advantage when compared to sonication as the operating 
wavelength is similar to the path length of the treatment vessel.  This results in less 
scattering of the acoustic energy field, so samples are not heated to the same high 
temperatures as in sonication and there is a better efficiency of cell breakage.  The 
acoustic energy field can be transmitted across the liquid contained in the chilled water 
bath, and the plastic or glass of the vessel being treated (Figure 1.8).  The mechanism of 
lysis is thought to be similar to the ultrasonic cavitations seen in sonication, where 
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expanding and collapsing bubbles result in a shock wave which cause viscous 
dissipative eddies resulting in shear stress (Davies, 1959; Clarke, 1970; Doulah, 1977).  
The release of product and other soluble proteins has been shown to be the same as 
high-pressure homogenisation for Saccharomyces cerevisiae cells expressing 
recombinant human papillomavirus (HPV) virus-like particles (VLPs) (Wenger et al. 
2008).  Additionally the process is controlled by a computer and capable of processing 
multiple samples in parallel, making it highly compatible with high throughput 
automation and integration within a microscale process sequence. 
 
Transducer
Water Bath
Focal Zone
Sample vial
 
Figure 1.8  The adaptive focusing acoustic (AFA) process.  Bursts of ultrasonic acoustic energy are 
focused on a discrete area in the sample vial, allowing lysis without contact and less sample heating.  The 
process is controlled by a computer which allows the duty cycle, intensity and duration of these bursts to 
be programmed and the automated treatment of multiple samples sequentially.  
1.1.7.3 Microscale Refolding 
The optimal conditions for refolding have to be determined for every new inclusion 
body product due to the absence of a universal refolding buffer.  This requires the 
empirical investigation of multiple parameters, which is both time consuming and 
resource intensive.  Protein refolding is largely scale-invariant, therefore the microwell 
plate format can be used for the rapid and meaningful screening of many process 
conditions (Middelberg, 2002).  A microscale approach enables rapid optimization early 
on in process development by using low quantities of often expensive material and 
allows multiple conditions to be tested in parallel.  In addition, the integration of 
microscale approaches with robotic platforms allows high throughput studies.  The 
microwell format has been successfully utilised for the high-throughput screening of 
protein refolding reagents in the microwell format by several authors (Vincentelli et al., 
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2004; Willis et al., 2005; Mannall et al., 2009; Dechavanne et al., 2011).  This approach 
has been combined with fractional factorial and other Design of Experiment (DoE) 
approaches, and has been reported to efficiently screen many combinations of additives 
to optimise refolding yields (Williams et al., 1982; Mannall et al., 2009; Dechavanne et 
al., 2011).   
1.1.8 Analytical methods 
In order to study different stages of the inclusion body process, techniques are required 
that can assess the effectiveness of different methods of cell lysis and the release of 
inclusion bodies.  Additionally a generic method is required able to analyse refolds in a 
way compatible with high throughput microscale methodology.  
1.1.8.1 Laser diffraction  
Laser diffraction particle size analysers can be used to measure particle size distribution.  
They benefit from high speeds, good reliability, high reproducibility, they cover a wide 
particle size range and require small sample volumes (Ma et al., 2000; Storti and 
Balsamo, 2010).  They provide an indirect measurement of spherically equivalent 
particles.  The technique is based on the principle that particles diffract light at an angle 
which relates to their size, and as particle size decreases this angle of diffraction 
increases logarithmically (smaller particles diffract light at high angles) (Beuselinck et 
al., 1998). 
1.1.8.2 Intrinsic Fluorescence 
Proteins have intrinsic fluorophores resulting from aromatic amino acid side chains, 
generally tryptophan and tyrosine residues.  The polarity of the environment the 
tryptophan residue is experiencing affects the emission wavelength, providing 
information on the conformational changes of the protein (Renard et al., 1998).  Hence 
fluorescence if often used to monitor protein folding (Pace and Laurents, 1989; 
Vidugiris et al., 1995; Chiti et al., 1999). 
1.1.8.3 Flow cytometry 
During cell lysis, inclusion bodies must be completely released so they can be harvested 
using centrifugation to exploit the density difference between the inclusion bodies and 
cell debris.  In order to improve downstream recovery productivity, a technique is 
required that can be used to distinguish inclusion bodies from intact cells to monitor the 
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efficiency of release.  The number of techniques available to measure cell rupture is 
scarce.  Phase contract microscopy is used as standard, but it is time consuming and 
subject to large errors. Flow cytometry methods have been developed for monitoring 
bacterial cell viability using a variety of dyes.  These methods rely on a dye which 
targets DNA to distinguish between live and ruptured cells, but all dyes have varying 
degrees of membrane permeability.  Recently a newer dye, SYTOX Green, has been 
developed which is impermeable to cells and consequently only binds nucleic acid with 
a high affinity when cells have been ruptured (Millard et al., 1995; Roth et al., 1997; 
Lebaron et al., 1998).  It has recently been explored as a technique for studying 
inclusion body release as well as bacterial lysis, and allows resolution of the IB granules 
form cell debris and whole cells (Medwid et al., 2007).  This enables cell rupture to be 
followed, in this example during different passes of homogenisation, and potentially 
allows the quantification of IBs during fermentation.  Wållberg et al. (2005) used multi-
parameter flow cytometry to quantify the production of promegapoietin (PMP) IBs 
during fermentation, which were labelled with primary and secondary fluorescent 
antibodies.  This allowed them to follow the accumulation of protein during the 
fermentation and the heterogeneity in the population of cells producing inclusion 
bodies.  
1.1.8.4 Summary 
In conclusion, devices on the market exist which could be integrated with the sequence 
to determine particle size and hence gain process information.  The intrinsic 
fluorescence techniques described in literature could also be applied on top of an 
automated platform to determine the folding environment at high throughput.  These 
techniques will be studied and further developed in this work. 
1.1.9 Proteins studied 
1.1.9.1 Lysozyme  
Hen egg white lysozyme (HEWL) is one of the best characterized and most studied 
biological macromolecule (Matagne et al., 1997) and therefore is an ideal model system 
for refolding studies.   
1.1.9.1.1 Structure 
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HEWL is a small protein of 129 amino acids, with a molecular weight (Mr) of 14305.  It 
consists of two main structural domains: 
1. Four α-helices and a C-terminal 310 helix (α-domain) 
2. A triple-stranded antiparallel β-sheet, a 310 helix and a long loop (β-domain) 
These are linked by a short double-stranded antiparallel β-sheet and four disulphide 
bonds, as illustrated in Figure 1.9. 
Figure 1.9  Schematic view of hen egg white lysozyme.  The α-domain is shown in red and the β-domain 
in blue).  Taken from (Radford et al., 1992b) 
1.1.9.1.2 Folding 
The earliest detectable event in lysozyme folding, less than 1 ms, is the formation of an 
extensive fluctuating secondary structure and a substantial degree of hydrophobic 
collapse, where the hydrophobic residues are buried in the centre of the structure 
(Wildegger and Kiefhaber, 1997).  Far UV experiments show that a substantial area of 
native secondary structure is formed within a few milliseconds (Matagne and Dobson, 
1998).  “Dead-time” labelling reveals the presence of embryonic native-like structure in 
α-domain forms at a very early stage in folding.  Different kinetic pathways (fast or 
slow) can be taken after the initial events of secondary structure formation and 
hydrophobic collapse, as the collapsed states are highly heterogeneous (Matagne and 
Dobson, 1998).  Secondary structure develops independently in the two distinct 
structural domains to form intermediates.  The slow and fast pathways of folding are 
illustrated in the schematic of the energy surface for lysozyme folding shown in Figure 
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1.10.  This is based on simulations performed using a simple lattice model to describe 
folding and is consistent with experimental data currently available (Dobson et al., 
1998).   
Figure 1.10  Schematic of an averaged effective energy surface based on experimental results for 
lysozyme refolding.  P is related to the configurational entropy of the system (the extent of accessible 
space available to the molecule), E is the averaged effective energy and Q is a progress variable 
corresponding to the number of native contacts.  Three different possible trajectories are illustrated with 
coloured arrows.  Yellow- the fast folding pathway, green- a slow folding pathway that must overcome a 
high energy barrier, and red- a slow folding pathway that must return to a less folded state before 
proceeding along the valley corresponding to the fast folding pathway. Taken from Dobson et al., (1998). 
1.1.9.1.2.1 Fast track of lysozyme folding 
Approximately 25% of molecules fold along the fast track.  The polypeptide has been 
observed to form native-like structure in a time constant of approximately 10 ms, 
normally seen for the folding rate of small, single-domain protein, which has a 2 state 
folding process and has no detectable intermediates (Kiefhaber, 1995; Radford and 
Dobson, 1995; Matagne et al., 1997).  The pathway has been proposed to occur via an 
intermediate with extensive native-like structure in both α and β-domains, as hydrogen-
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exchange protection occurs fast for both domains (shown as the minimum on the left-
hand side of Figure 1.10) (Matagne and Dobson, 1998).  However this intermediate is 
not entirely native as it lacks the ability to bind a competitive inhibitor of the enzyme 
and hence the active site cleft has not yet formed.  Following the formation of the 
intermediate is the rate-limiting step.  The two partly folded structural domains then 
need to coalesce, overcoming an energy barrier, in order for the native state to be 
formed (Matagne and Dobson, 1998). 
1.1.9.1.2.2 Slow track of lysozyme refolding 
The remaining 75% of molecules fold via the slow track, of which 15% fold very 
slowly with time constant in the range of 20 s.  This could be due to limitations caused 
by the cis-trans isomerisation of one or both proline containing peptides bonds.  
Hydrogen exchange labelling studies (Miranker et al., 1991; Radford et al., 1992b) 
show that the majority of the remaining molecules gain extensive hydrogen-exchange 
protection in the α-domain.  This indicates an intermediate is formed with a structured 
alpha domain, but an unstable β-domain where the amides present become protected at 
a slower rate in a rate-limiting reaction (time constant ≈ 350 ms) (Matagne and Dobson, 
1998).  This partially folded state then has two pathways available.  The structure can 
either overcome a high energy barrier (the rate-limiting step) to achieve the native state 
by a process of rearrangement, or alternatively, it can unfold and fold via the fast 
pathway  (Matagne and Dobson, 1998).   
1.1.9.2 Dihydrofolate reductase  
Dihydrofolate reductase (DHFR) is a small, monomeric protein which catalyses the 
reduction of dihydrofolate to tetrahydrofolate by NADPH (Buchwalder et al., 1992).  
The kinetics of this reaction have been well described previously (Thillet et al., 1990).  
Tetrahydrofolate is an essential cofactor for the synthesis of several amino acids, 
purines and thymidylate.  DHFR also binds several synthetic antifolate drugs very 
strongly and is therefore the target for drugs such as methotrexate (a cancer drug used to 
kill tumour cells) and trimethoprim (an antibacterial drug) (Thillet et al., 1990).   
1.1.9.2.1 Structure 
DHFR has a highly conserved structure between vertebrates with a sequence homology 
of 89 % between mouse and human (Stammers et al., 1987).  The murine DHFR 
(mDHFR) used in this work has a molecular weight of 21,446 (Clark et al., 1996) and is 
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186 residues in length (Uversky et al., 1996).  A high resolution crystal structure for 
mDHFR has been reported by Stammers et al., (1987).  The active site occupies a large 
surface area of the structure due to the large nature of aromatic moieties of its ligands.  
The binding of one ligand greatly increases the affinity for the other by several thousand 
fold, due to ligand induced conformation changes in loops distant from the active site 
(Buchwalder et al., 1992).  The binding of ligands to a mutated DHFR has been shown 
to convert the structure from a molten globule state to a native-like state with functional 
activity (Uversky et al., 1996). 
1.1.9.2.2 Folding  
The folding of E. coli derived DHFR is thought to proceed through a two state transition 
and kinetic studies have shown the presence of several transient intermediates during 
folding (Clark et al., 1996).  Although the sequence homology is lower between 
eukaryotes and prokaryotes, crystal structures E. coli and human DHFR have shown the 
native confirmation has been evolutionary conserved (Bolin et al., 1982; Davies et al., 
1990) and hence folding mechanisms may also be similar for mDHFR.   
1.1.9.3  Insulin lispro 
Insulin (Humulin
®
) was the first recombinant product to gain market approval in 1982.  
The hunt for an insulin analogue with improved therapeutic properties led to the release 
of Insulin Lispro (Humalog
®
) (Walsh and Murphy, 1999).   
1.1.9.3.1 Structure 
Insulin is a small globular protein composed of an A-chain (21 residues) and B-chain 
(30 residues), with three disulphide bonds (two interchain, A7-B7, A20-B19 and one 
intrachain A6-A11).  The structure of Insulin Lispro is very similar to the native form of 
insulin, but the Pro-Lys amino acid residues are reversed at position B28 and B29.  This 
modification results in a faster acting insulin, with a shorter duration of action and an 
equal ability to lower glucose levels compared to normal insulin.  It also shows 
improvements in terms of better postprandial glucose control.   
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Figure 1.11  The structure of human proinsulin, taken from Heath et al., (1992)  
Figure 1.12  The structure of insulin lispro, taken from prescribing information for Humalog® available 
online (http://pi.lilly.com/us/humalog-pen-pi.pdf) 
1.1.9.3.2 Folding 
The A-chain and B-chain contain all the information needed to form the native 
structure.  The 3D structure of insulin shows it is mostly composed of three α-helical 
segments stabilised by the disulphide bonds.  Deletion of any these disulphide bonds 
leads to unfolding, however the A20-B19 disulphide bond appears to be the most 
important (Yan et al., 2009).   In vitro refolding of porcine insulin precursor (PIP) 
showed that the A6-A11 and A20-B19 disulphides form quickly.  The formation of A6-
A11 does not result in a more ordered structure (Qiao et al., 2001) and consequently 
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probably develops as a result from the proximity of these two cysteine residues in the 
polypeptide sequence (Hua et al., 2001).  The A20 and B19 residues are distant in 
sequence and hence must result from the structure becoming more ordered.  Yan et al., 
(2009) proposed that long range interactions of some side chains result in the 
polypeptide chain forming a transient unstable partially folded conformation where A20 
and B19 are in close proximity, as shown in Figure 1.13.  This results in the formation 
of a disulphide bond which stabilises the partially folded structure and is the critical step 
in order to allow further refolding. 
Figure 1.13  A schematic showing the early refolding stages of porcine insulin precursor (PIP), taken 
from (Yan et al., 2009)  
1.1.9.3.3 Manufacture 
Insulin lispro is produced from fermentation in E. coli of a precursor molecule with a 
short amino acid sequence.  This sequence is removed enzymatically to give proinsulin 
(Mr = 9390 Da (Heath et al., 1992)), which is then hydrolysed with trypsin and 
carboxypeptidase B to yield insulin lispro.  This then undergoes purification by 
chromatography and is crystallised with zinc and phenol.  The final product is typically 
formulated with M-cresol, zinc oxide, glycerol and a phosphate based buffer (Walsh, 
2004).   
1.1.9.4 Summary 
Lysozyme was selected for study as it is well characterised and often used as a model 
protein for the study of folding.  Therefore it could act as a model system for refold 
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assay development.  DHFR was chosen as previous work has been performed on its 
large scale production and refolding at the microscale, but there is a lack of published 
work regarding the impact of fermentation conditions on IB quality and refold yield.  
Therefore it provides an ideal protein for challenging the developed assays with IB 
material.   Insulin was studied as a more industrially relevant therapeutic protein and 
because of a lack of work investigating its refolding at the microscale and the effect of 
fermentation conditions on the IBs produced.   
1.2 Main conclusions of the literature survey 
Inclusion bodies are commonly formed in E. coli as a result of the high synthesis rates, 
overwhelming cellular folding machinery and altering the equilibrium between folding 
and aggregation.   Other contributing factors include the cellular stress brought on by 
heterologous protein expression and the differences in the folding environment from a 
eukaryotic cell.  Fermentation conditions influence whether the protein product is 
expressed solubly or as an inactive aggregated inclusion body.  However, little work has 
investigated the link between fermentation conditions and IB quality or refolding yield.  
The high concentration and purity of the protein formed in IBs can be advantageous for 
the production of therapeutic proteins, and their physical properties can be exploited in 
industrial processes.  However, for an economic process the efficiency of the refold step 
must be improved to maximise yield of soluble active product.  Dilution refolding is the 
most commonly used step for renaturation of protein in industry, where dilution of the 
denaturant in refold buffer causes spontaneous refolding of the protein.  Previous work 
has shown the yield is dependent on a range of factors such as protein concentration, 
final denaturant concentration, redox ratios and additives.  Optimising the refolding 
condition requires considerable effort during process development and is therefore a 
prime target for microscale processing to investigate important parameters.   
1.3 Thesis aims and outline  
The overall aim of this thesis was to establish a whole bioprocess to investigate the 
effect of upstream fermentation conditions on the final yield of active product from 
refolding.  This is based on the hypothesis that protein refolding can be performed and 
optimised at a microlitre scale and once established, can rapidly evaluate the impact of 
earlier bioreactor stages on whole bioprocess performance.  The equipment, materials 
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and methods used are detailed in Chapter 2.  The overall thesis aim required the 
following objectives to be achieved: 
 
1)  Develop an automated microwell dilution refolding system and demonstrate its 
suitability for investigating multiple refold variables.  In order to analyse the 
yield obtained in a 96-well microtitre plate, high throughput automated assays 
are required that can be generically applied to model systems as well as material 
from an industrially relevant strain.  This is demonstrated in Chapter 3. 
 
2) Extend the automated microscale refold operation with analytics to form an 
automated whole bioprocess at the microscale, encompassing fermentation, cell 
harvest by centrifugation, cell resuspension, lysis using AFA, IB harvest by 
centrifugation, IB solubilisation.  This allows the generation of E. coli 
fermentation broths under different fermentation conditions, which can then 
undergo processing in parallel to investigate the effect of process parameters on 
inclusion bodies.  This is detailed in Chapter 4.   
 
3) Adopt a whole bioprocess approach to optimisation and utilise the whole 
bioprocess sequence to investigate the effect of upstream fermentation 
conditions on downstream refolding yields and product quality.  This will allow 
optimisation of the fermentation process to maximise inclusion body refolding 
yield, rather than the typical approach to maximise fermentation product titre.  
The whole bioprocess was then applied to an industrially relevant strain 
provided by Fujifilm Diosynth Biotechnologies.  The results obtained are 
presented in Chapter 5. 
 
4) The final objective of the thesis was to validate the dilution refolding system by 
comparing refold yields to larger scales of operation for the industrially relevant 
strain.  The fermentation results and those obtained using the sequence as a 
whole were compared to pilot scale results for an industrially relevant protein to 
demonstrate the suitability for the microscale process as a tool for optimising 
yield during process development.  Chapter 6 presents the scale-up studies 
carried out with insulin. 
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5) The final chapter, Chapter 7, summarises the main findings and 
recommendations for future work. 
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2 Materials and Methods 
2.1 Lysozyme 
2.1.1 Materials and Equipment 
Hen egg white lysozyme lyophilized powder (HEWL) was obtained from Sigma-
Aldrich Ltd (Poole, Dorset, UK), at 50,000 units/mg protein and dialysed (10,000 MCW 
Snakeskin, Perbio Science UK Ltd, Cramlington, Northumberland, UK), DTT 
(Fermentas, York, UK).  All other chemicals used in this experimental section were 
purchased from Sigma-Aldrich Company Limited (Poole, Dorset, UK).  Refolds were 
conducted in UV-transparent 96 standard round well (SRW) microplates (“UV-star”, 
Grenier Bio-One, Gloucestershire, UK) unless stated otherwise. 
2.1.1.1 Equipment for manual refolds 
For manual experiments, some pipetting operations were performed using the plate 
reader (FLUOstar, BMG LABTECH, Ortenberg, Germany) to add liquid by direct 
injection into the microplate.  Absorbance and fluorescence measurements for these 
experiments were also performed using the same plate reader. 
2.1.1.2 Robotic platform equipment for automated refolds 
For the automated experiments, all refold plate preparations were fully automated using 
a robotic platform (TECAN Freedom EVO
®
, Reading, UK).  Shaking was achieved on 
a thermomixer orbital shaker platform (Eppendorf UK Limited, Cambridge, UK).  For 
the manual and automated comparison, oxidation and hierarchical experiments the 
absorbance and fluorescence measurements were carried out in a plate reader on the 
platform (TECAN Infinite 2000, Reading, UK). 
2.1.2 Denaturation and Refolding 
Refolds were conducted in triplicate, with standards and controls present in duplicate or 
triplicate.  Standards were prepared by dissolving lyophilised HEWL into aliquots of 
refold buffer to give the correct final protein concentration, whereas controls were 
buffer only.  Refolding was initiated by the addition of refold buffer to denatured 
protein, with the exception of experiments performed in the FLUOstar microplate reader 
where denatured protein was added to buffer containing wells.  Refolds were mixed 
after additions by pipette aspiration for at least 3 cycles. 
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2.1.2.1 Selection of wavelengths for aggregation detection and 
solubility   
HEWL was dissolved in a denaturing solution of 6M guanidine hydrochloride 
(GdnHCl) and 25mM dithiothreitol (DTT) to give a concentration of 10 mg.ml
-1
.  The 
solution was then vortexed for 1 minute and incubated for two hours at room 
temperature.  Buffers were prepared with different excipients as shown in Table 2.1 and 
were incubated for 1 hour to equilibrate before use.  Standards were prepared by 
dissolving lyophilised HEWL into aliquots of the buffers in Table 2.1.  A volume of 300 
μl of standard and control (buffer only) solutions were added to different wells in a 
microwell plate format. A volume of 280 μl of buffer was added to different wells for 
the refold, and the microwell plate was placed in the microplate reader.  A volume of 20 
μl of denatured protein solution was then added to the wells containing 280 μl in order 
for refolding to take place. 
 
Table 2.1  Lysozyme refold buffers 
 
 Buffer components 
1 25 mM cysteine, 1 mM EDTA and 0.1 M Tris-HCl pH 8.2.   
2 L-arginine 0.14 M, 25 mM cysteine, 1 mM EDTA and 0.1 M Tris-HCl pH 8.2.   
3 Sucrose 0.20 M, 25 mM cysteine, 1 mM EDTA and 0.1 M Tris-HCl pH 8.2.   
2.1.2.2 Absorbance changes during refolding 
2.1.2.2.1 Quantifying aggregation  
Sample preparation was as in Section 2.1.2.1.  Two plates were prepared identically 
with 15 µl of denatured protein and 285 µl of Buffer 1 (Table 2.1).  Two refold 
conditions were tested,  half of the refolds (18 repeats per plate) and standards (6 repeats 
per plate) with a high DTT (25 mM) concentration during denaturation, whereas the 
other half had low DTT (0.625 mM) concentration.  One plate was placed in the plate 
reader and the other plate was left on the bench at room temperature.  At the time points 
(0, 50 and 100 min), the contents of three of the wells on the corresponding bench 
microplate were pipetted into eppendorfs and centrifuged (13000 rpm, 5 min).  This was 
repeated for both DTT concentrations. 
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2.1.2.2.2 Inducing aggregation to monitor formation over time 
Denatured HEWL was prepared as described in 2.1.2.3 but at two different protein 
concentrations and 4 different DTT concentrations in order to give the refold conditions 
shown in Table 2.2.  Plates were prepared as in Section 2.1.2.3.    
 
Table 2.2 Denatured protein and refold buffer conditions 
 
[Protein] 
(mg.ml
-
1
) 
[DTT] 
(mM) 
Redox pair Redox 
potential 
Buffer components [Final 
Protein] 
(mg.ml
-
1)
 
7.5 25 Cysteine:cystine Balanced 5 mM cystine, 10 mM 
cysteine, 50 mM Tris 
0.5 
7.5 25 Cysteine:cystine Oxidising 10 mM cystine, 50 mM Tris 0.5 
15 32 DTT:cystamine Balanced 4 mM cystamine, 50 mM 
Tris 
1 
15 6 DTT:cystamine Oxidising 4 mM cystamine, 50 mM 
Tris 
1 
15 62 DTT:cystamine Reducing 4 mM cystamine, 50 mM 
Tris 
1 
2.1.2.3 Fluorescence changes during refolding (fluorescence over 
time at different redox ratios) 
HEWL was solubilised in a denaturing buffer of 8M GdnHCl, 50mM Tris.HCl, 6mM 
DTT to give a final concentration of 15 g.l
-1
 and left at room temperature for 2 hours to 
equilibrate.  The excess DTT in the solubilised denatured protein was used to establish 
varying redox ratios in the refold buffer by reducing different portions of the oxidised 
form.  Refolding buffers were prepared as shown in Table 2.3 and equilibrated for 1 
hour. Standards were prepared by adding HEWL to the refold buffers to give a 
concentration of 1 mg.ml
-1
.  Refold buffer was then added to microwells to give a 
volume of 280 μl in each well.  The denatured protein and denaturing buffer (for the 
control wells) were then added via injection in the plate reader of 20 μl to give a 15 fold 
dilution and a final concentration of 1 mg.ml
-1
 in the refold. 
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Table 2.3 Refold buffers and DTT concentration in denatured protein to give different redox potentials 
 
Buffer (redox 
pair) 
[DTT] (mM) Redox potential Components 
DTT:cystamine 32 Balanced 4 mM Cystamine 50 mM Tris 
DTT:cystamine 6 Oxidising  4 mM Cystamine 50 mM Tris 
DTT:cystamine 62 Reducing 4 mM Cystamine 50 mM Tris 
 
2.1.2.4 Example of end point analysis (effect of final lysozyme 
concentration) 
Denatured HEWL was prepared as in Section 2.1.2.1 and a serial dilution was 
performed using denaturing buffer (6M GdnHCl, 25mM DTT) to give a range of 
concentrations.  These were then refolded by adding 15 μl denatured protein to 285 μl 
of refold buffer 2 (Table 2.1) using injection in the BMG plate reader (1:20 dilution).  
Control buffer (0.3M GdnHCl, 25 mM DTT, L-arginine 0.14 M, 25 mM cysteine, 1 
mM EDTA and 0.1 M Tris-HCl pH 8.2)  and standard (1 mg.ml
-1
 in control buffer) 
were prepared as in Section 2.1.2.1, but the standard was then serially diluted in control 
buffer. 
2.1.3 Automated Hierarchy and oxidation experiments 
HEWL was denatured in 8 M guanidine hydrochloride (GdnHCl), 50 mM Tris.HCl, 
pH 7.2, and 6, 26 or 56 mM dithiothreitol (DTT) to a final lysozyme concentration of 15 
mg.ml
-1
, vortexed for 1 minute and incubated for two hours at room temperature.  For 
the oxidation experiments a different set of redox potentials were used, 6 mM DTT was 
used to create a very oxidising condition (ratio of 0.1:1), 32 mM DTT to give a 
balanced condition (redox ratio of 2:1) and 62 mM DTT to give an almost entirely 
reducing condition (redox ratio 1:0.009).  The total concentrations of guanidine and of 
reduced and oxidised cystamine were kept constant.  The final concentration of 
guanidine after a 1:20 dilution was 1.2 M.  In all other experiments, refold buffers were 
prepared with various redox potentials and concentrations of Tris.HCl, pH 7.2, EDTA 
and GdnHCl (Table 2.4).  All buffers were equilibrated for one hour prior to use.  
Standards contained lysozyme prepared in the appropriate final refold conditions, 
equilibrated for two hours before use.  300 μl of native protein standards, denaturing 
buffer and refold buffer controls were each added in triplicates to random wells of a 
microplate, denatured protein was then added (20 or 15 μl) to remaining wells.  
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Refolding was initiated by the addition of 280 l or 285 l refold buffer to the 
denatured protein giving a dilution factor of 15 or 20, respectively. 
 
Experiments to investigate the effect of oxidation were also carried out in SPE 96-Deep 
Square Well (DSW) plates (Sigma-Aldrich, Dorset, UK).  DSW plate format has been 
reported to improve surface aeration and increase air-liquid mass transfer due to the 
baffling action of the square edges (Duetz and Witholt, 2004; Doig et al., 2005b).  
Final volumes of 1 ml were used while maintaining a 20-fold dilution factor.  Two 
identical plates were prepared and tested under shaken and static conditions, 
respectively.  One DSW plate was shaken at 1000 rpm and a 3 mm shaking diameter, 
corresponding to an estimated gas-liquid mass transfer coefficient (kLa) of 0.072 s
-1 
(Micheletti et al., 2006). 
 
Table 2.4  Refold buffers used for lysozyme 
 
 Buffer components 
1 25 mM cysteine, 1 mM EDTA, 0.1 M Tris.HCl 
2 25 mM cysteine, 1 mM EDTA, 0.1 M Tris.HCl, 0.14M arginine 
3 25 mM cysteine, 1 mM EDTA, 0.1 M Tris.HCl, 0.3M GdnHCl 
4 25 mM cysteine, 1 mM EDTA, 0.1 M Tris.HCl, 0.3M GdnHCl, 0.14M 
arginine 
5 25mM cystamine, 50mM Tris.HCl and 0.717M GdnHCl, 1mM EDTA 
6 4mM cystamine, 50mM Tris.HCl and 0.715M GdnHCl (used in 
oxidation experiment with different [DTT] to create different redox 
potentials) 
7 4mM cystamine, 50mM Tris.HCl and 0.678M GdnHCl 
8 5mM cystine, 10mM cysteine, 50mM Tris.HCl,  0.717M GdnHCl 
(balanced) 
9 2.86mM cystine, 14.29mM cysteine, 50mM Tris.HCl,  0.717M GdnHCl 
(reducing) 
10 10mM cystine, 50mM Tris.HCl,  0.717M GdnHCl (oxidising) 
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2.2 DHFR 
2.2.1 Materials and Equipment 
Dihydrofolate reductase (DHFR) was expressed as inclusion bodies in E. coli XL10-
Gold Kan
r
 pQE40.  All chemicals used in this experimental section were purchased 
from Sigma-Aldrich Company Limited (Poole, Dorset, UK), with the exception of the 
following; NADPH tetrasodium salt from VWR International (Lutterworth, Leicester, 
UK), DTT from Fermentas (Sheriff Hutton, York, UK), Ni-NTA His Bind resin 
(Novagen, Merck), orthophosphoric acid and glycerol from Alfa Aesar (Heysham, 
Lancaster, UK).  Shake flasks were prepared in a laminar flow hood (Herasafe, Heraeus, 
Thermo Scientific) incubated in an incubator shaker (ISF-1-W, Kühner AG, Basel, 
Switzerland).  
2.2.1.1 Large scale Equipment 
Fermentations were conducted in a stainless steel 20 L bioreactor (Applikon 
Biotechnology, Schiedam, Holland) with a top driven impeller.  The impeller has three 
6-bladed Rushton turbine type impellers of diameter 0.75 m.  The bioreactor had 4 
equally spaced baffles, and a working volume of 15 L and an aspect ratio of 3.  
Temperature control was achieved via a vessel jacket, through which either steam or 
cooling water was passed. The dissolved oxygen tension (DOT) was measured using 
DOT probe (Broadley Technologies Ltd., Bedford, UK) that was calibrated with 
nitrogen and air for 0% and 100% respectively. pH was measured by pH probe 
(Broadley Technologies Ltd., Bedford, UK), which was calibrated using standards. The 
DOT and pH probes were sterilised in situ along with the media.  Cell and inclusion 
body harvest was achieved by centrifugation at the pilot scale using the CSA-1 disk 
stack centrifuge (GEA Westfalia Separator Inc, NJ, USA).  Cells were lysed using the 
Manton-Gaulin Lab 60 high pressure homogeniser (APV Baker, Crawley, UK).  
Inclusion body pellets were centrifuged in the Avanti J-E lab-scale centrifuge (Beckman 
Coulter, High Wycombe, UK). 
2.2.1.2 Microscale Equipment 
For the refold experiments in Chapter 3, refold plate preparations were fully automated 
using a robotic platform (TECAN Freedom EVO
®
, Reading, UK).  Shaking was 
achieved on a thermomixer orbital shaker platform (Eppendorf UK Limited, Cambridge, 
UK) and the absorbance and fluorescence measurements were carried out in a plate 
reader on the platform (TECAN Infinite 2000, Reading, UK).   
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For the microscale bioprocess sequence experiments in Chapter 4, experiments were 
performed using an alternative robotic platform (Gemini, Tecan Reading, UK) and a 
different plate reader (GENios, Tecan, Reading, UK), all contained in a laminar flow 
hood (Bigneat Cabinet, Waterlooville, UK).  Incubation during fermentation and 
thermochemical cell lysis was achieved by incubating a 96-DSW on a thermomixer 
(Thermomixer Comfort, Eppendorf AG, Hamburg, Germany). Disposable 
polypropylene troughs (Tecan Reading, UK) Deep square well polypropylene plates 
were used for the microwell fermentations (SPE 96-Deep Square Well collection 
(DSW) plate, Sigma-Aldrich, Dorset, UK).  After fermentation, plates were covered 
with plastic covers (Axymat Silicone sealing mat, Axygen, CA, USA) and centrifuged 
(Rotanta 46 RSC, Hettish Zentrifugen, Germany).  Cell lysis was achieved with 
adaptive focused acoustics AFA in the Covaris E210 (Woburn, MA, US) in either 96-
well round bottom well microplates (96 Well MasterBlock, 1ml, Polypropylene, Greiner 
Bio-one, Gloucestershire, UK) or capped glass vials (13 x 65 mm tube, KBiosciences, 
Hertfordshire, UK).  Thermochemical cell lysis was performed in 96-well, round 
bottom, polypropylene microplate (96 Well MasterBlock, 1ml, Polypropylene, Greiner 
Bio-one, Gloucestershire, UK) incubated on the thermomixer (Thermomixer Comfort, 
Eppendorf AG, Hamburg, Germany). 
 
A) 
Centrifuge
HPLC
Laminar flow 
hood
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B) 
Plate reader
Robotic 
arm
Liquid 
handling 
arm
Hatch for 
centrifuge
Plate 
incubator
                    
C)
Image is the copyright of Tecan, taken from the Gemini User Manual 
Figure 2.1  Photographs showing the external (A), internal view (B) and the software user interface (C) 
of the Tecan platform, demonstrating the containment of the whole bioprocess on one platform (with the 
exception of the AFA device). 
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2.2.2 Large scale process 
2.2.2.1 Inoculum preparation 
The inoculum was prepared in two seed stages, 250 ml shake flask was inoculated with 
1 ml of frozen cell stock, containing Terrific Broth (TB), pH 7.2, ampicillin 100 μg.ml-1, 
kanamycin 30 μg.ml-1 and cultured for 8 hours.  This was then used to inoculate a 2 L 
shake flask with Terrific Broth (TB), pH 7.2, ampicillin 100 μg.ml-1, kanamycin 30 
μg.ml-1 and cultured for 12 hours.   
2.2.2.2 Large scale fermentation and processing 
A 10% inoculum was used to inoculate TB media in a 20 L fermenter. Operating 
conditions were set at 37 ºC, pH 7.2, with an airflow rate of 1 vvm and an initial stirrer 
speed of 400 rpm.  The impeller was set on cascade control with a DOT threshold of 
30%.  Cells were induced during the early exponential phase (approx. at 3.5 hours) with 
a final concentration of 0.125 mM IPTG.   
 
After 8 hours of fermentation, cells were harvested using a CSA-1 disk stack centrifuge 
run at 9860 rpm, at a flow rate of 100 L.h
-1
. Cells were resuspended in 50 mM Tris.HCl, 
pH 7.2 to approximately 50 g.L
-1
, then lysed using a high pressure homogeniser at 500 
bar for 5 passes.  Inclusion bodies were harvested using a flow rate of 100 L.h
-1
 in the 
CSA-1 centrifuge.  The inclusion body paste was aliquoted and sedimented further in a 
lab-scale centrifuge for 5300 rpm for 30 minutes at 7 ºC and the pellets stored at -80 ºC 
or -20 ºC.  Pellets were then washed, denatured and used in refolds, or otherwise 
purified further by Ni-NTA affinity and refolded under the same conditions to be used 
as standards.   
2.2.3 IB washing 
A frozen IB pellet was first resuspended to give approximately 100 g.L
-1
 in 50 mM Tris 
pH 7.2 using sonication on ice and divided into two aliquots (washed and unwashed) 
before being centrifuged for 10 minutes at 13,300 rpm at 5°C.  The inclusion body 
aliquot for washing then had multiple cycles of resuspension on ice using sonication and 
centrifugation 10 minutes at 13,300 rpm at 5°C.  The first step in Triton buffer (0.5% 
v/v Triton X-100, 50 mM Tris, 50mM NaCl pH 7.2), then guanidine hydrochloride 
buffer (0.6 M GdnHCl, 50 mM Tris, 50 mM NaCl pH 7.2).  The pellet undergoes 3 
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washes in Tris buffer (50 mM Tris, 50mM NaCl pH 7.2) to remove any traces of 
guanidine or Triton before refolding.   
2.2.4 Purification for standards 
DHFR IB pellets were denatured in 8 M urea, 0.01 M Tris.HCl, pH 8.0 and equilibrated 
onto Ni-NTA His Bind resin.  The denatured protein was eluted with a gradient to 0.01 
M Tris.HCl, 8 M urea pH 4.5, then dialysed against 0.01 M Tris.HCl, 8 M urea, pH 7.2.  
Protein concentrations were measured by absorbance at 280 nm, assuming a molar 
extinction coefficient of 25092 M
-1
cm
-1
 (Pace et al., 1995) and molecular weight of 
21446 Da (Clark et al., 1996).  SDS-PAGE showed the presence of a single protein.  
These samples were used as standards using the same dilution refolding procedure used 
for the denatured inclusion bodies.   
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2.2.5 Microscale Bioprocess Sequence 
A fully automated bioprocess sequence was created, with all operations performed using 
a robotic arm and automated liquid handling.  All process steps were performed on the 
Tecan robot, with the exception of cell lysis which was performed on the Covaris device 
(AFA).  The Covaris was not located on the Tecan platform, but its operation was 
controlled by a computer that allows high throughput treatment of up to 24 glass vials at 
preselected conditions.  The programs written (known as scripts) for the tecan robotic 
platform required extensive work as multiple iterations were required to ensure a script 
that allowed walk away operation.  Otherwise unexpected errors might lead to the 
termination of the script (such as a failure to detect the liquid level during aspiration).  
This required a substantial research effort to ensure all eventualities had been planned 
for and included in the script to provide work arounds to errors (for example on 
detection failure move to maximum depth). 
 
The bioprocess sequence was run as a series of programs, some of which contained sub 
programs.  This made operation easier (run errors were problematic with the older 
Gemini software when re-initiating scripts part of the way through) and provided 
flexibility for adapting scripts.  Figure 2.2 shows the structure and order of programs, 
with sub programs shown on the right hand side.  Once created and tested extensively to 
ensure these programs ran reliably, they were saved for future use and modification for 
different experiments.  
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Centrifuge operation 
and setting variables
1)  Preparation of 
fermentation plate
2) Running and sampling 
the fermentation
3)  Centrifugation (cell harvest), 
removal of broth, resuspension
and transfer to vials
4) Cell lysis on Covaris
5) Centrifugation (IB harvest), 
removal of supernatant
6) Solubilisation of IB pellet and 
refolding
7) Assays RP-HPLC 
 
Figure 2.2 Automated program structure, showing the main scripts on the left and sub-programs 
represented on the right   
2.2.5.1 Microwell fermentation 
2.2.5.1.1 Inoculum preparation 
Shake flasks (500 ml) containing 100 ml of Luria broth and 30 μg.mL-1 kanamycin and 
ampicillin 100 μg.mL-1 were inoculated by adding 0.9 ml of frozen cell stock of 
Escherichia Coli (E. Coli) XL10-Gold Kan
r
 pQE40, a construct that forms DHFR 
inclusion bodies during expression.  The shake flasks were then left overnight (13-14 h) 
shaking at 200 rpm and 37°C.  
2.2.5.1.2 Platform sterilisation 
The platform located inside a laminar flow hood was sterilised prior to use with 70% 
ethanol and UV irradiation for 15 minutes.  Disposable polypropylene troughs were 
used and pre-sterilised using UV irradiation for 15 minutes in a laminar flow hood.  
Deep square well polypropylene plates were used for the microwell fermentations and 
sterilised on the robotic platform.  
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2.2.5.1.3 Automated fermentation program 
A program was initiated for the automated preparation of the fermentation plate.  This 
involved the liquid handling arm of the robot filling each well with 950 μl of Terrific 
Broth containing 30 μg.mL-1 kanamycin and ampicillin 100 μg.mL-1.  The media 
containing plate was then pre-warmed to 37°C on a thermomixer for 15 minutes.  The 
plate was then inoculated using 50 μl of overnight culture and agitated at 1000 rpm and 
37°C.  Another program was then immediately initiated for automated fermentation 
sampling during the fermentation, which employed the liquid handling arm for 
sacrificial well sampling and the robotic arm to transfer the microplate to a platereader 
for measurement of the optical density (absorbance at 600 nm).  This program enabled 
the sampling to be repeated every hour until the end of the fermentation by aspirating a 
minimum volume of 10 μl from duplicate wells and transferring to a SRW 96 well plate 
and diluting with water to give a final volume of 250 μl.  The absorbance at 600 nm was 
then measured using a plate reader located on the platform.  Expression was induced by 
the addition of 10 μl of isopropylthiogalactosidase (IPTG) to give a final concentration 
of 0.125 mM. 
2.2.5.2 Cell harvest and Resuspension 
The 96-DSW plates were covered with plastic covers, and are the only step that requires 
manual intervention other than offline cell lysis.  The microwell plate is then transferred 
via robotic handling arm (RoMa) to the centrifuge and spun down at 5°C, 4000 rpm for 
15 minutes.  The fermentation broth was then removed using the liquid handling arm 
and 300 μl transferred to a 96 well plate.  The robotic arm then transferred the plate to a 
microplate reader to measure absorbance at 600 nm.  Following centrifugation, the cells 
must be resuspended in 50 mM Tris buffer pH 7.2 to give a solids concentration of 
approximately 50 g.L
-1
 wet cell weight in order to match large scale processing 
conditions.  The fermentations reached an OD of 12 A.U., which using the calibration 
curve corresponds to a dry cell weight of 5 g.L
-1
 and hence a wet cell weight of 
approximately 20 g.L
-1
.  Therefore in order to achieve a concentration of 50 g.L
-1
 the 
cells need to be resuspended in 400 μl of buffer using 3 pipette aspiration cycles and 30 
minutes of shaking using a thermomixer.   
2.2.5.3 Lysis by Sonication 
Resuspended cells were lysed on ice in 2.2 ml eppendorf tubes by sonication (10 cycles 
10 s on, 10 s off).   Most experiments were instead carried out using an alternative 
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method with longer treatment times (8 cycles 20 s on, 20 s off) as it was noted this led 
to smaller errors. 
2.2.5.4 Lysis by Adaptive Focusing Acoustic (AFA)  
Resuspended cells were either transferred to 96-well round bottom well microplates or 
to capped glass vials in a 4 by 6 rack, using an automated script on the Tecan platform.  
Cells were then lysed using AFA in the Covaris E210 after part submersion of the plate 
or vials in the degassed water bath of the instrument, at an incubation temperature of 8 ± 
4 °C, above the acoustic transducer.  Wenger et al (2008) reported complete release of 
virus-like particles from recombinant human papillomavirus at a duty cycle of 20%, 500 
cycles per burst and an acoustic radiation intensity of 85W, and found these comparable 
to using a high pressure homogenisation.  Therefore these conditions were initially 
chosen with a 4 minute treatment time.  Due to product release problems, this was later 
increased to 4 minutes of duty cycle 20%, 1000 cycles per burst and an intensity of 10.  
This lysis step in the Covaris was controlled by software that enabled the automated 
treatment of up to 24 sample vials by moving the rack in relation to the transducer at the 
bottom of the water bath. 
2.2.5.5 Thermo-chemical lysis 
Cell pellets were incubated in a solution of 50 mM Tris, 0.1% v/v Triton X-100, 5 mM 
EDTA, 50 μg.ml-1 lysozyme, pH 7.2, with a total volume of 1 ml and an approximate 
cell concentration of 50 g.l
-1 
wet cell weight.  The pH was adjusted to pH 9 with 8M 
sodium hydroxide (NaOH).  Cells were then incubated in a 96-well, round bottom, 
polypropylene microplate at 37°C and 200 rpm using a thermomixer. 
2.2.5.6 IB harvest 
The lysed cells were centrifuged in tubes for 10 min at 13300 rpm and 5°C.  The 
supernatant was then discarded to leave the inclusion body.  For the experiments on the 
effect of fermentation conditions on DHFR IBs, the lysed cells were transferred to a 96-
DSW well plate using automated liquid handling, covered and centrifuged at 5°C, 4000 
rpm for 15 minutes to pellet the inclusion bodies.  The supernatant was removed using 
automated liquid handling again. 
2.2.6 Denaturation and Refolding 
IB pellets were resuspended in solubilisation buffer (50mM Tris.HCl, 6M GdnHCl, 
2mM DTT pH 7.2) and subjected to 3 cycles of sonication (10 s on, 10 s off).  
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Denatured inclusion body and purified DHFR samples were refolded by 1:20 or 1:15 
dilution in each of the refold buffers (Table 2.5).  Tris buffer was chosen as a 
benchmark and the other two buffers were chosen based from previously established 
work to optimise a buffer for this protein (Davies 2009).  The automated protocol 
described previously for lysozyme was adapted for use with DHFR.  Refold dilutions 
were carried out with either 20 µl denatured protein and 280 µl refold buffer (1:15), or 
15 µl denatured protein and 285 µl refold buffer (1:20).  Plates were covered and 
incubated for 24 hours before assaying. 
 
For the study of the effect of fermentation conditions on DHFR refolding, inclusion 
body pellets were solubilised to 0.5-0.64 mg.ml
-1
 in 50 mM Tris.HCl, 6 M GdnHCl, 
2 mM DTT, pH 7.2 by shaking at 22 ºC for 4 hours, centrifuged for 10 minutes at 13000 
rpm and 4 ºC to remove any remaining solids, and the supernatant of denatured protein 
used for refolding.   
 
Table 2.5 Refold buffers used for DHFR 
 
 Buffer Components 
1 Tris 50mM Tris.HCl, pH 7.2 
2 Optimised 50mM Tris.HCl, 0.25M arginine, 2mM cystine.2HCl, 2mM cysteine, 
pH 7.2 
3 Reducing 0.25 M Potassium phosphate, 0.1 M potassium chloride, 1 mM DTT 
2.3 Insulin 
2.3.1 Materials and equipment 
2.3.1.1 Materials 
The expression host used was E. coli BL21 (DE3) with the expression vector pET-29a 
containing the gene for Humalog insulin and kanamycin resistance.  All chemicals used 
in this experimental section were purchased from Sigma-Aldrich Company Limited 
(Poole, Dorset, UK), with the exception of the following; ethanolamine from Fischer 
Scientific (Loughborough, Leicestershire, UK), glycerol from Alfa Aesar (Heysham, 
Lancaster, UK), magnesium sulphate heptahydrate from VWR International 
(Lutterworth, Leicester, UK) and DTT from Fermentas (Sheriff Hutton, York, UK). 
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2.3.1.2 Large scale Equipment 
A jacketed 146.5 L fermenter was used for the large scale fermentations (Biostat
®
 
D100, B. Braun Biotech International, Melsungen, Germany), with a working volume 
of 100 L and a top driven impeller of 3 Rushton turbines (Di= 0.16 m).  It was equipped 
with a digital control tower (DCU 3, Braun Biotech International).  The fermenter has 4 
equally spaced baffles and an aspect ratio of 3.  Inoculation occurred by pumping 
inoculums from a shake flask (101U/R Sci-Q, Watson-Marlow, Falmouth, Cornwall, 
UK).  Feed was also pumped into the fermenter from a sealed, sterile carboy (323S/D 
Sci-Q, Watson-Marlow).  Cells were harvested by aliquoting into 1 L bottles and 
centrifuging (Avanti J-20 XP, Beckman Coulter, High Wycombe, UK). high 
performance disperser (T 25 digital Ultra-Turrax, IKA
®
-Werke, Staufen, Germany) 
homogenisation (Niro-Soavi high pressure homogeniser “Panda 2K”, GEA Process 
Engineering, Columbia, MD, US) 
2.3.1.3 Microscale Equipment 
The equipment used is identical to that in Section 2.2.1.2 for the microscale bioprocess 
sequence. 
2.3.2 Large scale process 
2.3.2.1 Inoculum Preparation 
Media was prepared as detailed in Table 2.6 and adjusted to a pH of 7.2 with 1M 
sodium hydroxide.  Two 2L baffled shake flasks containing 450 ml of media were 
autoclaved at 121°C for 30 minutes, along with a solution of 50% w/v glucose 
monohydrate solution.  A 50 mg.ml
-1
 kanamycin solution was prepared and sterilised 
using a 0.22 μm sterile syringe disc filter (Acrodisc, Pall, NY, US).  Kanamycin and 
glucose monohydrate were then added aseptically to the cooled shake flask to give a 
final concentration of 0.05 mg.ml
-1
 and 1% w/v, respectively.  The flasks were pre-
warmed in an incubator at 200 rpm and 37°C for 1 hour and then 200 μl of thawed cells 
were aseptically transferred to both flasks.  The flasks were then incubated for 10 hours. 
 
Table 2.6 vLB Basal Media 
Component  Concentration (g.L
-1
) 
Bacto Yeast Extract 5 
Select soytone 10 
NaCl 10 
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2.3.2.2 Large scale fermentation 
Trace metal solution was prepared as detailed in Table 2.7, along with 1M magnesium sulphate 
solution, 1M Calcium chloride solution, 10% v/v orthophosphric acid, 25% w/w ammonia solution 
and 50 mg.ml
-1
 kanamycin.  The feed solution was prepared as detailed in  
Table 2.10 and autoclaved at 121°C for 30 minutes.  Valves for phosphoric acid, 
ammonia, feed, inoculum and were prepared along with a valve for post sterilisation 
media supplements with a filter (0.2 μm Sartopore 2 150 capsule filter, Sartorius 
Stedim) and autoclaved at 121°C for 30 minutes.   
 
Table 2.7  Trace metals composition 
 
Components Trace elements (per L) 
Ortho-phosphoric acid 48.00 ml 
FeSO4.7H2O 3.36 g 
ZnSO4.7H2O 0.84  g 
MnSO4.H2O 0.51 g 
Na2MoO4.2H2O 0.25 g 
CuSO4.5H2O 0.12 g 
H3BO3 0.36 g 
 
Table 2.8  Media composition for all three fermentations.  Concentrations shown are per litre of media. 
 
 1 2 3 
NH4SO4 14.0 g 14.0 g 14.0 g 
Glycerol  35.0 g 15.0 g 40.0 g 
Yeast Extract 20.0 g 20.0 g 40.0 g 
KH2PO4 2.0 g 2.0 g 2.0 g 
K2HPO4 16.5 g 16.5 g 16.5 g 
NaCl 0.5 g 0.5 g 0.5 g 
Citric Acid Anhydrous 7.5 g 7.5 g 7.5 g 
Ortho-phosphoric acid 1.5 ml 1.5 ml 1.5 ml 
Mazu Antifoam 0.2 ml 0.2 ml 0.2 ml 
 
After preparation of the fermenter and calibration of pH and O2 probes, the fermenter 
was filled with media, prepared as described in Table 2.8, and the fermenter and base 
2  Materials and Methods  G. Ordidge 
 
78 
media were sterilised in situ at 121°C for 30 minutes.  After cooling, lines were primed 
and the base media was supplemented with 1M magnesium sulphate solution (10 ml per 
L), 1M Calcium chloride solution (140 ml per L) and trace metals solution (34 ml per 
L).  The fermentation operating parameters were set as temperature 37°C, stirrer speed 
N = 250 rpm (unless stated otherwise), airflow rate 1 vvm and pH 7.0.  The pO2 was 
calibrated and a sample removed to confirm pH values using an off-line system.  The 
pO2 controller was set using a minimum set point of 30% using a cascade method and 
then gas mix using oxygen enrichment.  The kanamycin (1 ml per L) was then added 
immediately prior to inoculation.  The fermenter was inoculated with shake flask culture 
(5 ml per L) using a pump.  Samples were removed aseptically via the sample valve at 
frequent intervals to measure OD.  Feeding was initiated after a DOT spike via a pump.  
Induction occurred 1 hour after feeding commenced by aseptically adding sterile filtered 
0.5 M IPTG stock solution to give a final concentration of 0.5 mM.  Samples were taken 
approximately every 3 hours for OD, wet and dry cell weight measurements.  The 
fermentation was complete approximately 12 hours after induction (unless stated 
otherwise). 
 
The media used in each of the three different fermentations in Chapter 6 are shown in 
Table 2.8.  The first and second fermentations were fed batch, whereas the third 
fermentation was batch and hence no feeding took place.  The second and third 
fermentations (low and high kLa matched conditions) were run with no cascade control 
and consequently no enriched oxygen gas blending and a constant impeller speed.  
Control of the pH was utilised (unlike in the microwell kLa run where this is not an 
option) due to the precipitation problems of the media at high pH.   
2.3.2.3 Downstream processing 
The harvested cells were centrifuged in 1 L bottles for 15 minutes at 8000 rpm  and 
4°C.  The cell pellets were stored in the freezer at -20°C.  Cells were the defrosted and 
resuspended using a high performance disperser in phosphate buffered saline (PBS), 
137 mM NaCl, 10 mM phosphate, 2.7 mM KCl, pH 7.4 to give a volume which is 
double the original fermentation volume.  Cells were lysed using homogenisation and 3 
passes at 800 ±100 bar at 15°C.  The inclusion bodies were then harvested by 
centrifugation for 20 minutes at 8000 rpm and 4°C.   
2  Materials and Methods  G. Ordidge 
 
79 
2.3.3 IB washing 
The inclusion bodies were then washed by resuspension in purified water to the 
equivalent volume as the original fermentation volume and re-centrifuging twice.  The 
washed and unwashed inclusion bodies were then resuspended to give a 5% or 10% 
slurry in purified water and stored in the freezer at 20°C. 
2.3.4 Denaturation and Refolding 
For the large scale refolds, washed and unwashed inclusion bodies were solubilised in 
4.5 M urea, 365 mM ethanolamine, 10 mM DTT to give a concentration of 10 g.L
-1
 or 
1.5 g.L
-1 
for 1 hour. The protein was then refolded by rapid dilution in buffer at varying 
dilution factors by the addition of protein to a 250 ml bottle with magnetic stirrer to give 
a final volume of 200 ml.  For condition 13, the refold was conducted with a final 
volume of 4.5 L in a 5 L plastic container with liner and mixing was achieved using a 
top driven motorised impeller.  The refold buffers used were buffer 1 (0.288 mM 
cystamine, 10% v/v hexylene glycol, 20 mM ethanolamine, pH 10.5) and buffer 2 (10 
mM Tris, 10 mM glycine, 1 mM EDTA, 0.5 mM cysteine, 4.5 mM cystine pH 10.5).   
2.3.5 Microscale Bioprocess Sequence 
2.3.5.1 Microwell fermentation 
2.3.5.1.1 Inoculum preparation 
A baffled shake flask containing 100 ml of Luria Bertani (LB) media, 5 g.L
-1
 yeast 
extract, 10 g.L
-1
 tryptone and 10 g.L
-1
 NaCl pH 7.2, was inoculated with 1 ml of 
defrosted E. coli cell stock and 50 μg.ml-1 kanamycin and grown overnight at 37°C and 
250 rpm.  The inoculums typically reached an OD of 2.5-3 A.U. 
2.3.5.1.2 Fermentation preparation 
Media was prepared with the compositions detailed in Table 2.9, Table 2.9 and Table 
2.11, the pH adjusted with NaOH or hydrochloric acid, and sterilised for 30 minutes at 
121°C.  Stock solutions of 1 M MgSO4.7H2O and 1 M CaCl2.2H2O were prepared and 
sterilised for 30 minutes at 121°C.  The feed was prepared by combining MgSO4.7H2O 
(30 ml.L
-1 
1 M stock solution) and glycerol (714 g.L
-1
) and sterilised for 30 minutes at 
121°C.  For the glucose batch media, glucose was also sterilised separately as a high 
concentration stock solution.  The trace metal stock solution and antibiotics were 
sterilised by filtration (Minisart NML Syringe Filters, Sartorius Stedim, Surrey, UK).  
After cooling and aliquoting the media into sterilised troughs, trace metals (34 ml per 
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L), supplements of 1 M MgSO4.7H2O (10 ml per L) and 1 M CaCl2.2H2O (2 ml per L) 
and kanamycin were added and mixed to give the final media.  This was then added to 
the sterilised platform along with the inoculums and sterile water for dilutions. 
 
An IPTG stock solution of 50 mM was prepared and filtered sterilised into a sterilised 
trough and place on the platform.  Cells were induced by the addition of 10 μl at the 
programmed time point to give a final concentration of 0.5 mM. 
 
Table 2.9  Media composition for Terrific Broth (TB) pH 7.2 
Components Terrific Broth (per L) 
Yeast Extract 24.00 g 
Tryptone 12.00 g 
Glycerol 4.00 ml 
KH2PO4 2.31 g 
K2HPO4 12.54 g 
 
Table 2.10  Feed solution 
Component Concentration (per L) 
1M MgSO4.7H2O 30 ml 
Glycerol 714 g 
 
Table 2.11 Medium composition for batch versus fed batch comparison experiment pH 7.0 
Components Batch medium (per L) Fed batch medium (per L) 
NH4SO4 14.0 g 14.0 g 
Glycerol  40.0 g 35.0 g 
Yeast Extract 40.0 g 20.0 g 
KH2PO4 2.0 g 2.0 g 
K2HPO4 16.5 g 16.5 g 
NaCl 0.5 g 0.5 g 
Citric Acid Anhydrous 7.5 g 7.5 g 
Ortho-phosphoric acid 1.5 ml 1.5 ml 
2.3.5.1.3 Automated fermentation program 
The fermentation was performed as described for DHFR with automated plate 
preparation, inoculation, induction and hourly sampling with OD measurements.  A 
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feeding strategy was added into the existing loop to give a feeding rate of approximately 
11 g.L
-1
.h
-1
.  When comparing batch and fed batch, sterilised distilled water was added 
to the batch wells instead of feed to ensure volumes were constant between the two 
conditions.  A summary of the fermentation conditions used in this chapter are shown in 
Table 2.12. 
 
Table 2.12  Fermentation conditions 
Variable Induction 
time (h) 
Media Feeding 
started (h) 
Fermentation 
length (h) 
Induction time 3.5, 4, 4.5, 5 Glycerol fed batch 5 18 
Batch and  
Fed-batch 
6 Glycerol batch, 
glycerol fed batch  
5  18 
Carbon source 3.5 LB, TB, Glucose 
batch, Glycerol batch 
n/a 22 
 
2.3.6 Denaturation and Refolding 
Inclusion body pellets were defrosted and solubilised in a denaturing buffer of 4.5 M 
urea, 365 mM ethanolamine, 10 mM DTT pH 10.6 at a concentration of 0.4 mg.ml
-1
 and 
left to shake at 800 rpm for 4 hours.  Refolding was achieved by automated microscale 
dilution refolding, with a dilution factor of 18 fold and a final refold volume of 300 μl.  
The buffers used for refolding are shown in Table 2.13. 
 
Table 2.13  Insulin refold buffers 
Refold Buffer Components 
1 0.288 mM cystamine, 10% v/v hexylene glycol, 20 mM 
ethanolamine, pH 10.5 
2 10 mM Tris, 10 mM glycine, 1 mM EDTA, 0.5 mM cysteine, 4.5 
mM cystine pH 10.5 
3 1M acetic acid pH 3.8 
2.4 Determination of kLa using static gassing out method 
2.4.1 Large scale fermenter 
The static gassing out technique (Suhaili et al., 2010) was used to calculate the kLa in a 
baffled 146.5 L fermenter, with 3 Rushton impellers, filled with the media detailed in 
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Table 2.8.   The probe (InPro 600, Mettler Toledo, Leicester, UK) was calibrated by 
zeroing during sterilisation and set to 100% using air and the maximum impeller speed.  
The media was purged of oxygen using nitrogen to achieve a DOT below 20%.  The 
increase in DOT over time was then recorded at various impeller speeds, with a constant 
gas flow rate of 1 vvm and a temperature of 37°C.   The probe response time was also 
measured as a 63.2% stepwise change (Tribe et al., 1995) and the response time with no 
mixing (impeller speed= 0 rpm) was 0.011 h ± 0.007.   At the lowest impeller speed the 
delay was found to be negligible and therefore neglected in the calculation of kLa. 
1/ kLa = 0.053 h 
τ =0.011 h <<1/ kLa 
2.4.2 Microscale DSW plate 
The static gassing out technique (Doig et al., 2005a; Islam et al., 2008) was used to 
calculate kLa in microwell plate format using batch media (Table 2.11) and a 
temperature of 37°C.  The probe was calibrated to 0% using a superficial nitrogen gas 
stream. The probe response time was calculated by purging the oxygen saturated system 
(DOT= 100%) by gassing in nitrogen until a DOT below 37%.  The probe response 
time was defined as the time needed to achieve a 63% stepwise change.  It was 
calculated as 4.96 ± 0.013 h
-1
.  As the probe response time is very small in comparison 
to the kLa’s expected, it was considered to be negligible and not taken into account in 
the calculation of kLa. 
 
The dissolved oxygen tension (DOT) was measured using an oxygen sensitive 
fluorescence patch connected by a fibre optic cable to an oxygen measuring instrument 
(Oxy4 Oxygen Metre, PreSens, Regensberg, Germany).  A DSW plate was adapted to 
include a well with a 3 mm diameter Perspex window at the bottom.  The oxygen patch 
can then be placed inside the well at the Perspex window and the detection probe to be 
attached to the outside of the window using a connector (Figure 2.3).  This allows the 
measurement of the fluorescent signal and consequently the dissolved oxygen 
concentration the patch is exposed to (using PreSens software to convert the signal to 
DOT).  Details of the  design can be found in Islam, (2007); Ferreira-Torres, (2008). 
 
The gas-liquid mass transfer kLa was measured at different shaking speeds and fill 
volumes using the set-up described.  The well was filled with batch media (and in some 
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experiments 0.02% PPG) and pre-warmed for 30 minutes, the shaking speed set and a 
nitrogen stream was introduced until the DOT had decreased to below 20%.  Once the 
nitrogen had been removed, air was allowed to transfer to the media via superficial gas 
transfer.  The instrument recorded the DOT values every 2 seconds. 
 
Oxygen 
sensor
Perspex window
Connector
DOT probe f ibre 
optic cable
Plastic body of the 
outer well
 
Figure 2.3  Diagram of microwell oxygen probe for kLa determination.  
2.5 Analytical Techniques 
2.5.1 Sodium dodecyl sulfate polyacrylamide gel 
electrophoresis (SDS-PAGE)   
Fermentation samples were prepared by pipetting 1 ml of cell broth into 2.2ml 
eppendorf tubes.  The cells were then cooled to 4C in ice and centrifuged at 13000 rpm 
and 4C for 10 minutes to harvest the cells.  The supernatant was then discarded and the 
pellet resuspended in 50mM Tris.HCl pH 7.2.  This was then sonicated on ice (10 
cycles, 10 s on, 10 s off) to lyse the cells and release the inclusion bodies.  The 
disrupted cells were then centrifuged again at 13000 rpm, 4C, for 10 minutes.  The 
supernatant was decanted and collected as the soluble fraction for analysis.  The pellet 
was then re-suspended in 50mM Tris.HCl pH 7.2 and vortexed to mix or denatured in 
50mM Tris.HCl, 6 M Urea, pH 7.2.  
 
SDS-PAGE was performed using NuPAGE
®
 Tris Glycine 12% pre-cast gels 
(Invitrogen, USA) and 1x Tris-glycine running buffer. Samples were denatured and 
reduced by adding 2x concentrated Laemmli sample buffer (% (w/v) SDS, 20% glycerol 
(v/v), 10% (v/v) 2-mercaptoethanol, 0.004% (w/v) bromophenol blue and 0.125 M Tris 
HCl, pH  6.8) in a ratio of 1:1 and heated to 90°C for 8 minutes in a thermomixer.  The 
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samples were then mixed and 10 or 20 µl loaded onto the wells of the gel, along with 5 
μl of ladder.  Electrophoresis was then conducted at 80Vfor approximately 90 minutes 
(Invitrogen Novex Mini Cell, Life Technologies, NY, USA).  The bands were then 
visualised by staining with Coomassie stain for 1 hour (0.5g/l coomassie blue, 50% 
methanol, 10% acetic acid) and then destaining with purified water overnight.  The gel 
was then captured using Gel Doc-It Imaging system (UVP, CA, USA) and protein 
bands were quantified using Labworks software (UVP, CA, USA).   
2.5.2 Total protein concentration 
The total protein concentration was determined using a Bradford assay.  A standard 
curve was prepared from a solution of 2mg.ml
-1
 bovine serum albumin (BSA) serially 
diluted in Tris buffer to give concentrations ranging from 0.1 to 1.4 mg.ml
-1
.  Bradford 
Reagent was gently mixed and allowed to come to room temperature.  5 µl of the 
protein standards, buffer for controls, and samples of unknown concentration (diluted to 
give an approximate protein concentration of below 1.4 mg.ml
-1
) were added to a 96 
well plate in triplicate.  250 µl of Bradford Reagent was then added to each well and 
mixed by 3 cycles of pipette aspiration.  The samples were left to incubate at room 
temperature for 5 to 15 minutes and then absorbance measured at 595 nm in a 
microplate reader (Safire, TECAN, Reading, UK).  The net absorbance of each standard 
was then plotted against the protein concentration and used to determine the protein 
concentration of the unknown samples.  For the large scale fermentation experiments 
this was performed manually, but in all other experiments this was automated on the 
Genesis platform and absorbance measured on a different microplate reader (Infinite 
2000, TECAN, Reading, UK). 
 
Samples were prepared from cell suspensions were spun down at 13000 rpm and 4°C 
for 10 minutes.  The supernatant (soluble fraction) was removed via pipetting and 
reserved.  The pellet (insoluble protein fraction) was resuspended in 50 mM Tris, 6 M 
GdnHCl using sonication (3 cycles of 10 s on, 10 s off).  A standard curve was prepared 
with BSA dissolved and serially diluted in 50 mM Tris, 6 M GdnHCl.      
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2.5.3 Flow cytometry 
2.5.3.1 Fluorescence staining 
Samples were diluted using 0.2 μm filtered 0.5 M Tris pH 8.5 to give a cell 
concentration of approximately 1 x 10
6
 cells.ml
-1 
before staining (to result in 10,000 
events in 300 s time frame).  The cell count was established using the CASY cell 
counter and analyser (Roche Diagnostics, West Sussex, UK).  SYTOX Green Nucleic 
Acid Stain (Molecular Probes, Invitrogen) was used as provided in a 5 mM solution in 
DMSO.  Cells were stained by the addition of 4 μl to 1 ml of diluted cells, gently mixed 
and left for a minimum of 40 minutes prior to analysis. 
2.5.3.2 Measurement 
Samples were analysed using a Beckman Coulter XL MCL flow cytometer (Beckman 
Coulter, Fullertone, CA, USA), which detected light scattering and fluorescence 
emissions.  Samples were illuminated by an air cooled argon ion laser (488 nm, 15 mW) 
and fluorescence detection occurred using a standard filter configuration.  Each 
experiment was set to collect 10,000 events or to timeout after 300s.  Voltages and gains 
were set as follows: 50 V and 2.0 for forward scatter (FS), 131 V and 5.0 for side scatter 
(SS), 286 V and 1.0 for fluorescence filter with bandwidth 525 nm (FL1).  Data was 
analysed using EXPO32 ADC Analysis. 
2.5.4 Particle sizing  
The Malvern Mastersizer 2000 laser sizer (Malvern, Worcestershire, U.K.) enabled the 
measurement of particle size between 0.02 to 2000 m by laser diffraction.  Drops of 
the homogenised sample were added to the small volume sample dispersion unit until 
the level of obscuration reached 15%. 
2.5.5 Cell concentration (biomass) 
2.5.5.1 Insulin fermentation 
For wet and dry cell weight measurements, 10 ml of sample was added to pre weighed 
glass test tubes and centrifuged in a bench top centrifuge for 15 minutes at 5000 rpm.  
The supernatant was then discarded and mass of the tube with wet pellet was measured 
and the wet cell weight calculated.  The test tube was then placed in an oven at 80°C 
and left overnight to dry, before it was then re-weighed to determine the dry cell weight.   
OD measurements were performed by blanking the spectrophotometer with water, 
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diluting the sample to within the appropriate linear range (<1 A.U.) and measuring the 
absorbance at 600 nm.  
2.5.5.2 DHFR and microscale fermentation 
Wet cell weight and dry cell weight were determined by adding 2 ml of cell suspension 
to a pre-weighed 2.2 ml tube (Eppendorf).  This was then centrifuged at 13000 rpm and 
4°C for 10 minutes.  The supernatant was then removed using a pipette and discarded.  
The tube was then weighed and the wet cell weight calculated.  The tube was then 
placed in an oven at 80°C and dried for 24 hours prior to re-weighing to give the dry 
cell weight. 
2.5.6 Acetic acid quantification 
A Megazyme (Co. Wicklow, Ireland) acetic acid kit was used to determine the 
concentration in fermentation broth samples.  Samples were heated to approximately 
80°C for 20 minutes to denature enzymes that might interfere with the assay.  Undiluted 
samples were mixed in a plastic cuvette with distilled water, a buffer containing 
nicotinamide adenine dinucleotide hydride (NADH), adenosine triphosphate (ATP), 
phosphoenolpyruvate (PEP), polyvinylpyrollidone (PVP) and coenzyme A (CoA) 
solution and a solution containing D-lactate dehydrogenase (D-LDH), 
phosphotransacetylase (PTA) and pyruvate kinase (PK).  The spectrophotometer was 
blanked against water at 340 nm, and after 2 minutes the absorbance of the samples was 
read.  The reaction was then started by adding acetate kinase suspension, mixing by 
gentle inversion whilst covered in parafilm and reading the absorbance again after 4 
minutes.  The absorbance change was then used to calculate the concentration of acetic 
acid (See Appendix 9.4.2). 
2.5.7 Lysozyme assays 
2.5.7.1 Absorbance 
Absorbance was measured at 280, 340 and 600 nm.  The buffer control was subtracted 
from all standards and refolds.   
2.5.7.2 Intrinsic Fluorescence 
Intrinsic fluorescence was measured by excitation at 280 nm and emission at 340 nm, as 
described previously (Aucamp et al., 2005, 2008).  The buffer control was subtracted 
from all standards and refolds.  Intrinsic fluorescence was determined relative to that of 
a standard in the same buffer condition to account for effects of the buffer on 
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fluorescence intensity, and experimental variations in the voltage gain applied to the 
instrument photomultiplier tube, to give relative fluorescence (where a relative 
fluorescence of 1 is a refold with the same intrinsic fluorescence as the standard). 
2.5.7.3 Lysozyme activity  
Samples of 10 l were taken after 24 hours, transferred to a 96-SRW plates (96- well 
micro test plates PS, Sarstedt, Leicester, UK), and diluted 1:10 with 0.1 M potassium 
phosphate, pH 6.6 for the activity assay.  Diluted samples were assayed by transferring 
10 µl into a new plate and adding 290 µl of Micrococcus lysodeikticus cell suspension 
(0.3 g/L in 0.1M potassium phosphate pH 7).  The decrease in absorbance at 450 nm 
and at room temperature was measured for 3 minutes and activities determined as the 
gradient of the initial linear region of the curves.  Rates calculated from buffer only 
samples were subtracted and the final rates compared with those obtained for standards 
of native lysozyme (assigned an activity value of 100%). 
2.5.7.4 Circular dichroism 
Prior to circular dichroism (CD), samples were dialysed for at least 24 hours using a 
buffer of 1.2M guanidine hydrochloride, 50mM Tris.HCl and 4mM cystamine to 
decrease the concentration of DTT present.  The protein concentration was determined 
using a spectrophotometer and then adjusted to 0.1 mg.ml
-1
 by diluting with dialysis 
buffer.  Samples were then filtered through a 0.2 µm filter.  Refold samples and 
standards were measured in 300 µl cuvettes with 0.1 cm pathlength.  The mean 
ellipticity (ΔMRE, deg cm2 dmol-1) was used to monitor the secondary structure of 
lysozyme. Data was smoothed for repeats by taking the average for two points either 
side of each data point.    Circular dichroism spectra (190-300 nm) were measured on a 
202 SF spectrometer (AVIV Associates, Lakewood, NJ) at 25°C using a quartz 
precision cell cuvette with a pathlength of 1 mm. 
2.5.8 DHFR Assays 
2.5.8.1 Absorbance 
Absorbance at 280, 340 and 600 nm was measured in a plate reader.  The buffer control 
was subtracted from all standards and refolds.   
2.5.8.2 Intrinsic fluorescence  
Intrinsic fluorescence of refolded samples was measured in the plate reader (TECAN 
Infinite 2000, Reading, UK), using 280 nm excitation and 340 nm emission.  
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Fluorescence intensities were simultaneously measured for the standard native proteins 
at the same buffer conditions for direct comparability, however due to their poor 
refolding they were not used as standards as for lysozyme.       
2.5.8.3 DHFR activity 
The activity was determined in 96-well plates from the rate of decrease in absorbance at 
340 nm (A340) for NADPH consumption as DHFR reduced dihydrofolate (DHF) to 
tetrahydrofolate (THF).  40 µl of assay buffer (50mM Tris.HCl, 50µM EDTA, pH 7.2) 
was added to each well,, followed by 50 µl of 1 mM NADPH in assay buffer.  60 µl of 
undiluted sample was then added and incubated for 5 minutes.  Reactions were initiated 
by the addition of 50 µl 1 mM DHF in assay buffer and mixed by aspiration-dispense.  
The A340 was measured every minute for 25 minutes in the plate reader.  The rate of 
decrease in absorbance was then normalised by the final protein concentration. 
2.5.9 Insulin Assays 
Absorbance and fluorescence assays were performed as previously detailed in Section 
2.5.8.1 and 2.5.8.2. 
2.5.9.1.1.1 Preparation of fermentation samples for HPLC 
Fermentation samples were pelleted by centrifugation at 13300 rpm for 5 minutes at 
5°C, then resuspended in phosphate buffered saline (PBS) by vortexing.  Cells were 
then lysed using sonication (20 cycles, 8 s on, 8 s off).  The lysed cells were then 
centrifuged 13300 rpm for 10 minutes at 5°C to harvest the IBs.  The IBs were then 
solubilised in 7.6 M urea, 24 mM DTT, 343 mM ethanolamine, mixed by vortexing and 
left to mix on a shaker for 30 minutes.  Aliquots were then transferred to 
microcentrifuge tube and centrifuged 13300 rpm for 5 minutes at 5°C and filtered using 
an 0.22 μm syringe filter into HPLC vials.  Refold samples were either transferred 
straight to HPLC vials with inserts or if aggregates were present they were filtered first 
before transferring to vials. 
2.5.9.1.2 Reverse phase HPLC for titre and refolding yield determination 
A reverse phase HPLC assay was used to quantify the titre of insulin in crude 
fermentation samples and the yield of bioactive insulin in refold samples.  A C18 
Nucleosil
®
 100-5 reverse phase column (Agilent Technologies, CA, US), was used on 
an Agilent 1200 series High Pressure Liquid Chromatography System using 
ChemStation software and a detection wavelength of 210 nm.  A linear 
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acetonitrile/water gradient of 0.1% (v/v) TFA (18-90 % over 39 minutes) at a flow rate 
of 1 ml.min
-1
 was used, with a sample injection volume of 100 μl.  A standard curve 
was created using recombinant human insulin solution (Sigma-Aldrich, Gillingham, 
UK) of varying concentrations (0.05-0.75 mg.ml
-1
) in order to calculate the insulin 
concentration.  The yield for the large scale fermentations was determined using a lower 
injection volume of 50 μl using a different column (Poros R2/10, Applied Biosystems) 
and HPLC system (Walters Alliance HPLC system with Empower software).  The yield 
for the large scale refolds were determined by RP-HPLC using the same method and 
system but a different column (XBRIDGE, Waters, Elstree, Hertfordshire).  Refold 
samples were taken after 16 hours after the initiation of refolding, centrifuged 
(Multifuge 1 S-R, Heraeus DJB Labcare, Newport Pagnell, Buckinghamshire, UK) for 
10 minutes at 13,200 rpm and filtered through a 0.2 μm syringe filter (Acrodsic Syringe 
filter or Fluorodyne II Membrane, Pall, Portsmouth, UK).
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3 Assay Development
1
 
3.1 Introduction  
The optimisation of the refolding step is crucial during process development and must 
be determined on a case by case basis for every new inclusion body product.  Despite 
knowledge of the main factors involved in refolding, no universal refolding buffer has 
been reported to date, and so multiple parameters must be investigated empirically to 
optimise the refolding yield of each new protein.  Such protein screening studies can be 
time consuming given the large number of potential parameters that may affect yield.  A 
high-throughput microscale screening approach is a possible solution.  It would enable 
rapid optimization early on in process development using low quantities of often 
expensive material and allow multiple conditions to be tested in parallel.  Protein 
refolding is largely scale-invariant, therefore the microwell plate format can be used for 
the rapid and meaningful screening of many process conditions (Middelberg, 2002).  In 
addition, the integration of microscale approaches with robotic platforms allows higher 
throughput studies and greater precision and accuracy of liquid handling operations.  
Numerous studies have used a microwell format for the high-throughput screening of 
protein refolding reagents (Vincentelli et al., 2004; Willis et al., 2005; Mannall et al., 
2009; Dechavanne et al., 2011).  The combination of high-throughput microwell 
screening methods with fractional factorial and other Design of Experiment (DoE) 
approaches have been reported to efficiently screen and allow the optimisation of many 
combinations of additives to improve refolding yields (Williams et al., 1982; Mannall et 
al., 2009; Dechavanne et al., 2011).  Therefore the microwell approach was used to 
analyse multiple refolding parameters at a high throughput. 
 
A common challenge experienced in microplate-based refolding is the analytical 
bottleneck caused by the parallel study of a large number of conditions and the absence 
of suitably high-throughput and generic assays of biological function to identify the 
correct folding of most proteins.  Absorbance measurements can be used as a rapid 
                                                 
1
 Results from Section 3.3.2 onwards have been published Ordidge, G.C., Mannall, G., 
Liddell, J., Dalby, P.A., and Micheletti, M. (2012). A generic hierarchical screening 
method for the analysis of microscale refolds using an automated robotic platform. 
Biotechnology Progress 28, 435–444. 
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method to differentiate aggregates from soluble protein.  Several wavelengths have been 
previously used to indirectly measure the concentration of insoluble aggregates by 
scattering light (Vincentelli et al., 2004; Mannall et al., 2009).  However single 
measurements with surrogate assays such as turbidity or absorbance cannot readily 
distinguish between soluble native and misfolded proteins.  Intrinsic tryptophan 
fluorescence can be a suitable probe for studying refolding as it can distinguish the 
folding environment of the protein and has already been used to follow lysozyme 
refolding (Dobson et al., 1994; Raman et al., 1996; Terashima et al., 1996; Katoh et al., 
1999).  The gold standard for establishing yield however remains an activity assay or 
HPLC assay.  Reversed-phase HPLC assays can be used to resolve native and misfolded 
species, but the technique is relatively slow and time consuming.  Therefore, it is 
important to minimise the number of samples that require analysis by more costly and 
time intensive techniques such as HPLC or biological function assays.  The absorbance 
and fluorescence assays were employed with a view to reducing the analytical 
bottleneck caused by high throughput microwell studies.   
 
The microscale approach was demonstrated using two different proteins.  Lysozyme 
was selected as a model protein for initial studies due to its readily available supply, 
well characterised folding pathway and the large number of previous refolding studies 
(Buswell and Middelberg 2002; Buswell and Middelberg 2003; Lee et al. 2002; T. 
Kiefhaber 1995; Wildegger and Thomas Kiefhaber 1997; Radford et al. 1992; Roux et 
al. 1997).  Yields for lysozyme refolds appear to be optimal at a ratio of 1:1-3:1 and a 
total thiol concentration of 5-15 mM (Hevehan and De Bernardez Clark 1997).  Several 
studies have reported high yields of lysozyme when refolding at high protein 
concentrations (up to 5 mg/ml) whilst maintaining a concentration of 1-2M of 
denaturant (Hevehan and De Bernardez Clark 1997; Mannall et al. 2007).  Additionally 
a number of low molecular weight additives are known to reduce lysozyme aggregation, 
therefore there is plenty of scope for studying yield improvements.  DHFR was chosen 
as it could be produced in inclusion bodies by fermentation in E. coli and the assays 
could be tested using a more challenging feed stream to give more industrially relevant 
results.  Inclusion bodies are contaminated by varying levels of impurities such as host 
proteins, nucleic acids and cell membrane components, which can affect renaturation 
yields (Maachupalli-Reddy et al. 1997).  It is also possible that their presence may 
interfere with some of the assays to be tested.  Therefore the assays were developed 
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using readily available lysozyme and then challenged with inclusion body material to 
test their effectiveness.  
 
The aim of this chapter is to develop a generic, automated and high-throughput 
microscale process sequence with suitable assays for protein refolding.  This will enable 
rapid process development and a deeper understanding of their contribution to yield 
using a one factor at a time approach.  The microwell format was used to investigate the 
factors affecting refolding as it gives rapid, meaningful information and allows 
automated high throughput experimentation.  The assays for protein refolding must be 
reproducible, accurate, and allow rapid ranking of refold conditions in order to optimise 
the protein refolding process based on factors such as pH, buffer, excipients, protein 
concentration and dilution ratios.  They also must be capable of handling a large number 
of samples in order to avoid an analytical bottleneck.  Absorbance, fluorescence and 
activity assays were considered for information richness, generic application and 
capacity for high throughput analysis. 
3.2 Materials and Methods 
Experiments with lysozyme were conducted as described in 2.1.1 (Materials and 
Equipment) and 2.1.2 (Denaturation and Refolding).  Refold buffers are summarised 
again here to aid referral.  Assays were carried out as described in 2.5.7 Lysozyme 
assays. 
 
Table 3.1 Lysozyme refold buffers for 3.3.1.1 Selection of wavelengths for aggregation detection and 
solubility, 3.3.1.2 Absorbance changes during refolding and buffer 2 and 3.3.1.4 Example of end point 
analysis 
 
 Buffer components 
1 25 mM cysteine, 1 mM EDTA and 0.1 M Tris-HCl pH 8.2.   
2 L-arginine 0.14 M, 25 mM cysteine, 1 mM EDTA and 0.1 M Tris-HCl pH 8.2.   
3 Sucrose 0.20 M, 25 mM cysteine, 1 mM EDTA and 0.1 M Tris-HCl pH 8.2.   
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Table 3.2 Denatured protein and refold buffer conditions for 3.3.1.2 Absorbance changes during 
refolding 
 
[Protein] 
(mg.ml
-
1
) 
[DTT] 
(mM) 
Redox pair Redox 
potential 
Buffer components [Final 
Protein] 
(mg.ml
-
1)
 
7.5 25 Cysteine:cystine Balanced 5 mM cystine, 10 mM 
cysteine, 50 mM Tris 
0.5 
7.5 25 Cysteine:cystine Oxidising 10 mM cystine, 50 mM Tris 0.5 
15 32 DTT:cystamine Balanced 4 mM cystamine, 50 mM 
Tris 
1 
15 6 DTT:cystamine Oxidising 4 mM cystamine, 50 mM 
Tris 
1 
15 62 DTT:cystamine Reducing 4 mM cystamine, 50 mM 
Tris 
1 
 
Table 3.3 Refold buffers and DTT concentration in denatured protein to give different redox potentials, 
as used in 3.3.1.3 Fluorescence changes during refolding and 3.3.3.1 Oxidation 
 
Buffer (redox 
pair) 
[DTT] (mM) Redox potential Components 
DTT:cystamine 32 Balanced 4 mM Cystamine 50 mM Tris 
DTT:cystamine 6 Oxidising  4 mM Cystamine 50 mM Tris 
DTT:cystamine 62 Reducing 4 mM Cystamine 50 mM Tris 
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Table 3.4  Refold buffers used for 3.3.4 Hierarchical assays using lysozyme  
 
 Buffer components 
1 25 mM cysteine, 1 mM EDTA, 0.1 M Tris.HCl 
2 25 mM cysteine, 1 mM EDTA, 0.1 M Tris.HCl, 0.14M arginine 
3 25 mM cysteine, 1 mM EDTA, 0.1 M Tris.HCl, 0.3M GdnHCl 
4 25 mM cysteine, 1 mM EDTA, 0.1 M Tris.HCl, 0.3M GdnHCl, 0.14M 
arginine 
5 25mM cystamine, 50mM Tris.HCl and 0.717M GdnHCl, 1mM EDTA 
6 4mM cystamine, 50mM Tris.HCl and 0.715M GdnHCl (used in 
oxidation experiment with different [DTT] to create different redox 
potentials) 
7 4mM cystamine, 50mM Tris.HCl and 0.678M GdnHCl 
8 5mM cystine, 10mM cysteine, 50mM Tris.HCl,  0.717M GdnHCl 
(balanced) 
9 2.86mM cystine, 14.29mM cysteine, 50mM Tris.HCl,  0.717M GdnHCl 
(reducing) 
10 10mM cystine, 50mM Tris.HCl,  0.717M GdnHCl (oxidising) 
 
Experiments with DHFR were conducted as described in 2.2.1 (Materials and 
Equipment) and 2.2.6 (Denaturation and Refolding).  Refold buffers are summarised 
again here to aid referral.  Assays were carried out as described in 2.5.8 DHFR Assays. 
 
Table 3.5 Refold buffers used for DHFR 
 
 Buffer Components 
1 Tris 50mM Tris.HCl, pH 7.2 
2 Optimised 50mM Tris.HCl, 0.25M arginine, 2mM cystine.2HCl, 2mM cysteine, 
pH 7.2 
3 Reducing 0.25 M Potassium phosphate, 0.1 M potassium chloride, 1 mM DTT 
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3.3 Results and Discussion 
3.3.1 High-throughput assay selection 
3.3.1.1 Selection of wavelengths for aggregation detection and 
solubility   
A number of different wavelengths have been reported in the literature for detecting 
aggregate particles, such as 450 nm (Raman et al., 1996), 340 nm, 390 nm (Vincentelli 
et al., 2004) and 600 nm.  Conventionally 280 nm is used for determining protein 
concentration.  In order to select the appropriate wavelengths, experiments were 
conducted with buffers containing different excipients.  Figure 3.1 (a, b, c) shows the 
absorbance profile during refolding for three widely used wavelengths, 280 nm, 340 nm 
and 600 nm, under three different buffer conditions.  Despite all the refold conditions 
having the same protein concentration in the refold (and buffer effects removed by 
subtracting a control), the refolds have vastly different absorbencies ranging in starting 
absorbance from 0.5 to 2.0 A.U.  At 280 nm the absorbance of each of the three 
conditions is separated by approximately 0.75 arbitrary units (A.U.).   Compared with 
higher wavelengths the degree of separation between the refolds in different conditions 
is much better at 280 nm, at 600 nm the separation is much smaller ranging only from 
0.1 to 0.6.  This highlights that 280 nm can separate distinct refold conditions to a 
greater degree and might be expected to reflect a combination of differences in the 
concentration of soluble protein, the degree of light scattering by particles, or in the 
relative populations of natively folded, misfolded, and unfolded proteins. 
 
The ranking remains the same for all three wavelengths, the refolds in a buffer with no 
excipients have the highest absorbance, followed by sucrose buffer.  Overall, the high 
absorbance values correlated with the visible appearance of aggregation.  The refolds in 
arginine buffer have the lowest absorbance, with the absorbance remaining constant 
over time, indicating a soluble refold.  Arginine is known to act like a mild denaturant, 
maintaining conformational flexibility and preventing intramolecular interaction and 
aggregation during refolding.  It is often used as an excipient to aid refolding and 
suppresses aggregation of partially unfolded proteins and intermediates (Marston 1986).  
In the other conditions the absorbance changes over time and reaching a steady state 
appears to be slower in these conditions.  For 280 and 340 nm the absorbance decreases 
over the first 20 minutes for a buffer with no additives from a very high absorbance, 
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which indicates the fast formation of aggregates followed by some dissolution. On the 
other hand in the sucrose buffer a small increase is observed from a lower starting 
absorbance, which shows the rate of aggregation formation is different between these 
conditions.  The changing absorbance at 280 nm does not result from different 
proportions of folded and unfolded protein during refolding as the absorbance remains 
fairly constant for folded and unfolded protein (see Figure 9.1 in Appendix for 
absorbance of denatured and native protein in different buffers at different 
concentrations).  Unfolded protein results in more subtle variations in absorbance at 280 
nm, and denaturing the protein with guanidine hydrochloride results in a shift of the 
maximum absorbance to a shorter wavelength (Pace 1995).  Therefore the four times 
greater absorbance for additive free refolds compared to the refold in arginine results 
from light scattering by the presence of aggregates.  In conclusion, absorbance changes 
over time for some of the refold conditions, which reflects a transition from unfolded 
protein to both soluble native, and insoluble aggregated protein.  
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Figure 3.1  The effect of different wavelengths on the absorbance profile of refolds in different buffers a) 
280 nm, b) 340 nm and c) 600 nm.   
3.3.1.2 Absorbance changes during refolding 
Absorbance changes that occur as a function of time during refolding can be explained 
in part by the formation of insoluble protein.  This is illustrated during experiments to 
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investigate the impact of DTT and redox couples on the formation of insoluble protein.  
Figure 3.2 shows the effect of DTT concentration on the amount of soluble protein 
present during the course of refolding.  It demonstrates that the concentration of soluble 
protein increases with time during a refold at high DTT concentration, whereas at a 
lower DTT concentration the soluble protein concentration is stable at 0.17 mg.ml
-1
.   
This indicates that at a low DTT concentration there are no significant changes in the 
partition between soluble protein and insoluble aggregates, and any aggregates formed 
early on are not deconstructed to soluble protein to be refolded.  At a higher DTT 
concentration, the concentration of soluble protein immediately after the start of 
refolding is lower at 0.107 mg.ml
-1
, but increases to 0.156 mg.ml
-1
 after 50 minutes 
reaching a similar level as for a lower DTT concentration.  This shows that more 
soluble protein has become available for folding and the partition between soluble and 
insoluble protein is not constant for a high DTT concentration.   
The final yield of soluble protein after 100 minutes of refolding for a high DTT 
concentration is greater than at a low DTT concentration. A lower concentration of DTT 
could result in a lack of reducing power, altering the redox potential and resulting in a 
lack of reducing species to break incorrectly formed disulphide bonds in misfolded 
protein, resulting in a lower final yield of 0.167 mg.ml
-1
.  At a higher DTT 
concentration, the yield is initially lower but increases over time to reach a higher yield 
of 0.205 mg.ml
-1
.  Gerami et al. (2011) have shown that the refolding of recombinant 
tissue plasminogen activator (rPA) is sensitive to residual DTT concentration and DTT 
inhibits refolding.  Guise and Chaudhuri (2001) found that refolding yield of lysozyme 
is highest at low DTT concentrations and yield fell rapidly at concentrations above 
0.6 mM with their redox system (3 mM reduced glutathione, 0.3 mM oxidised 
glutathione).  A high DTT concentration could affect the rate of folding by breaking 
disulphide bonds in correctly folded protein or rapidly formed misfolds, resulting in a 
lower yield of native protein at the early stages.  If misfolded protein with incorrect 
disulphide bond pairs formed either intra-molecularly or inter-molecularly, high DTT 
concentrations could provide the reducing power to allow these disulphide bonds to 
break.  This provides the protein with another chance of folding to soluble native 
protein, allowing it to recycle through the refolding pathway again.  This demonstrates 
that absorbance changes over time as a result of refolding and aggregation kinetics.  
Large changes in absorbance result from the scattering of aggregates.  This effect is 
combined with small absorbance changes, which reflect native soluble protein folding. 
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Figure 3.2  The concentration of soluble protein during the course of a refold experiment at two different 
DTT concentrations (25 mM and 0.625 mM).   
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In addition to monitoring fluctuations in soluble protein, absorbance can also be used to 
monitor aggregation over time.  Aggregates can form at different rates and can be 
measured in real time using a wavelength of 600 nm.  Figure 3.3 shows aggregates form 
much more slowly with a DTT: cystamine redox pair and a final protein concentration 
of 1 mg.ml
-1
.  Aggregate levels reach their maximum 2 hours after refolding has been 
initiated.  In the presence of a different redox pair of cysteine: cystine aggregation 
occurs much faster with aggregate reaching a peak at 45 minutes after the start of the 
refold process even though the final protein concentration is half that of the DTT: 
cystamine redox pair (0.5 mg.ml
-1
).  At a lower protein concentration, refolding occurs 
at a faster rate giving higher yields (Raman 1996), therefore one would expect the lower 
protein concentration present in the cysteine: cystine condition to result in a higher yield 
and less protein aggregation.  However Buswell and Middelberg (2002) show folded 
native protein could also become incorporated into aggregates either via an intermediate 
or directly through the surface, so the increased aggregation found at a low protein 
concentration may result from the incorporation of native protein.  A decrease in 
absorbance is then observed between 1 and 4 hours for cysteine: cystine as aggregates 
become smaller in size and as a result scatter less light, suggesting deconstruction to 
form soluble protein as previously observed for high DTT concentrations.   
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Figure 3.3  Absorbance at 600 nm over time during a refold with different redox couples, (○) DTT 
cystamine, (●) cysteine, cystine. 
 
Figure 3.3 shows the formation of aggregates immediately after the addition of buffer to 
protein, demonstrating the short time scale involved in aggregation under certain 
conditions.  Goldberg (1991) reported that the majority of aggregation occurs by 5 
seconds, whereas the timescale of renaturation is minutes.  The results are in good 
agreement with the findings of Raman (1996) who used 450 nm to monitor the 
formation of aggregates and found that aggregation in the first 5 minutes was negligible 
but increased sharply afterwards reaching an absorbance of 1 A.U. after 30 minutes.  
Once aggregates form they may not be stable, as shown by the decreasing absorbance 
for cysteine: cystine in Figure 3.3 b).  Therefore it is important when assessing the 
highest yielding condition to choose an appropriate end point as early measurements 
may give misleading results.  It also illustrates how a steady state of aggregate 
formation is reached at different times depending on the redox pair used.  Therefore 
aggregation is not only dependent on the presence of excipients and the concentration of 
DTT, but also on the redox pair selected.  A limitation of this assay is that even if 
soluble protein is present, it does not necessarily mean that it is natively folded active 
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protein.  Therefore another assay is needed in order to evaluate the remaining soluble 
species and whether they have formed native protein.   
3.3.1.3 Fluorescence changes during refolding   
In order to rapidly assess the yield of soluble protein, fluorescence excitation at 280 nm 
and emission at 340 nm can be used to give information on the secondary structure of 
the protein.  Figure 3.4 shows the relative fluorescence of refolds at three different 
redox potentials and demonstrates the effect of redox potential on refolding.  Relative 
fluorescence was found to decrease during refolding.  Katoh et al. (1999) also 
demonstrated that relative fluorescence intensity sharply decreased during refolding, 
becoming constant after 100 minutes.  Raman et al. (1996) showed that denatured and 
reduced lysozyme has the highest fluorescence, followed by intermediate and native 
lysozyme.  The observed decrease in fluorescence may indicate the transition from 
unfolded to folded native protein.  
 
The ranking of the different redox potentials changes over time.  Initially the reducing 
condition has the highest fluorescence, and oxidising the lowest fluorescence which is 
the most similar to native state.  However the trend observed changes over time as the 
oxidising condition reaches the highest final fluorescence value similar to the native 
state with a fluorescence of 0.914 after 1200 minutes.  The balanced redox condition has 
the lowest final relative fluorescence of 0.827, suggesting a lower yield was achieved.  
From the fluorescence data you would conclude that the oxidising redox is the highest 
yielding condition.  It also highlights the different folding behaviour found for different 
redox potentials as they all display different fluorescence profiles and demonstrates 
again that an appropriate end point must be chosen for comparison.      
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Figure 3.4 Fluorescence over time for refolds at different redox potentials 
 
In conclusion kinetic measurements of fluorescence can increase the complexity of data 
analysis when multiple conditions are tested.  Additionally, it is time consuming in a 
microwell plate format, and the repeated measurement of fluorescence at short intervals 
can result in temperature changes in the plate which may affect evaporation and edge 
effects (Grant et al., 2009).  A constant temperature is hard to maintain in the microplate 
reader and the degree to which the temperature rises is subject to environmental 
conditions, an example of the temperature profile in the microplate is shown in Figure 
.9.2 of the Appendix.  The amount of information obtained by following the refold 
throughout time may not be necessary for a screening study of large numbers of 
refolding conditions as the final yield is the criteria for assessment.  Therefore the 
decision was made to focus on end-point analysis.  In fact the buffer that allows the 
fastest rate of refolding might not be beneficial as longer process times allow an 
overnight step, which does not rely on user interaction and can act as a break in the 
process.  This is often done as standard in process development buffer screens in 
industry.   
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3.3.1.4 Example of end point analysis 
End point analysis allows ranking of refold conditions by their overall performance in 
terms of final yield.  It was used to investigate the effect of protein concentration on 
refolding.  The final concentration of protein in the refold is known to affect the 
refolding yield (Goldberg et al., 1991; Raman et al., 1996).  Figure 3.5 shows the 
absorbance at 280 nm of refolds performed at different final lysozyme concentration.  
For most of the protein concentrations tested the absorbance of the refold is the same as 
the standard, indicating that all of the protein present in the refold solution is soluble.  
At higher lysozyme concentrations, however, the standards and refold values differ 
slightly.  This could be due to aggregation resulting in less soluble protein concentration 
as observed at 0.7 and 0.8 mg.ml
-1 
(Figure 3.5).  It could also results from the increased 
measurement error at absorbance values above 1 A.U or the error associated with the 
preparation of the samples.           
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Figure 3.5 Absorbance at 280 nm for refolds at different final protein concentrations.  Standards of the 
same protein concentration as refold shown with best fit line.  Standard deviations are shown for each 
point, which is an average of three experimental repeats. 
 
Figure 3.6 shows the relationship between relative fluorescence (relative to a native 
standard) and refolds at different final protein concentrations.  Initially the fluorescence 
decreases rapidly between a protein concentration of 0.1 and 0.2 mg.ml
-1
, and then it 
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decreases relatively less as the protein concentration increases to 0.6 mg.ml
-1
, before 
increasing slightly to 1.0 mg.ml
-1
.  Refolds with similar relative fluorescence have 
protein folded similarly as their tryptophan residues are reporting the same 
environment.  This indicates that the refolds at protein concentrations of 0.2-1 mg.ml
-1 
may have similar yields. 
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Figure 3.6  Fluorescence for refolds at different final protein concentrations 
 
In order to confirm the yield predicted using intrinsic fluorescence, an activity assay 
was used.  Figure 3.7 shows the relationship between activity and the final lysozyme 
concentration of the refold.  The lowest concentration of 0.1 mg.ml
-1
 gives the highest 
refold yield of 0.0173 ΔOD.min-1.mg-1.  The refold yield decreases rapidly to only 0.010 
ΔOD.min-1.mg-1 for a protein concentration of 0.2 mg.ml-1.  The renaturation yield 
remains fairly constant for further increases in protein concentration until a 
concentration of 0.9 mg.ml
-1
 is reached where yield decreases again. The highest final 
protein concentration of 1.0 mg.ml
-1
 has the lowest yield with an activity of only 0.04 
ΔOD.min-1.mg-1.  The relative fluorescence for the most active protein is 1.4 Fl.U., 
which appears to indicate a native or near native state.  The decreasing fluorescence up 
to a concentration of 0.6 mg.ml
-1
 correlates to a decrease in activity, which could result 
from folding to a less active but native form or due to the formation of misfolded 
soluble protein.  The increase in fluorescence for a concentration above 0.6 mg.ml
-1 
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correlates with the decrease in activity and is probably due to the formation of insoluble 
aggregates, which scatter the fluorescence signal.  Therefore fluorescence provides 
information regarding the folding environment, which can potentially be combined with 
an absorbance assay to filter out aggregating samples. 
 
The relationship between protein concentration and yield agrees with the results 
obtained by Goldberg et al. (1991) which showed activity decreasing when the protein 
concentration increases from 0.05 to 1 mg.ml
-1
.    Raman et al. (1996) also showed 
activity decreases when protein concentration increases from 0.05 to 0.25 mg.ml
-1
, and 
found the activity decreases rapidly between 0.1 and 0.2 mg.ml
-1
 with yields of 
approximately 70 and 30% respectively.  The protein concentration for refolding, based 
on the results obtained in this work, is 0.1 mg.ml
-1
 as this concentration gives the 
highest yield.  Lower concentrations are known to be the best for refolding but not 
always economical (Rudolph and Lilie 1996).    For an industrial process the yield is not 
the only factor to consider.  In fact, a high final protein concentration is also desirable to 
avoid costly concentration steps after refolding.  Based on the results obtained in this 
work it is advisable to conduct the refold with a final concentration of 0.8 mg.ml
-1
 to 
maximise both yield and concentration. 
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Figure 3.7 Activity for refolds at different final protein concentrations.  Error bars represent averages of 
duplicate or triplicate refolds. 
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3.3.2 Translation from manual to automated set-up 
 
Refolding protein from inclusion bodies is the rate-limiting step in process development 
as a large number of conditions needed to be screened on a trial and error basis.  
Therefore using a 96-well format allows the parallel screening of many different 
conditions, for example different buffers, redox reagents and additives, using minimal 
quantities of product.  Combining this approach with the use of an automated robotic 
platform to perform the refolding process step and related assays offers distinct 
advantages over manual pipetting operations, including improved precision, accuracy, 
speed and process efficiency.  Automated liquid handling should also improve 
reproducibility between experiments, giving more comparable results between 
experiments.  In order to demonstrate that our automated process could reliably 
reproduce manually obtained results, experiments were performed with the same 
material and microplate reader for comparison.  An illustration of the automated process 
is shown in Figure 3.8.   
 
3  Assay Development  G. Ordidge 
 
108 
 Robotic arm 
manipulation
Absorbance at 
280 & 600 nm, 
Fluorescence
AnalysisLiquid handling 
operations
Preparation & refold
Addition of denatured 
protein, dilution buffers, 
controls, standards
24 hrs
Dilution
Activity Assay
Absorbance at 
450 nm
Addition of potassium 
phosphate
Sample 
withdrawal
Sample 
withdrawal
Addition of M. 
lysodeikticus
Stages
 
Figure 3.8 Schematic of automated refolding process and assays 
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A good correlation between manual and automated assays was obtained with only 
minor deviations from the parity line, which may be due to a small systematic error in 
the methods.  Figure 3.9 shows a parity plot of the manual and automated absorbance 
data.  Each datum represents an average of 3 values obtained in different wells, for a 
wide range of different refolding conditions, or experiments performed on separate 
days.  The errors for manual and automated refolding measured using the absorbance 
assay are comparable, with an average error of ±0.017 A.U. for manual and ±0.020 
A.U. for automated.  The best fit line shows a slight offset from the line of parity, 
illustrating that manual refolds give slightly higher results at an absorbance above 1.8 
A.U. and may be related to the difficulty to obtain accurate readings in microplate 
readers.   
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Figure 3.9  Absorbance at 280 nm of refolds prepared manually compared with refolds prepared using an 
automated platform. 
 
Figure 3.10 shows a comparison between automated and manually obtained for 
fluorescence data.  A very good agreement was obtained in this case.  The average error 
for manual was ±540 Fl.U compared with ±503 Fl.U for automated data, showing 
greater accuracy for automated techniques.  The average error for the activity assay also 
gave a smaller error for automated techniques, with ±0.0019 and ±0.0015 OD.min-
1
.mg
-1
 for manual and automated respectively.  Once again a deviation from the line of 
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parity was observed for the activity measurements (Figure 3.11), which could result 
from the experimental methods.  For the manual experiment, the plates experience 
different lag times after addition of the enzyme substrate to the first well and the first 
absorbance reading, leading to systematically decreased rate relative to the true initial 
rate.  By contrast, automation allows the delay between the addition of the M. 
lysodeikticus and the first measurement in the plate reader to be shorter than when using 
the manual method and the delay can be kept constant between experiments.   
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Figure 3.10  Fluorescence of refolds prepared manually compared with refolds prepared using an 
automated platform. 
 
The best fit line for the activity data is skewed by a single datum point (-0.056, -0.072).  
This error could be a consequence of the small volumes involved in microscale 
techniques, which result in a greater source of random errors due to the pipetting 
accuracy of small volumes.  The standard error for refolded samples is higher than that 
of standard and control solutions, perhaps due to the error involved in aliquoting small 
volumes of protein when preparing the refold.  In addition, inherent with refolding is the 
stochastic nature of the formation of aggregates.  Aggregates may be seeded by surface 
defects in the wells or by dust particles present in solution causing different results 
between wells of the same conditions.  Standard errors were greater for the activity 
assay than absorbance or fluorescence measurements, indicating that errors with this 
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analysis technique are greater.  This is most likely due to the additional transfer of 
liquid samples required to prepare the activity assay, resulting in larger combined errors. 
Activity Automated (OD.min
-1
.mg
-1
)
-0.14 -0.12 -0.10 -0.08 -0.06 -0.04 -0.02 0.00 0.02
A
c
ti
v
it
y
 M
a
n
u
a
l 
( 
O
D
.m
in
-1
.m
g
-1
)
-0.14
-0.12
-0.10
-0.08
-0.06
-0.04
-0.02
0.00
0.02
 
Figure 3.11 Activity of refolds prepared manually compared with refolds prepared using an automated 
platform. 
 
The results demonstrate the automated sequence can be used to carry out parallel 
microscale refolding experiments and evaluate a large number of experimental 
conditions.  Despite the small volumes used and the stochastic nature of each individual 
refold, the results were comparable and errors involved were relatively small.  The main 
advantage of the automated sequence is the consistency of results obtained between 
different experiments, and the significant decrease in preparation and process time.  
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3.3.3 Developing a set of hierarchical generic assays 
 
An activity assay is the gold standard for assessing protein refolding because of the 
relationship between structure and function, but is not generically available for all 
proteins due to its specificity. While no single generic assay provides all the information 
needed to determine the refolding yield, several generic orthogonal assays can be used 
in conjunction (as shown in the previous section) and potentially applied to optimise 
any protein refolding process.  However such assays still require confirmation of yield.  
A common problem when assessing the refolding of novel therapeutic proteins with no 
available activity assay is the lack of suitable high throughput assays.  A RP-HPLC or 
UPLC assay could be developed but still require sample processing times of at least 15 
minutes per sample to obtain quantitative yield information.  This can be time 
consuming for a microwell plate where 96 different refold conditions can be evaluated.  
Therefore by combining the generic orthogonal assays described into a hierarchy, it 
enables the most rapid and lower cost assays to be performed as an initial screen to 
eliminate low-yielding refold conditions, saving the most resource intensive assays for 
the most promising conditions.   
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Figure 3.12 Schematic of proposed structure for hierarchical assays 
 
The first stage of our hierarchy, absorbance at 600 and 280 nm (A600, A280), was 
chosen to detect aggregates that indicate poor refolding and to measure soluble protein 
(Figure 3.12).  However, absorbance alone is not capable of distinguishing between 
native or misfolded soluble protein.  Therefore a second screening step, measuring 
intrinsic protein fluorescence, was chosen to provide information on the degree of 
native-like tertiary structure formed relative to a native standard.  The absorbance 
screen could potentially act as a filter to eliminate the frequently misleading influence 
of aggregate formation on the fluorescence assay.  If a purified and natively folded 
protein standard is unavailable, a target fluorescence value can often be obtained from 
the protein folding literature, which indicates the direction that the fluorescence needs to 
change to increase the yield.  The conditions with a high native-like structure can then 
be confirmed using the final stage in the hierarchy, an activity or HPLC assay to 
quantify yield in terms of functional protein present.   
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3.3.3.1 Oxidation 
The automated microscale refolding process with integrated absorbance, fluorescence 
and activity assays was used to investigate the effect of two different mixing methods 
on the lysozyme refolding yield, pipette aspiration alone in a static system and pipette 
aspiration used in conjunction with shaking.  It is not known if redox potential is 
constant throughout refolding or if it is altered by exposure to air and pipetting.  
Shaking allows the introduction of air bubbles which could potentially perturb the redox 
potential.  If even vigorous shaking is not able to perturb redox ratio, then exposure to 
air in a static microwell system cannot alter redox potential.   
 
It was hypothesized that shaking could affect the yield through two different 
mechanisms.  In the first mechanism, shaking could increase the oxygen transfer rate 
and hence the dissolved oxygen in solution altering the redox potential.  Air oxidation is 
used as a method for shuffling disulphide bonds during refolding through aeration or 
static exposure of the vessel to air.  The dissolved oxygen can then oxidise the reduced 
thiol compound forming a disulphide bond, leading to the creation of a redox pair that 
causes disulphide-bond shuffling.  Both shaking at high speeds and pipette mixing 
during plate preparation increases the amount of oxygen dissolved into the refolding 
solution and could potentially alter the redox ratio of the buffer on a timescale that is 
faster than the refolding process. 
 
The second mechanism through which shaking could affect yield is by increasing the 
presence of air bubbles in the liquid phase which could act as seeding sites for 
aggregation.  Vigorous shaking causes the formation of bubble and vortices, which 
increase the area of the air-liquid interface.  Proteins commonly adsorb at the air-liquid 
interface, and due to the surfaces hydrophobicity it acts as a seeding site for aggregation 
(Treuheit et al., 2002).  An increase in free energy occurs when the protein 
conformation changes and polar residues are orientated towards the aqueous phase and 
non-polar (hydrophobic) residues towards the air phase, thus leading to the denaturation 
of native protein at its surface (Wierenga et al., 2006).  Enzymes have been reported to 
lose activity during adsorption. Furthermore, denatured and partially folded 
intermediates are prone to aggregation as hydrophobic regions normally buried in native 
protein are free to interact inter-molecularly to form aggregates (Fink, 1998).   
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A high refolding yield of lysozyme was previously obtained using a refolding buffer of 
1.2 M GdnHCl, 4 mM cystamine and 50 mM Tris by Mannall et al. (2007).  Therefore 
this refolding buffer and denatured lysozyme containing 6, 32 or 62 mM DTT (as 
described in Table 2.3) were selected to evaluate the impact of different redox and 
shaking conditions upon the refolding yield.   
3.3.3.1.1 Generic assays  
The generic absorbance and fluorescence assays were used as the first level of the 
hierarchy.   Figure 3.13 shows the absorbance at 600 nm for shaking and static refolds 
using refold buffers with three different redox potentials.  Aggregation was not 
observed under shaking or static conditions.  Figure 3.14 shows only a marginal loss of 
fluorescence was observed for oxidising and balanced redox conditions when the 
refolds were shaken compared to static.  In contrast, for the reducing condition the 
fluorescence of the shaken refold sample was approximately half that obtained for static 
conditions.  This difference indicates the protein in the shaken refold is reporting a 
different average environment around the tryptophan and tyrosine fluorophores, due to 
either partial refolding or non-native tertiary structure, such as that in misfolded protein.   
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Figure 3.13 Absorbance at 600 nm at three different redox potentials (oxidising, balanced and reducing) 
after refolding lysozyme for 24 h in static and shaking 96-deep square microwells. 
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Figure 3.14  Relative fluorescence at three different redox potentials (oxidising, balanced and reducing) 
after refolding lysozyme for 24 h in static and shaking 96-deep square microwells. 
3.3.3.1.2 Specific assays (2nd level of hierarchy) 
The activity assays performed confirm the finding that agitation decreases the final 
refolding yield for the reducing condition, as can be shown in Figure 3.15.   Initially, it 
was expected that shaking would enhance the oxidation of cysteamine in the reducing 
condition to establish a redox pair for disulphide bond shuffling, thus resulting in a 
higher refolding yield compared to the equivalent static condition.  However the yield 
was lower when shaking, suggesting that shaking is unable to alter the redox potential to 
a more optimal redox potential for disulphide shuffling.  The decrease in yield could be 
attributed to the physical effects of shaking.  Shaking could increase the occurrence of 
misfolded protein and trap it at solid-liquid or air-liquid interfaces where hydrophobic 
residues preferentially interact with the interface or other proteins with exposed 
hydrophobic surface.  The inability of shaking to increase yield through changing redox 
potential is supported by the findings under an oxidising and balancing redox potential.  
For a balanced redox condition, only a minor decrease in activity was observed from 
84% to 75% upon shaking.  Additionally, the low activity obtained for the static 
oxidising condition (37%) was not further diminished by shaking (42%), indicating that 
shaking potentially has no effect when further oxidation of the redox pair cannot take 
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place.  This indicates that the redox potential is not perturbed significantly by shaking 
for different redox ratios.    
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Figure 3.15  Activity at three different redox potentials (oxidising, balanced and reducing) after refolding 
lysozyme for 24 h in static and shaking 96-deep square microwells.  Activity is expressed as a percentage 
of the activity of a native standard. 
 
Figure 3.15 also shows that both the oxidising conditions gave a lower yield despite 
having the same fluorescence and absorbance as the balanced refold conditions (Figure 
3.14 and Figure 3.13 respectively).  This highlights that the fluorescence assay would in 
certain cases be misleading if used in independently. The high intrinsic fluorescence 
observed for the low yielding oxidising condition does not represent fully active protein, 
but an inactive state with native-like fluorescence but only 50% of the maximum 
activity obtained.  An oxidising redox potential has been reported to result in soluble 
inactive lysozyme as it can prevent the formation of correct disulphide pairings (De 
Bernardez Clark et al., 1998) and can lead to misfolded but stable states where the 
disulphide bonds are trapped in non-native pairs (Mannall et al. 2007).  Therefore the 
high fluorescence and low yield could result from species trapped with non-native 
disulphide bonds due to the lack of reducing species available to break them.  The 
tryptophan residues in these species report the same overall natively folded environment 
but are not within any slightly misfolded regions of the protein which lead to 
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inactivation, as shown by the high relative fluorescence.  If this misfolding occurs 
rapidly, it is unlikely to be affected by the increase in air-liquid or solid-liquid interfaces 
under shaking, particularly if the protein forms stable near-native misfolds that do not 
expose hydrophobic surface.  Similarly, if refolding to form stable native protein is 
rapid under a balanced redox, the refold yield would not be significantly affected by the 
physical effects of shaking, such as increased rate of interaction with air-liquid or solid-
liquid interfaces.  However, under the reducing condition the stability of the refolded 
protein would be low even if it is in a near-native state, due to the potential of the 
reducing redox to break native disulphide bonds.  Consequently, the presence of air-
liquid or solid-liquid interfaces upon shaking presents a surface upon which the unstable 
protein can readily unfold, leading to inactivation.   
 
Shaking could also have a stronger impact on refolding under reducing conditions 
because the rate of folding is slower due to a lack of oxidising species in solution.  
Previous work has shown that the rate of active protein formation is slowed under 
strongly oxidising conditions because of the increased time taken to shuffle the 
disulphides into the native pairings (Mannall et al., 2007).  Conversely the same could 
be said for a lack of oxidising species under a reducing condition, which would make 
disulphide bond formation difficult (much like the reducing conditions in the cytoplasm 
that lead to inclusion body formation initially). Three out of four disulphide bonds are 
required to form for lysozyme to be active (Eyles et al., 1994).  Without the formation 
of disulphide bonds, the conformation would not be stabilised to the native state.  
Goldberg and Guillou (1994) found that substantial secondary structure was formed 
within 4 ms when refolding lysozyme, whereas when refolding under reducing 
conditions no such secondary structure was formed in this timescale.  De Bernardez 
Clark et al. (1998) showed there was an optimum redox potential (GSH/GSSG ratio= 
1.5-2.5) and outside this range refolding was slower for both more reducing and more 
oxidising redox potentials.  Refolding outside of this range appears to affect the stability 
of the refold as they are more susceptible to the effects of shaking. 
3.3.3.1.3 Verification of assay results using circular dichroism 
In order to confirm that the assay was able to correctly identify active protein, further 
analysis of the secondary structure of the refolded lysozyme was carried out using 
circular dichroism (CD).   Lysozyme is a globular protein with two domains, an α-
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domain with 3 α-helices and 1 C-terminal 310 helix, and a β-domain, consisting of a 3 
stranded anti-parallel β-sheet and 1 loop and therefore possesses diverse structural 
elements.  CD spectra of lysozyme are typically characterised by a peak around 210 nm 
followed by a shoulder which extends to 240 nm (Johnson 1990).  Figure 3.16 shows 
the CD spectra of refolded lysozyme having an activity of 35%.  It has a similar shape 
to the standard, as expected, and other reported spectra for lysozyme (Johnson, 1990; 
Gu et al., 2004).  Lysozyme mostly consists of alpha helix, however the β-sheet 
normally overshadows the effect of the second α-helix peak, and in this work the noise 
caused by the presence of DTT eclipses this effect.  Therefore the refolded protein 
shares the same structural features as the native lysozyme and some of the protein 
present has refolded to a native-like state.  This supports the activity data and confirms 
that a folded state has been reached.  However the signal for the refolded protein is 
lower than the standard, despite normalising by protein concentration, perhaps due to a 
mixed population of protein.  It could result from the presence of intermediate, which 
Raman et al. (1996) showed to have a lower signal. 
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Figure 3.16 Circular dichroism spectra of a high activity refold (–) and native active lysozyme (- -) 
 
Figure 3.17 shows the CD spectra of refolded protein with an activity of 2%.  The 
refolded sample lacks the secondary structure detected for the standard.  Whilst there is 
some α-helical structure present, the characteristic peak with shoulder is absent.  The 
35 0.494 0.100 0.027 
Activity % Fluorescence A280 A600 
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CD spectra of the refolded protein does not display the features associated with a 
completely random coil structure (negative peak around 195 nm), and the sample may 
have some α-helical properties, due to the slight negative peak at 210 nm.  The positive 
peak observed at 205 nm could be attributed to the presence of noise from the low 
concentration of DTT present in the sample, but could also result from the presence of 
anti-parallel β-sheet.  Partially folded intermediates typically have significant native-
like structure, whereas aggregates show a greater amount of β-structure relative to the 
native form (Fink, 1998).  Therefore the presence of some α-helix and perhaps an 
increase in β-structure could indicate the presence of aggregates. 
 
The tables in Figure 3.16 and Figure 3.17 summarise the assay results for the samples 
tested using CD.   The low fluorescence and lack of activity support the lack of structure 
discovered in the corresponding CD spectrum in Figure 3.17.  The sample with a higher 
fluorescence and activity had a CD spectrum similar to the native standard (Figure 
3.16), supporting the presence of refolded protein in this sample.  Therefore the CD 
supports the assay results for both a low and a higher activity condition. 
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Figure 3.17 Circular dichroism spectra of a low activity refold (–) and native active lysozyme (- -) 
 
In summary, the physical effects of mixing (bubbles and vortexes introducing surfaces 
for denaturation) appear to be significant during refolding.  By contrast, the entrained 
2 0.179 0.030 0.013 
Activity % Fluorescence A280 A600 
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oxygen concentration does not appear to be changing the redox potential sufficiently to 
alter the refolding yield over a 24 hour period, and therefore it is likely that it remains 
constant in a static period over this time.  These results demonstrate the importance of 
mixing mode and have allowed us to identify an optimum mixing condition for 
microscale refolds, in this case the static balanced redox ratio, for subsequent folding 
studies. These results suggest that the best use of the intrinsic fluorescence assay would 
be for eliminating low yielding conditions in screens of multiple conditions, rather than 
for specifically identifying the highest yielding conditions, as it can be misleading in its 
predictions.  In order to gain a greater understanding of how this might work, we aimed 
to explore a hierarchical assay concept with a larger data set. 
3.3.4 Hierarchical assays using lysozyme 
3.3.4.1 Absorbance 
Figure 3.18 shows the relationship between absorbance measurements at 600 nm and 
lysozyme activity after refolding in 12 different buffers and two different dilution 
factors.  The cut-off point of 0.25 A.U was selected based on visual observations of 
aggregates at absorbance values higher than this value, due to the scattering of light by 
large aggregates.  Consequently, high absorbance is correlated to low activity.  Low 
absorbance values were observed for soluble refolds with a range of activities, and the 
cut-off point included almost all samples that had activity greater than 40%.  This assay 
identified aggregation in 32% of conditions tested, thus reducing the number of samples 
for the next stage in the hierarchy to 68%.  In the remaining soluble samples, 54% had 
activities >50%, indicating that absorbance scattering is a suitable first filter to eliminate 
aggregating refold conditions from further study.  Nevertheless, it does not identify the 
degree of folding in the soluble phase, as highlighted by 48% of samples with an 
absorbance less than 0.25 A.U. also having an activity of less than 50%.  One refold 
condition is present which has a high activity and high absorbance which contradicts the 
relationship between low absorbance and high activity.  While this could be a 
systematically erroneous data point, the triplicate data had a standard deviation of 7%.  
This condition could indicate a kinetic partition between refolding to soluble active 
protein and misfolding to aggregates, with the sample containing a mixture of inactive 
aggregates and native active protein.   Kiefhaber (1995)  found 20% of lysozyme folds 
via a direct pathway rather than an intermediate even at high protein concentrations and 
that this pathway may out-compete aggregation.  The aggregation of lysozyme has also 
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been found to level off regardless of protein concentration Goldberg et al. (1991).  
Therefore it is possible to find active protein even in the presence of aggregates.  
However it is more likely that it is a consequence of the dilution step prior to activity 
measurements, which may have re-solubilised some of the aggregates in this case, 
leading to a greater reported activity.   
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Figure 3.18  Absorbance (600 nm) as a function of activity for lysozyme refolds.  Aggregating samples 
(○), soluble samples (●) and cut-off line at 0.25 A.U. (- -). 
3.3.4.2 Fluorescence 
The relationship between relative fluorescence and activity for both aggregating and 
soluble refolded lysozyme is presented in Figure 3.19.  Adjusting the intrinsic 
fluorescence to relative fluorescence allows rapid identification of high yielding 
conditions as values close to 1 represent native structure formation with 
correspondingly high levels of activity (denatured protein has a relative fluorescence 
close to zero).  The relative fluorescence for aggregated samples ranged from 0.4-2.2.  
Aggregates often result in misleading high intrinsic fluorescence values due to light 
scattering, whereas all soluble samples had fluorescence values below 1.1.  The overlap 
between these two populations highlights the importance of first filtering out aggregates 
using the absorbance assay. 
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Soluble refolds conditions with a relative fluorescence close to 1.0 were generally 
associated with a high lysozyme activity, indicating a high level of native protein 
environment.  The majority of high activity samples had fluorescence values above 0.6 
A.U.  In general, as the relative fluorescence increases from 0.2 to 1.0, the activity also 
increases (Figure 3.19), indicating progressively higher refolding yields as more native 
structure is obtained.  Interestingly, relative fluorescence values greater than 1 are 
associated with low activity, suggesting the presence of soluble misfolded protein with 
near-native structure and fluorescence intensity greater than that of the native protein.  
This is supported by our previous findings for oxidising refolds, which had a high 
relative fluorescence but low activity (Section 3.3.3.1.2).  The greater than native 
fluorescence indicates increased burial of tryptophan and tyrosine fluorophores into 
hydrophobic regions that are related to those found in the native protein structure.  
Other authors have reported that intermediate folding states for lysozyme have a 
fluorescence intensity that is higher than native and refolded protein at the emission 
wavelength used (340 nm) Raman et al. (1996), and therefore the results observed could 
be explained by misfolded intermediates. 
 
The highest activity levels correspond to relative fluorescence values in the range of 
0.83-1.02 fluorescence units as shown by the cut-off lines in Figure 3.19.  Therefore, it 
is possible to select the highest yielding conditions for more detailed analysis by slower 
and more resource intensive assays to confirm yield.  In cases where direct assays for 
biological function are not available or suitable for high-throughput automation, 
refolding conditions could be selected based on fluorescence values in a pre-defined 
range as they are likely to have refolded to a high activity.   
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Figure 3.19  An activity measurement as a function of relative fluorescence for lysozyme refolds.  Each 
point represents a triplicate or average of 9 data points.  Aggregating samples (○), soluble samples (●) 
and cut-off lines at 0.83 and 1.02 A.U. (–). 
3.3.4.3 Activity assay  
The highest activities were reported under conditions of 1.2M final guanidine 
concentration and a DTT:cystamine redox pair with varying redox potentials.  This 
agrees with previous findings that this is an optimal condition for refolding (Mannall et 
al., 2007).  A guanidine concentration of 1-2 M has been reported to help maintain 
chain flexibility and prevent interactions that lead to aggregation.  De Bernardez Clark 
et al. (1998) showed that increasing guanidine affected the competition between folding 
and aggregation, and found an optimum final concentration of 1.3M in the refold which 
skewed the refold in favour of folding.  Mannall et al. (2007) compared concentrations 
0.53 M and 2.38 M GdnHCl using the same redox pair and buffer and found a 
concentration of 1.2 M to be optimal for yield.   On the other hand, a low activity and 
the presence of aggregates were associated with a cysteine: cystine or DTT: cystamine 
redox pair with a low final guanidine concentration of 0.53 M.  The lower concentration 
of guanidine may prove insufficient to prevent intermolecular interactions, leading to 
the formation of aggregates.  The cluster of soluble refolds with low activity (4 data 
points) represent conditions with balanced or reducing cysteine/cystine redox buffer, 
with one under a reducing redox potential, DTT:cystamine and 1.2M guanidine.  The 
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reducing condition could prevent disulphide bonds from forming and a stable native 
fold from being reached as previously described (Section 3.3.3.1.2). 
3.3.5 Hierarchical assays using DHFR IBs 
3.3.5.1 Absorbance 
The hierarchical assays were then tested using inclusion body derived material of a 
different protein, DHFR to see if they could be translated to less pure and more 
industrially relevant material.  Figure 3.20 shows the relationship between absorbance 
(600 nm) and activity obtained with DHFR from purified, washed and unwashed 
inclusion bodies refolded at different concentrations using three different buffers, 3 final 
protein conditions and two different dilution factor (1:15 and 1:20).  Conditions with 
high absorbance showed no enzyme activity (with the exception of one data point), 
whereas conditions with low absorbance gave high activities due to more successful 
soluble refolds.  The aggregates found for DHFR have a much lower absorbance than 
for lysozyme (0.55 A.U. for DHFR compared with up to 1.25 A.U. for lysozyme), 
indicating larger aggregates were formed in the lysozyme refold conditions.  For the 
soluble DHFR refolds, activities ranged from 0-12 ΔOD.min-1.mg-1 and had an 
absorbance of less than 0.07 A.U.  The 0.25 A.U. cut-off for lysozyme could be used to 
differentiate soluble and aggregated condition, or a much lower cut-off point of 0.1 
A.U. could be suitable for DHFR.  In contrast to the data for lysozyme, almost all 
conditions with aggregate formation had no active activity.  The data falls into two 
distinct populations, the refold either resulted in aggregation with no active protein, or 
the protein remained soluble and refolded with varying levels of activity.  The data for 
lysozyme was more complex with mixed populations of aggregate, misfolded and active 
protein, resulting in conditions with a high absorbance and activities ranging from 0-
20%.  However it is possible that testing a wider range of conditions for DHFR could 
lead to the presence of both aggregate and active protein.   
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Figure 3.20  Absorbance (600 nm) as a function of activity for DHFR refolds.  Each point represents a 
triplicate.  Soluble refold samples, purified (●), unwashed (♦), washed (▲), and aggregated refold 
samples, purified (○), unwashed (◊), washed (Δ), and cut-off at 0.25 A.U. (- -). 
3.3.5.2 Fluorescence 
Figure 3.21 shows that an increasing fluorescence rapidly results in a more active 
refold, peaking at 6,000-10,000 A.U.  The initial relationship between fluorescence and 
activity agrees with previous work, which shows that unfolded DHFR has a lower 
fluorescence than folded DHFR at the emission wavelength used for this study 
(Uversky et al., 1996).  It has also been reported that after an initial decrease during the 
first few seconds of refolding, fluorescence increases over longer time points at 22°C as 
the DHFR folds (Clark et al. 1996).  Therefore the activity rise with increasing 
fluorescence reflects the protein taking on more native structure.  However once a 
fluorescence of 11000 A.U. is reached a gradual decrease in activity is observed, 
suggesting the presence of soluble misfolded protein in the refold that is lowering yield.  
The exact optimal fluorescence value for DHFR was unknown as no standards were 
available, consequently relative fluorescence could not be calculated.  Nonetheless, 
DHFR demonstrates an optimal fluorescence range for successful refolding as shown by 
the cut offs at 5110-7610 A.U, which select approximately 75% of the data points with 
an activity of over 10 ΔOD.min-1.mg-1.  Data points in this region are correlated with a 
high activity and therefore such information can be used as selection criteria for future 
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assays.  In this case, 12% of the conditions tested could be selected for further analysis.  
Lowering this activity threshold to 5 ΔOD.min-1.mg-1 gives new broader boundaries of 
fluorescence between 2446 and 9962, selecting 54% of all conditions tested for further 
studies.   
 
The distribution of fluorescence data relative to activity differs from lysozyme.  DHFR 
displays a positive skew, with a peak with a sharp shoulder on the left and a longer 
shoulder on the right.  This is a mirror image of the negative skew observed for 
lysozyme, where an increasing fluorescence caused a gradual increase in activity until 
fluorescence greater than 1 is reached and activity quickly decreases.  This reflects the 
different direction fluorescence is changing in during folding.  For lysozyme, 
fluorescence decreases as the protein folds Katoh et al. (1999), whereas for DHFR 
fluorescence increases during folding.  This is a result of the different 
microenvironment of the tryptophan residues in these two proteins, which can either 
become buried in non-polar environments, or exposed to fluorescence quenching by 
solvent or polar groups within the protein.  Consequently, intermediates and misfolded 
species will have a characteristic fluorescence which are in different parts of the plots 
for DHFR and lysozyme and may explain the reverse pattern observed.   
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Figure 3.21  Activity measurements as a function of relative fluorescence for DHFR refolds.  Each point 
represents a triplicate.  Soluble refold samples, purified (●), unwashed (♦), washed (▲), and aggregated 
refold samples, purified (○), unwashed (◊), washed (Δ), and cut-off lines shown at fluorescence of 5110 
and 7610 (–) and 2446 and 9962 (- -) A.U. 
3.3.5.3 Activity assay  
The optimal condition for refolding was for washed IBs with a final protein 
concentration of 0.035 mg.ml
-1
 using 50mM Tris.HCl, pH 7.2, which resulted in an 
activity of 13 ΔOD.min-1.mg-1.  The lowest yielding conditions were those 
corresponding to washed and unwashed inclusion bodies with a high protein 
concentration of 2.2 mg.ml
-1
 in the same buffer, illustrating the importance of low 
protein concentration in obtaining high yields.  The highest yields for refolding purified 
protein on the other hand were in Buffer 2 (Table 2) and by using different dilution 
factors and final protein concentrations yields of between 6.9 and 12 ΔOD.min-1.mg-1 
were achieved.  However washed and unwashed IBs refolded less successfully with this 
buffer, reaching activities of 5.4-9.1 and 3.9-7.6 ΔOD.min-1.mg-1 respectively.  This 
demonstrates how different refold buffers prove optimal for different levels of IB purity. 
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3.4 Conclusions 
 
Absorbance and fluorescence assays can be used in conjunction to rapidly evaluate a 
large number of refold conditions in a 96-well plate. Measurement of particulate 
formation by absorbance light scattering provides an initial filter to eliminate 
aggregating conditions.  Intrinsic fluorescence spectroscopy can then be used to identify 
conditions that produce protein with the most native-like tertiary structure. The refold 
process and assays were successfully translated to a robotic platform and were 
demonstrated to have approximately equal errors and advantages for assay consistency.   
 
Investigating the effect of oxidation and shaking on refolding confirmed that the 
automated assays could function as a hierarchy to eliminate unfavourable refolds.  The 
automated microscale refolding process and assay hierarchy were then used to explore a 
wider range of lysozyme refold conditions, showing relative fluorescence was a good 
predictor of yield once aggregating conditions have been screened out by an absorbance 
assay. The assays were demonstrated to be generically applicable to more industrially 
relevant IB proteins sourced from fermentation material, in the form of DHFR.  An 
optimal relative fluorescence range for both these proteins could be used as selection 
criteria for resource intensive and low throughput analytical methods to confirm yield.  
Confirming the final yield of fewer samples (corresponding to the highest yielding 
conditions) alleviates the analytical bottleneck and reduces time scales, allowing rapid 
optimisation of protein refolding at high throughput to achieve greater yields of 
bioactive product from inclusion bodies.  This established refolding and assay sequence 
could become an even more powerful tool if expanded to include other bioprocess steps 
typically studied during process development, thus limiting the number of costly and 
time consuming large scale studies.  The study conducted in this chapter was useful for 
establishing automated refolding and assays, however it is necessary to develop a 
sequence of operations with integrated assays in order to evaluate the whole process and 
be able to quantify changes made to upstream operations to final product quality and 
yield.  
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4 Development of linked automated microscale unit 
operations  
4.1 Introduction 
The development of a manufacturing process requires considerable laboratory and 
pilot scale work, often costly in terms of manpower, time and capital resources.  
Obtaining process design information early on is important to prevent process 
development from being a bottleneck stage and ending up on the critical path and 
ultimately delaying product launch (Titchener-Hooker et al. 2008). The latter would 
diminish the period of market exclusivity in which to recoup R&D costs.  In order to 
achieve this, process development must be both cost-effective and use minimal 
quantities of material.  Microscale experimentation offers a potential solution as it 
addresses both issues.  A number of studies have investigated microwell-based 
fermentation (Duetz et al., 2000; Elmahdi et al., 2003; John et al., 2003; Puskeiler et 
al., 2005), bioconversion (Doig et al. 2002; Lye et al. 2003), microfiltration (Jackson 
et al., 2006; Rayat et al., 2010), protein stability (Aucamp et al., 2005) and protein 
refolding studies (Vincentelli et al., 2004; Willis et al., 2005; Mannall et al., 2009; 
Dechavanne et al., 2011).  Combining multiple unit operations allows investigation of 
the parameters affecting each unit operation, the study of interactions between unit 
operations and the generation of material for downstream refolding studies. 
 
Integrating microscale experimentation with robotic platforms allows rapid process 
development as a large number of process conditions can be studied in parallel, 
resulting in enhanced experimental throughput and deeper process knowledge.  
Despite the capital cost of robotic platforms, automation has considerable advantages 
due to improved speed, accuracy, precision and efficiency.  It also enables walk-away 
operation improving efficiency and reducing human error.  Automation has been used 
to develop and link a number of individual unit operations using liquid handling, 
robotics and integration of centrifugation (Nealon et al., 2005).  This has facilitated 
the development of linked process sequences for fermentation and whole cell 
bioconversion (Ferreira-Torres et al., 2005; Baboo et al., 2012).  The “whole 
bioprocess” approach involves a sequence of unit operations at the microscale which 
can be used to predict large scale performance and analyse the effect of upstream 
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operations on downstream yields.  The availability of new techniques, such as AFA 
for microscale lysis, allows the application of these processes to intracellular products 
such as inclusion bodies.  In particular when microscale lysis is combined with novel 
flow cytometry techniques, process monitoring of cell rupture and inclusion body 
release is possible (Medwid et al., 2007).          
   
The aim of this chapter is to create a whole automated bioprocess from fermentation 
to inclusion body harvest developed at the microscale that can be combined with the 
solubilisation, refolding and assays described in the previous chapter.  The sequence 
is based on current industrial scale inclusion body processes and has been 
demonstrated using DHFR as a model system.  The sequence is not intended as a 
direct ultra scale down version due to the complexities involved in scaling each unit 
operation.  However it will allow the study of the impact of upstream fermentation 
conditions on downstream refolding yields.  The experimental approach required the 
inclusion body production process to be understood at the pilot scale first.  The 
microscale bioprocess was then developed by establishing robust fermentation in the 
microwell in order to supply material for the sequential development of each 
downstream unit operation.   
4.2 Materials and methods 
The microscale sequence experiments were conducted as detailed in 2.2.5.  The pilot 
scale process was conducted as described in 2.2.2.  The analytical techniques used to 
obtain results are detailed in 2.5.1- 2.5.4.  
4.3 Results and Discussion 
4.3.1 Introduction to Automated Microscale Bioprocess 
Sequence 
The whole bioprocess sequence is an extension of the automated refold and 
hierarchical assays described in the previous chapter and is illustrated in Figure 3.8.  It 
will provide upstream steps for the generation of DHFR inclusion bodies, which can 
then be solubilised and refolded to study the effect of fermentation conditions on 
inclusion body yield and quality.  The whole bioprocess sequence was formed by 
combining microscale unit operations for the fermentation, isolation and solubilisation 
of inclusion bodies (Figure 4.1).  It was developed to reflect the inclusion body 
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processes commonly employed in industry at the pilot and large scale and illustrated 
in Figure 4.2.  The large scale process consists of fermentation to produce intracellular 
inclusion bodies.  The cells are then harvested using centrifugation and resuspended in 
buffer.  The resuspended cells are then lysed using high pressure homogenisation to 
release the inclusion body from the cell and generate small cellular debris.  This 
material then undergoes centrifugation or microfiltration to separate the larger dense 
inclusion bodies from the smaller cellular debris.  The harvested inclusion bodies can 
then undergo multiple cycles of resuspension and centrifugation to wash contaminants 
associated with the surface of the inclusion bodies.  The washed inclusion bodies can 
then be solubilised in a high concentration of denaturant (urea or guanidine 
hydrochloride), and renatured, with or without prior purification using dilution 
refolding into a larger quantity of buffer (Clark, 2001).  The equivalent large scale 
unit operation is discussed and then compared to microscale alternatives. 
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Figure 4.1  Microscale Automated Bioprocess Sequence  
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Figure 4.2  Common Inclusion Body Bioprocess Sequence
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4.3.2 Fermentation 
 
Pilot scale fermentations in a 20 L vessel were conducted to reproduce previous 
growth and inclusion body expression, which can then be scaled down to the 
microwell resulting in a fermentation step related to the larger scale operation.  The 
material generated from the 20 L fermentations was also used for assay development 
experiments in the previous chapter.  Pilot scale fermentations were performed using a 
protocol optimised for inclusion body production, with induction set at the early 
exponential phase (Davies, 2009).  Table 4.1 shows OD, wet cell weight and dry cell 
weight obtained for 20 L fermentations at different temperatures. A post induction 
temperature drop was chosen to investigate the robustness of IB production as it can 
be used to slow growth and inclusion body production.  The results show cells 
reached optical densities (OD) of up to 12.6 A.U. and dry cell weights of 5.3 g.L
-1
.  
The dry cell weight (DCW) is expected to be proportional to the OD of cells, however 
after induction, the expression of inclusion bodies resulted in a higher absorbance than 
expected from the cell density.  It has been previously reported that disparities exist 
between turbidity profiles and cell concentration, which have been attributed to the 
formation of inclusion bodies after induction and morphological changes in the cells 
(Fieschko et al., 1985; Ryan et al., 1996).  At the 20L scale wet cell weights of 
approximately 14 g.L
-1
 have been reported with this expression system (corresponding 
to DCW~ 3.5 g.L
-1
).  Higher growth was only observed at 7L scale with wet cell 
weights of 35 g.L
-1
 (DCW~ 7.5 g.L
-1
) (Davies, 2009). 
 
Table 4.1 Cell growth at harvest (8 hours of fermentation) 
 
Temperature after 
induction (°C) 
OD 
(A.U.) 
Wet cell weight  
(g.L
-1
) 
Dry cell weight 
(g.L
-1
) 
37  11.4 43.5 5.3 
37  12.6 43.6
*
 5.3
*
 
37  12.0 42.0
*
 5.1
*
 
25  4.4 27.4 2.2 
*
Determined indirectly using calibration curves  
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Figure 4.3 shows the growth curves obtained for the different fermentation processes 
at the 20 L scale.  The cells were induced at 3.5 hours as early exponential induction 
was shown to be optimal for inclusion body production in this strain (Davies, 2009).  
After induction at the early exponential phase, the cells continue to grow well at 37 
°C, reaching ODs of around 12 A.U. 4.5 hours after induction.  The fermentation with 
a post-induction temperature drop to 25 °C shows no growth for a few hours 
immediately after induction and has significantly slower growth overall, with a final 
OD of only 4.4.  Jones et al. (1987) found that when the temperature is dropped to 10 
°C, growth stopped for 4 hours before a new growth rate is established.  In their study, 
the proteins expressed were in very limited amount and only 13 proteins were 
produced.  It is thought that a sub optimal temperature below 37 °C blocks an early 
step in protein synthesis to restrict bacterial growth (Broeze et al., 1978).   
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Figure 4.3  20 L DHFR fermentations at different post induction temperatures.  Induction time denoted 
by the line labelled I. 
 
Figure 4.4 shows the DOT, DCW and stirrer speed profiles obtained for the 
fermentation performed at 37 °C.  As the cells reach the early exponential phase, the 
available oxygen is below 40%.  In order to maintain a minimum dissolved oxygen 
concentration (DOT) of 30%, the impeller speed (set on cascade control) is increased 
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to maintain this concentration as the cells enter the exponential phase.  The impeller 
speed continues to increase as the cells grow and eventually remains constant around 
7 hours.   
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Figure 4.4  20L Fermentation profile with early exponential induction, grown at 37°C. Figure a) shows 
the dissolved oxygen tension (DOT), dry cell weight (DCW) and impeller speed. Figure b) illustrates 
the oxygen uptake rate (OUR) and carbon dioxide evolution rate (CER). 
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Figure 4.5 shows the SDS-PAGE results obtained using samples from the 20 L 
fermentation.  During induction, an increasing amount of DHFR is present, as can be 
observed with the increased thickness of the band at 24.5 kDa in lanes 5, 7 and 9.  
This agrees with the result found from a Bradford assay presented in Figure 4.6.  
Figure 4.6 shows the levels of soluble and insoluble protein present throughout 
fermentation.  Low levels of insoluble protein are present initially but, after induction 
at 3.5 hours, insoluble protein increases from 0.1 mg.ml
-1 
at 4 hours to 0.4 mg.ml
-1 
at 8 
hours.  Additionally, a large increase in the concentration of soluble protein present is 
detected, resulting from the increased number of cells.  Before induction a very faint 
band is present in lane 3 with the same molecular weight as the product, resulting 
from the expression of DHFR from the plasmid.  The low level of expression and the 
presence of DHFR before induction suggest the plasmid is constitutively active, 
which has previously been reported by Davies (2009).   
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Figure 4.5  SDS PAGE of 20 L Fermentation at 37 °C at different time points.  Lanes:   
1 Molecular weight ladder   
2 Soluble cell fractions of samples taken at 2 hours  
3 Insoluble cell fractions of samples taken at 2 hours  
4 Soluble cell fractions taken at 4 hours  
5 Insoluble cell fractions taken at 4 hours 
6 Soluble cell fractions taken at 6 hours  
7 Insoluble cell fractions taken at 6 hours  
8 Soluble cell fractions taken at 8 hours  
9 Insoluble cell fractions taken at 8 hours   
10 molecular weight ladder   
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Figure 4.6 Soluble and insoluble protein fractions during 20L fermentation at 37 °C measured by 
Bradford Assay 
 
Figure 4.7 shows the DOT, DCW, temperature and stirrer speed profiles obtained for 
the fermentation performed with a post induction temperature drop.  Initially the cells 
show similar growth to previous runs, although the dry cell weight and OD is slightly 
lower due to the inoculum having a lower cell density.  However once the cells start to 
grow exponentially, the DOT decreases.  When the cells are induced at the early 
exponential phase, growth reaches a steady state and the DOT increases again.  Post-
induction, growth starts again after a period of 3.5 hours, confirmed by a sharp 
decrease in DOT.  It is therefore believed that the fermentation would need to be 
conducted for a much longer time frame than 8.5 hours to achieve final dry cell 
weights similar to those observed previously. 
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Figure 4.7  20L Fermentation profile with early exponential induction and a temperature drop to 25 °C 
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Figure 4.8  SDS PAGE of insoluble cell fraction from 20 L Fermentation with post induction 
temperature drop to 25 °C.  Lanes contain the insoluble cell fractions for the following:  
1 Molecular weight ladder 
2  0.5 hours  
3 1.5 hours  
4 2.5 hours  
5 3.5 hours 
6 4.5 hours  
7 6.5 hours  
8 7.5 hours  
9 harvest  
10 Inclusion body harvested after the second centrifugation step. 
 
Figure 4.8 presents the SDS-PAGE results for insoluble cell fractions for the post-
induction temperature drop fermentation.  Despite the poor growth detected during 
this fermentation, the cells produce considerable amounts of insoluble DHFR as 
inclusion bodies.  Following the second centrifugation step inclusion bodies of high 
purity are observed.  This demonstrates that inclusion bodies are produced even under 
a lower temperature conditions that favours soluble production, and hence inclusion 
body production is robust in this strain.  Schein and Noteborn (1988) found 
decreasing the growth temperature to 23-30 °C resulted in 30-90% of the expression 
product becoming soluble, indicating that between 10-70% of the product still 
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remained in inclusion bodies.  During this fermentation, energy may be conserved by 
the slow growth rate and instead redirected towards IB production.  The cells are at a 
lower density at the end of the fermentation and have not been subjected to the same 
stress as for high cell density fermentations.  This could improve the cell debris size 
profile resulting in improved purification.  Wong et al. (1996) showed repeated 
homogenisation passes results in a better fractionation of inclusion bodies and cell 
debris improving inclusion body purity due to their differing sedimentation properties.  
If the cells are less resistant to shear, repeated homogenisation may help create small 
debris which is more easily separated from denser, larger inclusion bodies.   
 
After the fermentation methods had been established at the large scale, it was then 
necessary to transfer the protocol to the small scale to try and achieve similar growth.  
The fermentation was scaled down without maintaining a fixed parameter, as the goal 
was not to have a scaled down matched process but a means of investigating how 
perturbations in fermentation effect inclusion body refolding.  Figure 4.9 shows the 
growth profiles obtained using the same media (terrific broth) in shake flasks and 
microwell geometry.  For the shake flasks a long lag phase is observed for 3 hours and 
after 10 hours an OD of 6.2 A.U. is reached.  It appears that growth is reaching steady 
state after 10 hours, suggesting further incubation time would not result in higher ODs 
for this condition.  Micheletti et al. (2006) obtained DCW of 6 g.L
-1
 using an E. coli 
culture in 1 ml microwell 96 DSW plates grown at 1000 rpm, which corresponds to an 
OD of approximately 12 A.U..  The cells in this experiment grew to reach an OD of 
12.7 A.U., which matches that achieved at the 20 L scale. 
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Figure 4.9  Comparison of growth at 37°C with no induction in microwell (fill volume 1 ml, shaking 
1000 rpm) and 1L shake flasks (fill volume 100 ml, shaking 200 rpm) 
 
Optimisation of the inoculate preparation step was carried out to reduce the lag phase 
observed for E. coli growth in microwells (Figure 4.9).  Figure 4.10 shows the lag 
phase was reduced to 2 hours.  The shorter lag phase allowed the cells to reach an OD 
of approximately 12 A.U. in the same time scale of 8 hours as the 20 L fermentations.  
Cells were induced after 4 hours of growth to mimic the early exponential induction 
step at a larger scale.  Induction did not appear to slow growth significantly in the 
microwells, with an OD of 11.4 and 11.8 A.U. achieved in the induced and non-
induced wells, respectively, at the end of the fermentation.  The experiments 
demonstrated that growth similar to the 20 L can be achieved in microwells for this 
strain. 
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Figure 4.10  Automated microwell fermentation at 37 °C, with induction at 4 hours using 0.125 mM 
IPTG, fill volume of 1 ml and shaking at 1000 rpm. 
4.3.3 Centrifugation for cell harvest 
 
Centrifugation to harvest cells from the 20 L fermentations involved the use of the 
CARR Powerfuge or CSA-1 centrifuge.  The aim of this step is to maximise both the 
cell separation and the dewatering levels.  At the microscale, the deep well plate was 
covered and placed in a microplate centrifuge along with an identical plate for 
balancing.  Table 4.2 shows that a percentage clarification of close to 100% can be 
achieved in only 15 minutes at 4000 rpm for the microwell fermentation broth.  This 
clarification level is much higher than that achieved in large scale centrifugation, 
which usually has lower clarification levels (Lander et al., 2005).  Higher centrifugal 
forces can be achieved in a small scale centrifuge in comparison to industrial 
centrifuges.  Additionally, material appears to settle quicker at the small scale.  It has 
been shown that ultra scale down (USD) centrifugation methodology over predicts 
clarification at process scale for high solid density feeds, possibly as a result of 
increased interparticulate forces at the microscale (Tustian et al., 2007).   
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Table 4.2 Clarification achieved for supernatant fraction after centrifuging microplate at 4000 rpm 
 
Sample Centrifugation time 
(min) 
OD Clarification 
(%) 
Feed 0 11.333 0 
Supernatant 10 0.101 99.787 
Supernatant 15 0.078 99.999 
Media - 0.077 100 
 
Following centrifugation at the microscale, the supernatant needs to be removed from 
the sedimented pellet in the bottom of the V-shaped well using the liquid handling 
arm of the robot to pipette the liquid.  Increasing volumes of supernatant were 
removed in order to observe the maximum volume that could be removed without the 
pellet being disturbed and cells becoming present in the supernatant (causing an 
increase in OD).  Figure 4.11 shows the OD of the removed fermentation broth as the 
volume removed by automated pipetting increases.  Initially OD is constant as the 
volume removed increases up to 710 μl.   As a larger volume is aspirated, the tip of 
the pipette comes into closer contact with the pellet, disturbing the pellet and resulting 
in more cells being carried over into the clarified fermentation broth.  The optimum 
volume for aspiration is 710 μl, however this will change for different fermentations 
depending on the wet cell weight and hence the final size of the pellet.  Other settings 
were adopted to try and minimise the breakthrough of cells, such as decreasing the 
pipetting velocity and minimising the liquid tracking distance (the depth by which the 
tip is below the liquid surface).  A lower volume of 400 μl was used in the automated 
sequence to avoid loss of cells.  Furthermore a wetter pellet reflects the larger scale 
where equivalent dewatering cannot be achieved, and consequently fermentation 
broth is carried over into the next step. 
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Figure 4.11 Clarification of supernatant after removal of different volumes from the pellet. 
4.3.4 Resuspension  
 
The cells were resuspended to give the same concentration as for the large scale 
process.  The OD was measured at each stage to monitor cell loss from the 
centrifugation and resuspension steps.  Figure 4.12 shows the concentration of cells 
present at each stage and illustrates where cells are lost in the process.  Despite the 
induced cells having a higher OD, the pellet of the non-induced cells was larger.  This 
is a result of the inclusion bodies resulting in a greater absorbance for the induced 
cells, which is not necessarily reflective of greater cell growth.  The non-induced cells 
with a larger pellet were more susceptible to disturbance by the liquid handling pipette 
tip and therefore more cells were lost in the broth supernatant after centrifugation.  
Additionally more cells failed to be resuspended because the pellet was larger in size 
and more difficult to fully resuspend.  The induced cells, on the other hand, had 
minimal losses during broth removal following centrifugation and also resuspended to 
a greater degree.  Consequently higher cell densities, as observed for the non-induced 
cells, can represent greater hurdles in the microscale process. 
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Figure 4.12  Cell losses during the microwell process for induced and non-induced cells, showing the 
cell concentration at fermentation harvest, in the broth removed after centrifugation, at the resuspension 
stage and the total cell loss from fermentation through to resuspension.  
4.3.5 Cell lysis using sonication and AFA 
Cell lysis can be challenging at the microscale because of the lack of high throughput 
technologies available in 96-well plate format.   Using a technique such as sonication 
for the treatment of 96 samples can be time consuming and labour intensive.  It also 
requires substantial liquid handling resulting in the loss of any cells that have failed to 
resuspend.  One potential solution is to use a mechanical disruption technique which 
is compatible with 96-well plate format.  The Covaris E210 uses adaptive focusing 
acoustics (AFA) to lyse cells and offers an automated solution which is compatible 
with 96-round bottom wells plates and glass vials. 
 
A method for lysis was developed based on the lysis protocol by Wenger et al., which 
shows optimal lysis at 20% duty cycle (dc) and an intensity (I) of 500 mV 
(intensity=10).  Duty cycle is the percentage of time in which the transducer is 
producing acoustic waves, and the intensity is proportional to the amplitude of the 
pressure wave.  The cycles per burst and the cell density were shown not to be 
important factors in cell disruption (Wenger et al., 2008).  A treatment time of only 2 
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minutes under conditions of dc= 20%, I=10 was found to be sufficient for complete 
release of soluble antibody fragment (Perez-Pardo et al. 2011).   
 
Samples were exposed to lysis conditions, set in the Covaris, for different times and 
compared to chemical lysis and standard lab sonication as shown in Figure 4.13.  The 
presence of increasing amounts of protein in the supernatant fraction shows that cell 
rupture has taken place and the contents of the cell is released.  In inclusion body 
processes the protein of interest is in the pellet, therefore a high concentration of 
protein in the supernatant (soluble) fraction and a relatively high purity in the pellet 
(insoluble) fraction is desirable.  Increasing the treatment time in the Covaris from 30 
seconds to 200 seconds does not result in any cell lysis in the microwell format, as 
demonstrated by the similar protein concentration obtained in the soluble fraction.  
Almost 100% of the protein remains in the pellet indicating the cells have not 
ruptured, as in the control condition of unlysed cells.  However cell lysis occurs when 
using chemical lysis in microwells and by sonication for the same volume and 
concentration of cells.  Under these conditions a greater concentration of protein 0.5 
mg.ml
-1 
is observed
 
in the soluble fraction, which is significantly greater than the 0.1 
mg.ml
-1
 present in the unlysed control well.  The differing concentration of insoluble 
protein present in AFA and unlysed samples results from liquid handling operations 
causing variability in the concentration of cells and consequently total protein 
concentration.   
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Figure 4.13  Protein release under different conditions, showing unlysed cells, cells treated with AFA 
in microwells for different lengths of time, sonicated cells and chemically lysed cells.  The 
concentration of protein in soluble and insoluble cell fractions is determined by Bradford assay.  
 
Figure 4.14 illustrates the protein concentration in the soluble and insoluble fractions 
of cells lysed under different conditions.  No significant difference is observed 
between the unlysed (control) sample and samples exposed to increasing periods of 
times of acoustic focusing, despite achieving a power input of 115 Watts (Wenger et 
al., 2008).  The soluble fractions show low concentrations of protein and only very 
faint protein bands are visible after electrophoresis (Figure 4.14).  The sonicated 
sample, on the other hand, has a higher concentration of protein in the soluble 
fraction.  Additionally, fewer bands are visible in the insoluble fraction as the pellet 
increases in purity and more contaminating soluble proteins are lost to the supernatant 
fraction.  
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Figure 4.14  SDS PAGE analysis of soluble and insoluble cell fractions of cell suspension exposed to 
sonication and different AFA (Covaris) treatment times in microwells.  Lanes:  
1 Molecular weight ladder.   
2 Insoluble fraction of control (no rupture) 
3 Insoluble fraction of 30 s AFA exposure 
4 Insoluble fraction of 100 s AFA exposure 
5 Insoluble fraction of 200 s AFA exposure 
6 Insoluble fraction of sonicated samples 
7 Soluble fraction of control (no rupture) 
8 Soluble fraction of 30 s AFA exposure 
9 Soluble fraction of 100 s AFA exposure 
10 Soluble fraction of 200 s AFA exposure 
11 Soluble fraction of sonicated sample 
 
Figure 4.15 shows that the inclusion body pellet also has a greater purity under 
chemical lysis or sonication.  The soluble fraction is populated by an increased 
number of high molecular weight proteins and the insoluble fraction shows the 
presence of DHFR and only two or three major contaminants.  The insoluble fraction 
for the Covaris induced lysis resembles that for the control with no lysis, both show 
DHFR in the presence of many other contaminants.  This finding is in agreement with 
results obtained using the Bradford assay where no lysis has occurred in the Covaris 
under these conditions (Figure 4.13). 
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Figure 4.15  SDS PAGE analysis of soluble and insoluble fractions of cell suspension exposed to 
sonication, AFA (Covaris) and chemical lysis.  Lanes:  
1 Molecular weight ladder 
2 Insoluble cell fractions for chemical lysis  
3 Soluble cell fractions for chemical lysis  
4 Insoluble cell fractions for control (unruptured cells) 
5 Soluble cell fractions for control (unruptured cells) 
6 Insoluble cell fraction for AFA treated cells  
7 Insoluble cell fraction  of sonicated cells   
8 Soluble cell fractions of sonicated cells  
9 Molecular weight ladder 
 
Cell lysis had not been observed using 400 μl and treatment times of up to 200 
seconds, therefore the range of conditions tested were extended to 400 seconds and 
different volumes were used.  Additionally vials were used instead of microwell 
plates, to investigate whether reason for the cell behaviour observed could be 
attributed to the microwell format.  Figure 4.16 shows that AFA treatment of cell 
suspension volumes of 300 μl and 500 μl in microwell plates resulted in the absence 
of protein in the soluble fraction as it was found for the control sample with no lysis.  
This indicates that no cell lysis has occurred, as confirmed by the blur of bands 
observed in the insoluble fractions corresponding to intracellular proteins.   
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Cell lysis is, however, observed when the treatment was carried out in vials, with 
significantly less bands of protein found in the insoluble fraction contaminating the 
recombinant protein.  The soluble fraction also has many bands present, showing that 
the cells have lysed and released their contents.  Lysis does not appear to be as 
complete as that previously observed for chemical lysis or sonication (Figure 4.15), 
where less contaminating protein is present in the insoluble fraction.  Cell rupture 
using hydrodynamic cavitation methods has been reported to release periplasmic 
proteins over cytoplasmic proteins (Balasundaram & Pandit 2001) and the size of 
inclusion bodies coupled with the size of the debris produced may result in IB 
separation being more difficult.  In this particular experiment however, AFA is shown 
to cause a clear improvement if compared to the sonication method, which appears to 
result in more contaminating protein in the insoluble fraction (Figure 4.16).  The 
variability in the results obtained using sonication methods may result from different 
cell suspensions being used.  The growth rate is known to influence cell lysis, with 
cells in the rapid growth phase rupturing more easily than those in stationary phase.  
Cells characterised by slower growth have had more time to produce peptidoglycans 
that strength cell walls (Balasundaram et al. 2009; Engler & Robinson 1981) and 
could therefore be more resistant to sonication.  The variability observed could also 
result from the sonication times not being long enough for complete cell lysis.  For 
this reason cycle time was increased from 10 cycles of 10s on and 10s off to 8 cycles 
of 20s on, 20s off.  
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Figure 4.16  SDS PAGE analysis of cell suspension exposed to sonication, AFA (Covaris) in vials and 
in microwells using different volumes.  Lanes:  
1 Molecular weight ladder 
2 Insoluble fraction for 500 μl cell suspension treated with AFA in vials 
3 Soluble fractions for 500 μl cell suspension treated with AFA in vials   
4 Insoluble fraction of 300 μl cell suspension treated with AFA in wells 
5 Soluble fraction of 300 μl cell suspension treated with AFA in wells 
6 Insoluble fraction of 500 μl cell suspension treated with AFA in wells 
7 Soluble fraction of 500 μl cell suspension treated with AFA in wells 
8 Insoluble fractions of a control with no lysis  
9 Soluble fractions of a control with no lysis 
10 Insoluble fractions of sonicated cell suspension  
11 Soluble fractions of sonicated cell suspension  
12 Molecular weight ladder 
 
Figure 4.17 shows the protein released in AFA in different formats as compared to 
sonicated and unlysed cells.  It supports the SDS PAGE analysis that the amount of 
protein that has been released is little when microwells plates were used with AFA as 
the protein concentration is approximately equal to that found in the soluble fraction.  
The concentration of protein in the soluble supernatant after AFA treatment in vials is 
very high reflecting cell rupture.  The soluble fraction has a concentration of 2 mg.ml
-
1
, which is over double the 0.81 mg.ml
-1
 found in the insoluble fraction.  A similar 
ratio can be observed in the sonicated sample, with 0.94 mg.ml
-1
 in the soluble 
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fraction and 0.45 mg.ml
-1
 in the insoluble fraction, which shows the fraction of 
protein release is approximately equal to that obtained in vials using AFA.  Slightly 
less protein is found in the pellet (insoluble fraction) of the vials, which agrees with 
the findings of SDS-PAGE (Figure 4.13) that less contaminating protein is present.  A 
similar fraction of release of soluble protein demonstrates that the efficiency of the 
lysis process is equivalent to, or even better than, traditional sonication methods.  
Lysis in vials was selected as the best cell rupture method using AFA for subsequent 
experiments. 
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Figure 4.17  Protein release using AFA with different formats (microwell and vial) compared with 
sonication.  The concentration of protein in soluble and insoluble cell fractions is determined by 
Bradford assay.  
 
Different volumes of cell suspension were investigated using the AFA methods in 
vials.  Volumes of 450, 600, 900 and 1350 μl were selected and all show soluble 
protein release into the supernatant and similar patterns of contaminating protein 
bands present in the insoluble fraction (Figure 4.18).   The results of the Bradford 
assay (Figure 4.19) performed using these sample volumes, show the soluble protein 
concentrations for all 4 volumes tested to be between 0.18 and 0.20 mg.ml
-1
.  The 
concentration of insoluble protein for a volume of 450 μl is lowest at 0.21 mg.ml-1, 
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with higher volumes having a slightly higher concentration between 0.25 and 0.27 
mg.ml
-1
.  This demonstrates that any of these volumes in vials display cell lysis under 
the conditions tested.  The lowest volume tested was chosen as this would prevent the 
pooling of material from multiple fermentation wells, allowing different conditions to 
be kept separate and potentially more fermentation variables explored.  
DHFR
-26 
-17 
-170 
-72 
-55 
-43 
-34 
-95 
-130 
MW (kDa)
1       2       3       4       5      6       7      8       9      10     11      12
 
Figure 4.18  SDS PAGE analysis of cell suspension exposed to sonication and AFA in vials using 
different volumes.  Lanes:  
1 Molecular weight ladder  
2 Soluble fractions of sonicated cells 
3 Insoluble fractions of sonicated cells  
4 soluble fraction of control (unruptured) cells  
5 Soluble fractions of 450 μl of cell suspension treated in vials with AFA 
6 Insoluble fraction of 450 μl of cell suspension treated in vials with AFA  
7 Soluble fraction of 650 μl of cell suspension treated in vials with AFA 
8 Insoluble fraction of 650 μl of cell suspension treated in vials with AFA 
9 Soluble fraction of 900 μl of cell suspension treated in vials with AFA  
10 Insoluble fraction of 900 μl of cell suspension treated in vials with AFA 
11 Soluble fraction of 1350 μl of cell suspension treated in vials with AFA. 
12 Insoluble fraction of 1350 μl of cell suspension treated in vials with AFA 
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Figure 4.19  Protein release using AFA in vials with different volumes, compared with a control of no 
lysis.  The concentration of protein in soluble and insoluble cell fractions is determined by Bradford 
assay.  
 
In order to establish the best method for cell lysis (sonication or AFA), information on 
the presence of cell debris was required.  In order to monitor changes in particle size 
Dynamic Light Scattering was used, as shown in Figure 4.20 for large scale 
fermentation data.  Intact cells appear to have an average size of 1.1 μm, with peaks 
showing larger aggregates of 5 μm and 120 μm.  After the first pass of 
homogenisation, the peak at 120 μm is no longer present, indicating the aggregates 
have been broken up by the shear experienced in the homogeniser.  The peak, present 
at 5 μm, also decreases.  The particle size of the main peak at 1.1 μm decreases to 0.8 
μm.  Davies (2009) found a peak at 0.7 μm after homogenisation of this strain, which 
had a high concentration of insoluble DHFR present.  It is therefore likely that the 
peak at 0.8 μm corresponds to inclusion bodies.  Successive passes of homogenisation 
result in the emergence of a new peak at 0.2 μm, resulting from cell debris.  Agerkvist 
et al. (1990) reported the transition of a cell debris peak from 0.457 to 0.191 μm after 
increasing passes of E. coli through a high pressure homogeniser.  The peak at 0.8 μm 
also decreases in volume slightly between the second and third pass, which could 
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result from a decrease in the number of inclusion body particle size due to shear 
effects.  After the second centrifugation step in the process to harvest the inclusion 
bodies, the peak at 0.2 μm disappears as the cell debris is lost in the supernatant and 
the inclusion bodies are harvested as the pellet. 
 
Figure 4.20  Particle size distribution for material from a 20 L fermentation, determined using laser 
diffraction for intact cells.  Whole cells and harvested IBs were compared with cells which had 
undergone different numbers of homogenisation passes at 500 bar in a Manton-Gaulin Lab 60 high 
pressure homogeniser. 
 
Particle size measurements carried out using DLS required 5-10 ml of material. In 
order to run a similar experiment with microscale-derived material, the content of at 
least 10 wells is required to obtain reliable results.  Therefore the technique is not 
ideal for the analysis of microwell scale experiments and flow cytometry was 
explored as an alternative.  Flow cytometry was used to investigate the difference 
between cells lysed using the Covaris and those lysed with a sonicator with regards to 
cell debris size and inclusion body release using SYTOX Green staining.  SYTOX 
Green is a cyanine dye which can only penetrate cells with compromised plasma 
membranes.  It has a high affinity for nucleic acids, and when bound gives a 500-fold 
increase in the fluorescence emission (Roth et al., 1997).  SYTOX Green gives 
superior detection in comparison to other available dyes (propidium iodide) and 
allows the discrimination of permeabilised cells from intact cells.  The staining 
process also increases the fluorescence of the inclusion bodies.  Medwid et al. (2007) 
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suggested the dye molecules diffuse into submicron pores in the inclusion body 
structure and become trapped.  This could explain why the relative amount of 
fluorescence is lower than that caused by nucleic acid binding.  Medwid et al. (2007) 
also showed that SYTOX Green is capable of distinguishing inclusion bodies from 
unruptured cells and cell debris, potentially enabling the quantification of IB 
production.   
 
Figure 4.21, Figure 4.22, Figure 4.23 and Figure 4.24 show the relative fluorescence 
and light scattering for unruptured cells, inclusion bodies, sonicated cells and Covaris 
lysed cells respectively.  Unruptured (intact) cells show a fluorescence peak at 300 
Fl.U (Figure 4.21).  When these cells are ruptured by sonication, this shifts to a lower 
relative fluorescence of 40, as shown in Figure 4.23.  The AFA treated sample also 
shows a shift to lower fluorescence, with a peak centred on a relative fluorescence of 
30 (Figure 4.24).  This demonstrates that lysis in the Covaris using AFA is resulting in 
cell rupturing and inclusion body release.  Medwid et al. (2007) found that SYTOX 
Green bound both cells and IBs and a lower fluorescence intensity indicted cell lysis 
and IB release.  The pure inclusion body sample has a peak fluorescence of 30 (Figure 
4.22), so the peaks in the lysed samples represent the inclusion bodies.  Both the 
sonicated and Covaris samples have a shoulder to the right of the main peak, which is 
a clear second peak centred around 70 Fl.U in the sonicated cells (Figure 4.23, Figure 
4.24).  This could result from cell debris containing nucleic acids which have bound 
dye.  The forward scatter data does not show a significant difference between intact 
cells and ruptured cells.  The particle size should be reduced upon lysis, but based on 
the dynamic light scattering data this change for 1.1 μm for an intact cell to 0.9 μm for 
an inclusion body might be too small.  Medwid et al reported that, while inclusion 
bodies could be resolved from background noise (their size exists at the lower limit of 
flow cytometry detection), they could not be resolved from unlysed cells using light 
scattering methods alone due to the significant overlap of intact cells and inclusion 
bodies.  However, the samples shown in Figure 4.24-4.25 do differ with regards to 
side scatter, with intact cells showing less granular content.  After lysis a greater range 
of granularities is visualised, with substantially more granular content observed due to 
the release of highly refractile nature of IBs.  In particular the sonicated cells have the 
highest granular content, this results from a greater release of inclusion bodies.  The 
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lack of highly granular large particles present compared with the AFA treated sample 
implies a greater degree of lysis.  Whilst the two lysis techniques differ in debris size 
and granularity, they both show inclusion body release.  
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Figure 4.21  Fluorescence (525 nm emission) histograms (a) and light scatter plots (b) for intact 
(unruptured) cells from microwell DHFR fermentation, stained with SYTOX Green and measured for 
their fluorescence, particle size and granularity using a flow cytometer (see Section Error! Reference 
source not found. for method).     
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Figure 4.22  Fluorescence (525 nm emission) histograms (a) and light scatter plots (b) for isolated 
unwashed DHFR inclusion bodies produced by 20L fermentation, stained with SYTOX Green and 
measured for their fluorescence, particle size and granularity using a flow cytometer (see Section 
Error! Reference source not found. for method).    
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Figure 4.23  Fluorescence (525 nm emission) histograms (a) and light scatter plots (b) for sonicated cells 
(see Section 2.2.5.3 for conditions) from a microwell DHFR fermentation, stained with SYTOX Green 
and measured for their fluorescence, particle size and granularity using a flow cytometer (see Section 
Error! Reference source not found. for method).   
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Figure 4.24  Fluorescence (525 nm emission) histograms (a) and light scatter plots (b) for AFA treated 
(see Section 2.2.5.4) cells from microwell DHFR fermentation, stained with SYTOX Green and measured 
for their fluorescence, particle size and granularity using a flow cytometer (see Section 2.5.3 for method). 
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4.3.6 Centrifugation for IB harvest 
 
Following cell lysis, a second centrifugation step is needed to achieve the required 
purity of inclusion body.  The density difference between inclusion bodies and cell 
debris can be exploited as inclusion bodies are dense and can be pelleted, whereas the 
cell debris can be lost in the supernatant.  Centrifugation acts as a crude purification 
step, resulting in the loss of some of the contaminating protein in the supernatant 
fraction.  During large scale experiments, the total concentration of protein lost in the 
supernatant was 0.72 mg.ml
-1 
(Figure 4.25).  This supernatant fraction has been further 
separated into its soluble and insoluble constituent parts, showing the loss of 0.42 
mg.ml
-1 
in the insoluble fraction, some of which corresponds to the loss of the product 
DHFR as shown by SDS PAGE (Figure 4.26).  However an insoluble protein 
concentration of 1.35 mg.ml
-1
 is observed in the centrifugation solids, with DHFR being 
the major protein present.   
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Figure 4.25  Protein concentration of insoluble and soluble fractions of centrifugation solids and 
supernatant, as using determined by Bradford assay. 
 
The SDS PAGE results (Figure 4.26) show the presence of a high concentration of 
DHFR with a significant amount of contaminants in the pelleted IBs obtained from the 
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centrifugation step.  The bands present at 36 kDa and 40 kDa could result from outer 
membrane proteins.  Bands present at 36, 38, 38.5 and 40 kDa have previously been 
attributed to outer membrane proteins of E. coli (Lugtenberg et al., 1975).  The 
harvested IB pellet is typically washed using multiple cycles of resuspension and 
centrifugation to remove some of these contaminants before refolding. 
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Figure 4.26  SDS PAGE showing soluble and insoluble fractions of supernatant and solids discharge of 
the first centrifugation step (cell harvest) and second centrifugation step after homogenisation (IB 
harvest).   
1. Molecular weight ladder   
2. Soluble fractions of the supernatant from the first centrifugation step 
3. Insoluble fractions of the supernatant from the first centrifugation step   
4. Soluble fractions of the pellet from the first centrifugation step 
5. Insoluble fractions of the pellet from the first centrifugation step  
6. Soluble fractions of the supernatant from the second centrifugation step 
7. Insoluble fractions of the supernatant from the second centrifugation step 
8. Soluble fractions of the pellet from the second centrifugation step  
9. Insoluble fractions of the pellet from the second centrifugation step 
10. Molecular weight ladder 
 
Figure 4.27 shows the SDS-PAGE results obtained with the resulting pellet and 
supernatant fractions after centrifugation at the microscale.  The supernatant fraction 
shows the presence of many contaminating protein, especially at higher molecular 
weights of 38 kDa and above, which will be lost during the centrifugation step.  In the 
inclusion body pellet, a range of contaminating proteins is present.  The presence of a 
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major contaminant at just under 40 kDa appears to match those found at the large scale 
that have been attributed to outer membrane proteins.  The release of soluble protein 
and a soluble product has been shown to be the same for AFA as high pressure 
homogenisation for one bacterial strain (S. cerevisiae) (Wenger et al., 2008), and 
consequently this would result in the same contaminant profile.  Therefore the proteins 
that contaminate the IB pellet at the large scale will also be present after IB harvest from 
AFA lysis.   
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Figure 4.27  SDS-PAGE showing the purification achieved for IBs harvested after different cell lysis 
methods.  Lanes:  
1 Molecular weight ladder 
2 Soluble fractions of sonicated cells (which appear not to have lysed) 
3 Insoluble fractions of sonicated cells (which appear not to have lysed)  
4 Insoluble fraction of control (unruptured) cells 
5 Soluble fractions of 450 μl of cell suspension treated with AFA 
6 Insoluble fractions of 450 μl of cell suspension treated with AFA 
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4.4 Conclusions 
 
The aim of this chapter was to develop a microscale process sequence for producing 
inclusion body material for refolding.  Fermentation in microwell was shown to produce 
comparable cell growth to that found at the 20L scale fermentations.  Cells cultivated in 
microwell plate format reached an OD of 12 A.U., the same as the average OD obtained 
from large scale fermentations.  100% clarification was achieved at cell harvest using 
material produced at the microscale and exceeded the clarification typically observed at 
industrial scale.  However it was difficult to remove the fermentation broth reproducibly 
without disturbance of the pellet.  Therefore a smaller volume was removed resulting in 
a wetter pellet, which is more similar to the larger scale where dewatering is less.  The 
cell resuspension step at the microscale posed some challenges as vigorous mixing is 
required to resuspend the pellet and consequently it was necessary to mix for a longer 
time than at large scale.  Higher ODs and larger pellets also resulted in more cell loss 
during the resuspension step.  The most challenging step to achieve at the microscale for 
high throughput studies was cell lysis.  Whilst AFA provides a solution, it is not 
achievable in the microwell format and the efficiency of inclusion body release appears 
to be lower than that achieved using sonication, as shown by the flow cytometry results.  
The level of purification achieved in the IB harvest in the following centrifugation step 
shows some similarities between large scale and the microscale as the major 
contaminant involved is present in both samples.  In conclusion a microscale process 
has been developed which can provide inclusion body material in sufficient quantities 
for refolding studies.  The next chapter will explore whether it can be used to study the 
effect of fermentation conditions on refolding and finally if it will give results which are 
relevant to the large scale. 
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5 Application of the microscale sequence to study the 
effect of fermentation variables on inclusion body 
refolding yield 
5.1 Introduction 
 
Aggregation of over expressed recombinant protein can be partly controlled by slowing 
the rate of heterologous expression.  Hence cultivation conditions that lead to increased 
cellular stress and greater protein synthesis rates also appear to promote inclusion body 
formation, such as high plasmid copy numbers, temperatures, cell densities, inducer 
concentration and strong promoters (Schein and Noteborn, 1988; Wang et al., 1999; 
Fahnert et al., 2004a).  Strandberg and Enfors (1991) found production temperature, 
extracellular pH and carbon source strongly influenced inclusion body formation and in 
particular induction temperature was important for optimizing product yield.  
Aggregation has been monitored in vivo using FT-IR and results have shown different  
inclusion body formation kinetics occur in cultures at temperatures of 37 and 27°C 
(Ami et al., 2005).  The technique also showed the protein obtained from the inclusion 
bodies had different conformational states depending on fermentation conditions, a 
finding supported by the work of others (Przybycien et al., 1994).   
 
While previous work has focused on the effect of culture temperature, there is still a 
lack of understanding in how key fermentation variables alter inclusion quality and 
consequently the yield of bioactive protein.  Maachupalli-Reddy et al. (1997) 
investigated the effect of typical inclusion body contaminants, such as DNA, RNA, 
phospholipids, lipopolysaccharides and other proteins, on lysozyme refolding.  
However they spiked contaminants into refolds and did not link different upstream 
fermentation conditions to changes observed in inclusion body quality.  Valax and 
Georgiou (1993) analyzed β-lactamase IBs produced in E. coli and demonstrated that 
protein composition is a complex function of growth conditions (temperature and pH) 
and protein expression system, with protein impurities ranging from 5% to 50%, at T = 
37 and 30°C respectively and a pH = 7.0.   
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This chapter examines the effect of fermentation conditions on the refolding yield of 
two proteins produced as inclusions bodies in E. coli, namely murine dihydrofolate 
reductase (mDHFR) and insulin Lispro.  Murine DHFR is a small monomeric protein 
(Mr 21 446) (Clark et al., 1996).  It has two domains and does not feature any prosthetic 
groups or disulphide bonds.  The folding pathway of murine DHFR has been 
characterised (Thillet et al., 1990) and the crystal structure is known to 2 Å (Stammers 
et al., 1987).  Davies (2009) has previously optimised DHFR refolding using 
diafiltration in an ultra scale down rotating disk filtration obtained from the same 
expression system.  In chapter 4 it was shown that a microscale bioprocess sequence can 
be used to generate IB material for refolding and would provide an efficient tool for 
rapid evaluation of different process conditions.  The structure of Insulin Lispro 
(Humalog
®
) is very similar to the native form of insulin, but the Pro-Lys amino acid 
residues are reversed at position B28 and B29.  Insulin lispro is produced from 
fermentation in E. coli of a precursor molecule (proinsulin) with a short amino acid 
sequence, and leads to the formation of inclusion bodies which can take up to 20% of 
the cells volume (Williams et al., 1982).  The in vitro folding mechanism of insulin has 
been studied (Liu et al., 2009) and a renaturation procedure that achieves yields of up to 
70% has also been detailed in literature (Winter et al., 2002).   
 
The aim of this chapter is to investigate whether the microscale process sequence 
established in Chapter 4 can be used to study a range of process variables and identify 
process changes that have an impact on subsequent operations and final product quality.  
In particular, an effort will be made to show that the developed process sequence can be 
used as a tool to study the effect of fermentation conditions on inclusion body quality 
and yield of active protein after refolding.  In order to do this, factors upstream of 
refolding were altered to study the impact on downstream protein refolding.  This was 
performed for both DHFR and insulin process sequences.  The fermentation variables 
chosen reflected those of interest to the collaborating company, Fujifilm Diosynth 
Biotechnologies. 
5  Application of the microscale sequence to study the effect of fermentation variables 
on inclusion body refolding yield  G. Ordidge 
 
171 
 
Materials and Methods 
5.1.1 DHFR 
The microscale sequence was performed as previously described in 2.2.5, with a 
fermentation time of 9 hours.  The conditions used for each variable studied are 
described in Table 5.1.  All inclusion bodies were stored at -20°C unless otherwise 
stated. 
 
Table 5.1  Conditions used during microscale DHFR fermentations 
 
Variable Inducer concentration 
(mM) 
Induction time 
(h) 
Induction time 0.125 3, 3.5, 4, 4.5, 5 
Inducer concentration 0.125, 0.25, 0.5 4  
Inclusion body washing 0.125 3 
Inclusion body storage 0.125 3 
 
Protein assays were performed as previously described in 2.5.2.  SDS-PAGE was 
performed as written in 2.5.1.  Inclusion bodies were washed as detailed in 2.2.3.  
Inclusion bodies were solubilised and refolded as described in 2.2.6, in the buffers 
described in Table 5.2.  Assays were conducted as detailed in 2.5.8. 
 
Table 5.2  DHFR refold buffers  
 
 Buffer Components 
1 Tris 50mM Tris.HCl, pH 7.2 
2 Optimised 50mM Tris.HCl, 0.25M arginine, 2mM cystine.2HCl, 2mM cysteine, 
pH 7.2 
3 Reducing 0.25 M Potassium phosphate, 0.1 M potassium chloride, 1 mM DTT 
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5.1.2 Insulin 
The microscale sequence was performed as previously described in 2.3.5.  The 
conditions used for each variable studied are described in Table 5.3.  All inclusion 
bodies were stored at -20°C unless otherwise stated. 
 
Table 5.3  Fermentation conditions 
 
Variable Induction 
time (h) 
Media Feeding 
started (h) 
Fermentation 
length (h) 
Induction time 3.5, 4, 4.5, 5 Glycerol fed batch 5 18 
Batch and  
Fed-batch 
6 Glycerol batch, 
glycerol fed batch  
5  18 
Carbon source 3.5 LB, TB, Glucose 
batch, Glycerol batch 
n/a 22 
 
Inclusion bodies were solubilised and refolded as described in 2.3.6, in the buffers 
described in Table 5.4.  Assays were conducted as detailed in 2.5.9. 
 
Table 5.4  Conditions used during microscale insulin fermentations 
 
Refold Buffer Components 
1 0.288 mM cystamine, 10% v/v hexylene glycol, 20 mM 
ethanolamine, pH 10.5 
2 10 mM Tris, 10 mM glycine, 1 mM EDTA, 0.5 mM cysteine, 4.5 
mM cystine pH 10.5 
3 1M acetic acid pH 3.8 
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5.2 Results and Discussions 
5.2.1 DHFR 
5.2.1.1 Inclusion body washing 
Inclusion bodies of greater purity can be obtained by washing with detergents, low 
concentrations of salts and urea (Taylor et al., 1986b; Khan et al., 1998; Lilie et al., 
1998).  Optimisation of the recovery and washing step can result in inclusion bodies 
with purities as high as 95% (Khan et al., 1998).  Achieving a high purity inclusion 
body before the solubilisation step increases refolding yield and decreases the number 
of chromatographic steps required after folding (Singh and Panda, 2005).  Figure 5.1 
shows the activity obtained after the refolding step with washed and unwashed inclusion 
bodies when two different buffers were used.  Yields of 2.83 and 1.76 ΔODmin-1mg-1 
were obtained when inclusion bodies were washed, 45% and 87% higher respectively 
than those achieved when no washing step was performed.  An attempt was made to 
quantify protein and DNA content in wash fractions, however, the concentrations 
obtained were below the sensitivity limit of the assays available (Bradford and 
PicoGreen
®
 assays).  Valax and Georgiou (1993) determined the nucleic acid 
concentration of β-lactamase inclusion bodies to be very low, less than 0.5% w/w of the 
protein content.  Results show a significant difference in yield, especially for Buffer 3 
where the yield increases from 0.94 to 1.76 ΔOD.min-1.mg-1.  This indicates that 
washing is clearly beneficial and capable of increasing yields by up to 88% in buffer 3 
(0.25 M Potassium phosphate, 0.1 M potassium chloride, 1 mM DTT) and 45% in 
buffer 1 (50mM Tris.HCl, pH 7.2).  Inclusion body washing is reported to remove 
contaminating lipids and also membrane proteins (Lilie et al., 1998), that could 
otherwise co-aggregate with the target product, resulting in yield losses.   Removal by 
IB washing can help increase the recovery of active product from denatured protein.  
However the presence of lipids is thought act as a folding enhancer and has shown to 
increase renaturation yields by 15% (Maachupalli-Reddy et al. 1997). 
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Figure 5.1  The activity of refolded DHFR under two different buffer conditions for washed and 
unwashed inclusion bodies, where buffer 1 (B1) is 0.288 mM cystamine, 10% v/v hexylene glycol, 20 
mM ethanolamine, pH 10.5 and buffer 3 (B3)  is 1M acetic acid pH 3.8. 
5.2.1.2 Inducer concentration 
IPTG is an expensive compound and the need for high concentrations of IPTG during 
large scale production can be costly.  Therefore minimising the required concentration 
is often desirable from an economic point of view.  Additionally, the concentration used 
can affect the expression level and cell growth.  Conditions that achieve strong 
promotion often result in inclusion body formation.  Choi et al. (2000) found that 
decreasing the concentration of IPTG from 1mM to 0.01 mM resulted in soluble 
expression instead of causing the formation of inclusion bodies.  Induction using IPTG 
alters the metabolism and growth characteristics of E. coli.  Kosinski et al. (1992) found 
concentrations of 0.05, 0.5 and 1 mM IPTG increased the specific growth rate of cells 
relative to non-induced cells.  In the same work it was reported that an intermediate 
concentration of 0.1 mM IPTG, however, caused a decrease in specific growth rate for 
different media and E. coli strains.  Optimisation of the inducer concentration is 
important not just from a titre perspective but because of its impact on the quality of 
inclusion bodies formed. 
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5.2.1.2.1 Fermentation 
The growth profiles of E. coli obtained at different inducer concentrations are shown in 
Figure 5.2.  The calibration curve between OD and dry cell weight is shown in Figure 
9.3 in the Appendix.  Cells induced with different concentrations of IPTG show 
remarkably similar growth profiles up until 8 hours of growth.  At inducer 
concentrations of 0.125 and 0.25 mM the growth can be observed to slow down after 8 
hours the OD decreases or plateaus, while at 0.5 mM the OD continues to increase.  
High IPTG concentrations have previously been found to give improved growth 
characteristics while low concentrations were found to damage cell growth (Kosinski et 
al., 1992).  The non-induced cells reach stationary phase earlier than induced cells and 
achieve a lower final dry cell weight.  Non-induced cells would be expected to achieve 
higher growth than induced cells as the cell is under less stress and can contribute all its 
energy to growth and metabolism rather than producing the recombinant product.  
Andersson et al. (1996) found that induction with 0.1 mM IPTG led to an increased 
maintenance requirement resulting in a 23% lower final biomass, a higher demand for 
glucose and more pronounced lysis towards the end of the culture.  The increased OD 
observed for induced cells may result from morphological changes and the formation of 
refractile inclusion bodies, which increase the reported OD as previously observed by 
Flickinger and Rouse (1993).    
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Figure 5.2  The growth profile of E. coli during fermentation in microwells and induction by different 
concentrations of IPTG.   
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Figure 5.3  The production of DHFR under different induction regimes.  DHFR concentration was 
determined by densitometry and purity from its relation to the total amount of protein determined by 
Bradford assay. 
 
The concentration of DHFR present (determined by densitometry) relative to total 
protein concentration (determined by Bradford assay) under different induction 
conditions is shown in Figure 5.3.  The non-induced cells are still producing DHFR 
despite no induction, as shown by a DHFR concentration of 0.15 mg.ml
-1
.  Intracellular 
product has been found to be present in non-induced cells previously (Andersson et al., 
1996).  The inducer concentration resulting in the highest protein level is 0.25 mM.  
This is also the condition where DHFR comprises the largest fraction of protein in the 
cell, which is an indication of higher purity.  Whilst a concentration of 0.125 mM also 
gives a high protein concentration of 0.31 mg.ml
-1
, it is a relatively small fraction of the 
total protein concentration present.  This could result from induction not taking place in 
all cells because of the low concentration.  An inducer concentration of 0.5 mM results 
in a similar concentration of DHFR as for 0.125 mM, and a slightly higher proportion of 
the protein present in the cell.  However, due to the errors involved in densitometry and 
Bradford the differences between these two conditions may not be significant. 
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5.2.1.2.2 Refolding 
Figure 5.4 shows the yields of refolds obtained from material induced at increasing 
IPTG concentrations.  The unwashed inclusion bodies refold with higher yields for Tris 
buffer (50mM Tris.HCl, pH 7.2) than reducing buffer (0.25 M potassium phosphate, 0.1 
M potassium chloride, 1 mM DTT), resulting in activities of 1.25 and 0.55 ΔOD.min-
1
.mg
-1 
respectively.  The buffer appears to have a higher impact on yield than the 
dilution factor for unwashed inclusion bodies. Yield is higher for a low dilution factor, 
perhaps because unwashed inclusion bodies have more lipids associated with them that 
aid folding at these dilution factors.   
 
The concentration of inducer used during fermentation affects the end yield of bioactive 
product when refolding unwashed inclusion body material at low dilution factors.  The 
optimum inducer concentration for unwashed IB folding is 0.25 mM.  Since the 
denatured inclusion bodies have been adjusted to give refolds of the same final protein 
concentration, it is not the increased production of inclusion bodies which is resulting in 
a higher yield but a change in the quality of the inclusion body produced.  An IPTG 
concentration of 0.25 mM achieves a maximum yield of 1.25 ΔOD.min-1.mg-1 compared 
with 1.00 ΔOD.min-1.mg-1 for 0.125 mM IPTG induction.  This condition may result in 
IBs which accumulate with less contaminants, or have improved properties in terms 
structure that might aid denaturation and renaturation.  Growth conditions (temperature 
and culture pH) have been found to have a significant impact on inclusion body 
composition.  Valax and Georgiou (1993) proposed that the growth conditions affect the 
“stickiness” of the surface of inclusion bodies, resulting in greater amounts of 
contaminating material being absorbed on-specifically following cell lysis.  
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Figure 5.4  Refolding yield of unwashed IBs produced as a result of induction using 0.125, 0.25 and 0.5 
mM IPTG.  A) Refolded using buffer 1 or 3 and a diluting either 15 or 20 fold.  B)  Refolded using buffer 
1 and 15 fold dilution.  Measurements are an average of 3. 
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Figure 5.5 shows the yield of active protein for washed inclusion bodies from 
fermentations induced with different concentrations of IPTG and refolded using 
different dilution factors and buffers.  The yields increase at the higher dilution factor 
tested, 20-fold.  The highest yield of 2.0 ΔOD.min-1.mg-1 was achieved for a 20 fold 
dilution in Tris and an IPTG concentration of 0.25 mM.  At a dilution factor of 15 fold 
yields were lower, and decreased from 1.4 ΔOD.min-1.mg-1 to 1.2 ΔOD.min-1.mg-1 at 
increasing IPTG concentration from 0.125 mM to 0.5 mM.  Unlike the unwashed 
inclusion bodies, lipids and proteins will have been removed by the washing step.  
Without lipids to aid refolding, yields are higher when the protein concentration is 
lower and intra-molecular interactions, likely to lead to misfolding and aggregation, are 
minimised.  Refolding in buffer 3 showed much higher yields of up to 1.57 ΔOD.min-
1
.mg
-1 
than for unwashed inclusion bodies (which had maximum yields of 0.55 
ΔOD.min-1.mg-1 in buffer 3). This indicates the buffers influence refolding differently to 
give different yields with the same starting IB material.  Washing inclusion bodies is 
important for maximising yields as shown by the increase in maximum yield from 1.25 
to 2.00 ΔOD.min-1.mg-1. 
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Figure 5.5 Refolding yield of washed IBs produced as a result of induction using 0.125, 0.25 and 0.5 mM 
IPTG and renatured using buffer 1 or 3.  Measurements are an average of 3, with error bars too small to 
be discernible for the condition of 0.5 mM IPTG, buffer 3 and 20 fold dilution. 
 
In conclusion, the inducer concentration used appears to have a small impact on 
inclusion body quality.  The concentration of IPTG used to induce cells can alter 
activity by up to 0.26 ΔOD.min-1.mg-1, as observed for washed inclusion bodies 
refolded in buffer 3.  The results also show that despite the fermentation condition, the 
yield can be increased by using buffer 1 and choosing an optimal dilution factor.  The 
dilution factor appears to be the most important factor for washed IBs, with a larger 
dilution factor of 20 increasing yield by 0.8 ΔOD.min-1.mg-1 for 0.25 mM induced 
material refolded in buffer 1.  Buffer 1 and induction by 0.25 M appears to be the 
optimal conditions for yield, with the choice of dilution factor depending on whether the 
inclusion bodies are washed or unwashed.  The effect of the refold buffer used is 
diminished by inclusion body washing, with the previously low yielding buffer 3 
showing improved yields for refolding washed inclusion bodies.  This suggests the 
contaminant profile plays a role in the interactions of refolding.   
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5.2.1.3 Induction time 
5.2.1.3.1 Fermentation 
The automated sequence was then used to investigate the effect of induction time on cell 
growth.  Figure 5.6 shows the growth profiles for cells induced at mid to late 
exponential phase.  Figure 5.7 illustrates the corresponding DHFR concentration present 
under each induction condition and the purity in terms of the percentage DHFR present 
to total host cell proteins. Figure 5.6 shows similar growth curves between induction 
time points for the first 6 hours of fermentation.  Earlier induction times result in growth 
profiles that achieve higher ODs than non-induced cells in the final three hours of 
fermentation.  For induction at 3.5, 4 and 4.5 hours the higher OD achieved could be in 
part due to the presence of large amounts of DHFR IBs as shown by the concentration 
of DHFR reaching 0.3 mg.ml
-1
 in Figure 5.7.  Kim and Lee (1996) found that induction 
at early exponential phase was important for a high level of expression.  However the 
increased OD for induction at 3 hours cannot be attributed to IBs light scattering as the 
concentration of DHFR expressed is lower than that observed for non-induced cells 
(Figure 5.7).  Despite showing good growth this condition shows very poor expression.  
Cells induced at 5 hours show an equivalent growth profile to non-induced cells.  The 
densitometry results shown in Figure 5.7 show only a slight increase in DHFR 
concentration for cells induced at 5 hours from 0.14 to 0.16 mg.ml
-1
.  However this 
DHFR is at a much lower purity of 20% than non-induced cells (31%), indicating that 
induction is likely to influence cell metabolism.  Later induction gives a lower 
proportion of IPTG per cell and switches on expression of the plasmid at a time when 
cells have entered mid-exponential growth.  In conclusion, the optimal condition is 
induction at 3.5 hours as it shows the highest ODs, the greatest DHFR concentration 
and the highest purity of DHFR.   
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Figure 5.6  Growth curves for E. coli induced at different times  
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Figure 5.7  DHFR concentration and purity under different induction regimes 
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5.2.1.3.2 Refolding 
Refolding the material from these fermentations shows that early induction produces 
inclusion bodies that refold to yield higher activities.  Figure 5.8 shows the activity of 
inclusion bodies refolded from fermentation material with different induction times 
using buffer 1.  The yield gain from using an early induction of 3 hours, as opposed to a 
later induction (4 hours onwards), results in an increase in activity of 0.38 ΔOD.min-
1
.mg
-1
, or a 16% increase.  However since this condition produces significantly less 
DHFR IBs as shown in Figure 5.7, an induction time of 3.5 hours remains the optimum 
as it will give an overall more favourable yield and a slight increase refold activity from 
2.45 to 2.57 ΔOD.min-1.mg-1 for 4 and 3.5 hours respectively. 
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Figure 5.8  Refolding yield of washed IBs produced as a result of induction at 3, 3.5, 4, 4.5 and 5 hours 
during fermentation and renatured using buffer 1 to achieve a 20 fold dilution.  The averages of triplicate 
refolds are shown. 
 
Lower refold yields are obtained refolding in buffer 3, as previously observed for 
inducer concentration.  Figure 5.9 shows the activities of inclusion body material from 
fermentations induced at different times refolded in buffer 3.  The maximum yield 
obtained after refolding in buffer 3 is 1.53 ΔOD.min-1.mg-1 for an induction time of 5 
hours, which in comparison is much lower than the 2.57 ΔOD.min-1.mg-1 maximum 
achieved for buffer 1.  A different relationship is shown between activity and induction 
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time, with both early and late induction showing yield increases compared with 
induction at 3.5 or 4 hours.   This shows that the yield gains between different induction 
regimes are buffer dependent and that buffer choice is more important than induction 
regime when achieving high yields. 
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Figure 5.9  Refolding yield of washed IBs produced as a result of induction at 3, 3.5, 4, 4.5 and 5 hours 
during fermentation and renatured using buffer 3 to achieve a 20 fold dilution.  The averages of triplicate 
refolds are shown. 
5.2.1.4 IB storage at -20°C versus -80°C 
Inclusion body harvest provides a window of opportunity to decouple upstream and 
downstream processing by freezing the pelleted inclusion body.  The effect of the 
freezing storage temperature on the final yield of inclusion body refolding is poorly 
understood.  Freezing exposes protein to stresses including low temperatures, high 
solute concentrations, pH changes and exposure to ice-water interface, which can lead 
to denaturation (Chang et al., 1996; Bhatnagar et al., 2007).  Highly concentrated 
protein solutions show the smallest loss in activity after freezing, with transferring 
directly into a -40°C freezer being preferable to immersion in liquid nitrogen freezing 
(Jiang and Nail, 1998).  A faster rate of cooling leads to a greater area of ice-water 
interface and Chang et al. (1996) proposed that denaturing during freezing can primarily 
be prescribed to denaturation at the ice-water interface.  Figure 5.10 shows the yield of 
active protein after refolding at microscale in three different buffers using inclusion 
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bodies from large scale fermentations stored at -20 °C and at -80 °C for a long period of 
time.  Inclusion bodies stored at -20 °C show consistently higher yields across all three 
buffers.  The increase in yield is significantly higher, with -20 °C inclusion bodies 
refolded in Tris buffer having a yield 81% higher than -80 °C stored inclusion bodies.  
From these results a temperature of -20 °C might be preferred for long term storage of 
IBs.  It was originally thought that -80 °C would prove optimal as this temperature 
would result in smaller ice crystals that would disrupt the protein structure less.  As the 
protein is stabilised and in a relatively protected state, the denaturing and damaging 
effects of the larger crystals formed at -20 °C would not have as much affect as in a 
soluble protein solution.  A temperature of -20 °C provides a higher yield than -80 °C, 
may be because by damaging the structure of contaminating protein, the contaminating 
protein is less able to cause yield reductions during refolding.  It is also possible that 
denaturation at the surface of the IB at -20 °C could aid the following denaturing and 
solubilisation step, ultimately leading to greater yields.  
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Figure 5.10  Refolding yield of washed IBs produced by large scale fermentation, stored at -20 or -80 °C 
and renatured using 3 different buffers.  The averages of triplicate refolds are shown. 
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The effect of temperature on inclusion body material obtained from the microscale 
process sequence and stored for a shorter length of time shows a less marked affect.  
Figure 5.11 shows the activity for inclusion body material stored again at -20°C and -
80°C, refolded in two different buffers.  A storage temperature of -20°C does not result 
in the significantly higher yield previously observed.  Refolding in Tris, a typically high 
yielding buffer, results in a slightly higher yield after storage at -80°C.  This could be 
attributed to the different buffers used in this experiment.  It has been previously 
observed that the choice of buffer has a large impact on the refolding success and can 
hinder yield losses due to poor expression conditions.  Additionally differences in the 
dewatering of the inclusion body pellets between large scale and small scale 
centrifugation could affect the rate of freezing and the size of ice crystals, resulting in 
the differences observed. 
 
Buffer type
TRIS Reducing
A
c
ti
v
it
y
 (

O
D
.m
in
-1
.m
g
-1
)
0.0
0.5
1.0
1.5
2.0
2.5
-20°C 
-80°C 
 
Figure 5.11  Refolding yield of washed IBs produced by microscale fermentation, stored at -20 or -80 °C 
and renatured using 2 different buffers to give a final protein concentration of 0.02 mg.ml
-1
.  The averages 
of triplicate refolds are shown. 
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Table 5.5 highlights the conditions found to yield more active DHFR, which could 
potentially be used to improve yields at the large scale.  Based on the findings from the 
microscale process sequence, an optimal condition can be determined.  However the 
interaction of these different optimal conditions is unknown as they have only been 
studied one factor at a time.  
 
Table 5.5  Summarised optimal conditions for a high yield of active DHFR 
 
Factor to control Optimum identified 
IPTG Concentration 0.25 mM 
Induction time 3.5 h 
Storage temperature -20 °C 
Refold buffer 1 
Dilution factor 15 fold 
5.2.2 Insulin 
5.2.2.1 Establishing insulin growth on platform 
E. coli was first grown in shake flasks to establish growth methods from frozen cell 
stocks and optimise inoculum preparation.  Figure 5.12 shows growth in shake flasks 
for LB and complex media.  In LB media growth appears to plateau early at around 12 
hours with a final OD of 3.25 A.U.  Cells grown in defined media reach a much higher 
final OD of 7, with growth slowing after 12 hours but continuing to grow gradually up 
until 24 hours.  This shows that inoculum prepared in LB should be used before 12 
hours of growth. 
5  Application of the microscale sequence to study the effect of fermentation variables 
on inclusion body refolding yield  G. Ordidge 
 
189 
 
Time (h)
0 5 10 15 20 25 30
O
D
 6
0
0
 n
m
 (
A
.U
.)
0
2
4
6
8
10
complex
LB
 
Figure 5.12  Growth profile for E. coli containing the insulin plasmid grown in shake flasks with no 
induction using two different media. 
 
This inoculum preparation procedure was then used to inoculate the microwell 
fermentation.  Growth profiles obtained at 1 ml scale fermentations are shown in Figure 
5.13.  After a lag phase of 4 hours, the cells enter the exponential phase, reaching the 
stationary phase around 9 hours.  The cells were induced at 10 hours, but this was 
already too late as the cells are approaching stationary phase as shown by the non-
induced cells.  The concentration of IPTG added may not be sufficient to result in 
induction in the large majority of the cell population as the OD is high (17 A.U.).  A 
small decrease is observed in the OD of induced cells 1 hour after induction, after which 
growth stops. 
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Figure 5.13  Growth profile for E. coli expressing insulin grown in microwells and induced at 10 h.   
 
Insulin is present in the induced cells in the insoluble fraction, indicating that insulin IB 
have been formed (Figure 5.14).  However it also appears to be present in the non 
induced cells as well.  The insulin molecule being expressed by the plasmid is a pro-
insulin with a short amino acid sequence attached, and consequently will have a much 
larger molecular weight than the Humalog insulin shown as a standard.  Humalog 
insulin has a molecular weight of 5.8 kDa and has been through enzymatic cleavage and 
hydrolysis to be converted from proinsulin (9.39) kDa to insulin. 
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Figure 5.14  SDS PAGE of induced cells during fermentation.  Lane 1 contains molecular weight ladder.  
Lane 2 and 3 are the soluble and insoluble fraction respectively of pre-induction cells.  Lane 4 and 5 are 
the soluble and insoluble fraction respectively of cells 3 hours after induction.  Lane 6 and 7 are the 
soluble and insoluble fraction respectively of cells 7.5 hours after induction.  Lane 8 and 9 are the soluble 
and insoluble fraction respectively of cells harvested after 11 hours.  Lane 10 and 11 are the soluble and 
insoluble fraction respectively of non-induced cells harvested after 11 hours.  Lane 12 contains a 
Humalog insulin standard. 
5.2.2.2 Induction time 
5.2.2.2.1 Fermentation 
Once the automated sequence had been established using insulin, the sequence was used 
to investigate the effect of fermentation conditions on the final yield of active insulin in 
this expression system.  Figure 5.15 shows the growth profile for cells induced at 
different times.  Induction between 4 and 5 hours results in a lower final OD as cells 
grow less after 8 hours compared with those induced at 3.5 hours.  However, final ODs 
for induction times between 4 to 5 hours match that observed previously for non-
induced cells, showing that induction at 3.5 hours is increasing the growth rate as 
previously observed for some induction conditions for DHFR expression.  Figure 5.16 
shows that acetate is present at a much higher concentration at the end of fermentation 
for cells induced at 3.5 hours.  This could be because the cells have reached a higher 
OD and consequently more acetate has been produced.  In comparison, no acetate was 
detected under the other induction conditions (within the sensitivity levels of the assay 
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which is 0.254 mg.l
-1
).  It is unlikely that no acetate would be present at the end of the 
fermentation when there is a high cell density.  These cells could have switched their 
metabolism from glycerol to acetate, and used the acetate present as their carbon source 
(Dharmadi et al., 2006; Murarka et al., 2008).  
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Figure 5.15  Growth profile for insulin expressing E. coli grown in microwells and induced at 3.5, 4, 4.5 
and 5 hours.  Feeding commences at 5 h hours. 
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Figure 5.16  Acetate concentration at harvest under different induction conditions (induction at 3.5, 4, 4.5 
and 5 hours) 
 
5.2.2.2.2 Refolding 
The inclusion bodies harvested from fermentation material induced at different times 
were refolded at a concentration of 0.015 mg.ml
-1 
in buffer 1 (0.288 mM cystamine, 
10% v/v hexylene glycol, 20 mM ethanolamine, pH 10.5), a buffer reported to be used 
in industry. Figure 5.17 shows the absorbance at three wavelengths for the refolds from 
IB material induced at different times.  No aggregation was observed visually and the 
high absorbance for a wavelength of 280 nm may reflect the protein concentration used 
in this condition.  The refolds are adjusted to the same starting concentration prior to 
refolding based on insulin concentration determination by HPLC.  However the errors 
involved with crude fermentation samples is quite high due to the presence of multiple 
contaminating proteins.  The high protein concentration could also result from 
contributions from contaminating proteins as well as insulin.  Previous experiments 
have shown that aggregates from insulin refolds result in a typical absorbance of 1-2 
A.U. (data not shown), which are much higher than those observed.  The yields from the 
refolds are relatively low achieving yields of between 5-10.5 %, as shown in Figure 
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5.17.  The highest yield is 10.5% for cells induced at 4.5 hours.  The lowest yield of 
4.2% is observed for cells induced only half an hour earlier.  There is no clear trend 
between induction time and refold yield, indicating that multiple factors are involved.  
Fluorescence does not appear to be a good predictor for yield in this case.  For a high 
fluorescence of 19000, a yield of 10.5% is obtained yet the refold with the next highest 
fluorescence has a yield of only 5.9%.  The refold with a low fluorescence of 9900 has a 
higher yield of 6.8%, suggesting a broad range of optimal fluorescence for insulin 
possibly resulting from mixed populations of intermediates folded and misfolded 
protein. 
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Figure 5.17  Inclusion bodies from fermentations induced at different time points and refolded in buffer 
1.  A) Absorbance at different wavelengths.  B) Intrinsic fluorescence and yield. 
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Refolding was also performed using another buffer successfully.  Figure 5.18 A) shows 
the absorbance profile for refolding IB material in buffer 2 and is very similar to that 
observed previously in Figure 5.17 A).  Buffer 2 (10 mM Tris, 10 mM glycine, 1 mM 
EDTA, 0.5 mM cysteine, 4.5 mM cystine pH 10.5) was reported to be optimal for 
refolding proinsulin (Winter et al., 2002).  The absorbance at 280 nm for IB material 
induced at 4.5 and 5 hours was again almost double that obtained for 3.5 and 4 hour 
induced material.  This could be due to contaminating proteins or errors in the correct 
determination of insulin concentration as previously described.  The yields obtained are 
higher than that obtained with buffer 1, achieving between 16 to 43% as illustrated in 
Figure 5.18 B).  The highest yield is obtained for an induction time of 4.5 hours.  The 
ranking is the same as observed for the other refold buffer, with an induction time of 3.5 
hours resulting in the next highest yield closely followed by 5 hours and then 4 hours 
with a yield of 15.8%.  The fluorescence measured is lower for buffer 2 despite the 
same protein concentration, resulting in fluorescence results of between 4900-11000 
Fl.U.  It is noteworthy that these conditions also resulted in higher yields than those 
refolded in buffer 1. 
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Figure 5.18 Inclusion bodies from fermentations induced at different time points refolded in buffer 2.  A) 
Absorbance at different wavelengths.  B) Intrinsic fluorescence and yield. 
A 
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5.2.2.3 Fed batch versus batch feeding strategies 
Fed-batch strategies are often used during high cell density fermentations to control the 
growth rate of cells.  Figure 5.19 illustrates the different growth profiles observed for 
fed batch and batch feeding strategies.  Cells initially grew faster in the fed-batch media, 
before reaching stationary phase after 5 hours.  The cells then remain in stationary phase 
even after feeding at 9 hours, although growth appears to commence again in the last 
hour of the fermentation. This could result from the feed rate being too slow initially 
and limiting growth.  The second phase of growth may result from a metabolic shift, for 
instance to metabolising acetate.    Fed-batch fermentation typically produces a higher 
biomass (Lewis et al., 2004), which could explain the high initial growth rate.  In 
contrast, the cells growing in the batch media grow slower initially and after 6 hours 
switched to a reduced growth rate, rather than the plateau observed for the fed-batch 
cells.  At 11 hours the cells then started to grow at a slightly faster rate, increasing in 
OD dramatically in the last hour of fermentation as described previously for the fed-
batch cells (Figure 5.19).  The batch fermentation contains a much higher initial carbon 
concentration and this could cause substrate inhibition and account for the slower 
growth in the batch culture during the first 12 hours of the fermentation (Lee 1996).  
The batch fermentation has a higher level of acetate at harvest as shown in Figure 5.20 
with an end concentration of 0.32 g.L
-1
, whilst fed batch has a concentration of 0.25 g.L
-
1
.  An excess of carbon under aerobic conditions leads to the formation of acidic by-
products, of which acetate is the most predominant.  During high cell density cultures, 
growth can be severely limited by the presence of acidic by-products (Landwall and 
Holme, 1977; Anderson et al., 1984; Lischke et al., 1993).  However the concentrations 
are below the minimum concentration to cause growth inhibition of 5 g.L-1 (Lee 1996).    
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Figure 5.19  Growth profile for E. coli expressing insulin grown in microwells and induced at 6 h.  
Feeding commences at 5 h for fed-batch fermentation. 
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Figure 5.20  Acetate concentration at harvest for batch and fed-batch fermentations 
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The inclusion body harvest material from the batch and fed-batch fermentation was 
refolded in buffers 2 and 3.  Buffer 2 had previously out performed buffer 1 (see Section 
5.2.2.2.2) and buffer 3 (1M acetic acid pH 3.8) was included as it was reported to be 
used in industry for refolding insulin.  Figure 5.21 illustrates the results from the 
hierarchical assays for refolding in acetic acid.  The absorbance at 280 nm is much 
higher at 0.88 and 1.3 A.U. than what was previously obtained for buffer 1 (0.46 A.U. 
for refold of 4.5 h induction IB material), despite the refolds being conducted at the 
same concentration.  The absorbance is particularly high for the fed batches refold with 
an A340 of 0.44 A.U, which could indicate the formation of fine aggregates.  However 
the A600 is still only 0.1 A.U. so large aggregates do not appear to be present.  The 
difference between batch and fed batch absorbance is also shown by the fluorescence 
measurements.  Fluorescence results obtained using the fed-batch material resulted in 
33% higher yield than batch IBs.  The yield for the batch refold is 19%, 4% higher than 
the yield obtained for the fed batch fermentation, therefore there may be some yield 
losses due to aggregation.  
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Figure 5.21  Inclusion bodies from batch and fed-batch fermentations refolded in acetic acid buffer 3.  A) 
Absorbance at different wavelengths.  B) Intrinsic fluorescence and yield. 
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Refolding in the buffer 2, which has been described as optimal for insulin by Winter et 
al. (2002), resulted in higher yields than in buffer 3 (acetic acid).  Figure 5.22 illustrates 
the results for buffer 2 and shows the absorbance is lower when refolding in this buffer 
than when refolding the same starting material in buffer 3.  This confirms that the high 
absorbance previously observed for acetic acid was buffer or refold state dependent (as 
opposed to being purely concentration dependent).  However the absorbance difference 
of 0.23 A.U. between fed batch and batch refolds remains, and could result from 
increased protein contaminants in the IB material from the fed batch fermentation.  
Table 5.6 shows the fermentation titre and illustrates a higher insulin titre for batch 
fermentation with a lower cell concentration.  Consequently the insulin is expected to 
have a higher purity than for the fed batch material, as there is a lower ratio of cellular 
material.  The insulin titre datum is supported by SDS-PAGE gels showing the 
concentration of insulin is higher for the batch fermentation, while the concentration in 
the fed batch sample is too low to be determine by densitometry at the dilution factor 
used (data not shown).  In order to achieve the same denatured protein concentration for 
batch and fed-batch fermentation in the solubilisation step, the batch sample was diluted 
by a greater factor.  Hence the level of contaminating protein is lowered further for 
batch refold and could explain the lower protein concentration (A280) observed in 
Figure 5.21.   
 
Table 5.6  Fermentation titre as determined by HPLC and dry cell weight. 
 
Fermentation condition Insulin concentration 
(mg.ml
-1
) 
Dry cell weight  
(g.L
-1
) 
Batch  1.4 12.7 
Fed-batch 0.9 20 
 
The yields obtained in Figure 5.22 B) are much higher than previously observed for all 
the other refold and fermentation conditions, with the highest yielding condition present 
in batch IB material which has a yield of 64%.  This is also significantly higher than the 
52% obtained from fed batch material.  Previous research studies indicate that fed batch 
is a better condition for protein expression in terms of increasing biomass yield (Lewis 
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et al., 2004), having a slower growth rate control to achieve better expression (Jensen 
and Carlsen, 1990; Riesenberg et al., 1991) and avoiding catabolite repression (Cutayar 
and Poillon 1989).  The dry cell weights indicate that the fed-batch fermentation yields 
a greater biomass (Table 5.6).  However the expression levels are lower and 
consequently the burden of contaminating proteins appears to be higher as illustrated by 
the high A280 shown in Figure 5.21A), resulting in aggregation and lower yields.  
Therefore in this case it can be speculated that batch fermentation is optimal for both 
fermentation titre and final yield of active product from refolding.   
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Figure 5.22  Inclusion bodies from batch and fed-batch fermentations refolded in buffer 2.  A) 
Absorbance at different wavelengths.  B) Intrinsic fluorescence and yield. 
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5.2.2.4 Media composition 
Figure 5.23 illustrates the fermentation growth curves obtained using different media 
compositions.  The optimal media for cell growth was shown to be a glycerol based 
complex media.  Cells grown in glycerol media reach a final OD of 22.3 and show 
exponential growth until 14 hours of fermentation.  On the other hand, cells grown in a 
glucose based media reach a lower OD of 21.2 and display a different growth profile, 
ending exponential growth at the earlier time of 12 hours.  The cells then start to grow 
significantly again after 18 hours, which implies a nutrient limitation and possibly a 
switch of metabolism.   
 
The cells grown in terrific broth (TB) have the poorest initial growth rate but after 15 
hours they begin to grow exponentially before reaching stationary phase at 18 hours.  
The cells grown in LB enter exponential phase earlier because the inoculum was grown 
in the same media.  However after 4 hours they reach the stationary phase earlier than 
those grown in TB, possibly as the cells grown in LB reach carbon limitation.  TB 
contains a defined carbon source (glycerol) as well as yeast extract and tryptone, 
whereas LB contains approximately five times less yeast extract.   
 
The cells grown in TB and LB have almost no acetate present, as shown in Figure 5.24.  
This could result from the lower cell densities achieved which result in less acetate 
production or could indicate the cells have utilised the acetate as a carbon source.  
During the majority of E. coli cultures once the glucose or glycerol has been consumed 
the cells reuse the acetate present through activation of the tricarboxylic acid cycle (Luli 
and Strohl, 1990).  Acetate is more of a problem at a pH of below 7, where a greater 
fraction is present as undissociated acid (Landwall and Holme, 1977).  TB has a good 
buffering capacity as it contains KH2PO4 and K2HPO4, which buffer the media and limit 
pH decreases.  Glycerol fermentation has been reported to produce acetate although its 
formation is strain dependent as the pathway that produces acetate is not essential for 
the metabolism of glycerol (Eiteman and Altman, 2006a; Murarka et al., 2008).  Hence 
the lack of acetate observed could result from a combination of these two factors.  The 
fermentations in glucose and glycerol based media are more likely to encounter 
problems with acetate toxicity due to their high cell densities and the low final pH 
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observed (Figure 5.24).  The level of acetate is high in both these fermentations 
reaching up to 0.35 g.L
-1
 (Figure 5.24), indicating that the carbon resources have not 
been completely depleted as acetate has not been utilised.  A concentration of 0.35 g.L
-1
 
has been reported as not being toxic to cells (Lee 1996).  The low final pH of 5.5 and 6 
for glucose and glycerol respectively could affect the intracellular environment.  
Strandberg and Enfors (1991) found that a lower fermentation pH results in an increase 
in total inclusion body protein (at induction temperatures of 39 and 42°C), but once the 
pH had dropped below 5.5 the activity of the protein decreased.  However a pH of 6.3 
has been found to optimal for growth on glycerol (Murarka et al., 2008).  
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Figure 5.23  Growth profile for E. coli expressing insulin grown in microwells and induced at 3.5 h.  
Cells are grown in 4 different medias: Luria Bertani (LB), Terrific Broth (TB), glycerol based complex 
media and glucose based complex media. 
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Figure 5.24  Acetate concentration and final pH at harvest for cells fermented in different medias, grown 
in microwells. 
 
Inclusion bodies harvested from these fermentations were then refolded using the 
microscale process sequence in buffer 2.  The inclusion bodies all showed a low 
absorbance at the three wavelengths, as illustrated in Figure 5.25 A).  The absorbance at 
280 nm showed only small differences between the four separate fermentation 
conditions.  Intrinsic fluorescence showed more sensitivity to variation between the 
fermentation conditions, with TB and glucose derived inclusion bodies having a higher 
fluorescence of 13300 and 12000 Fl.U respectively.  TB and glucose derived inclusion 
bodies also had the lowest refold yields of 17% and 18% respectively (Figure 5.25 B).  
Inclusion bodies from the LB fermentation had a lower fluorescence of 10400 FL.U., 
but the refold yield remained a relatively low 19%.  Inclusion bodies formed during 
growth on the glycerol based media had the lowest fluorescence of 9370 and the highest 
yield of 33%.  Therefore a glycerol based complex media is optimum for both cell 
growth and IB quality, although it results in the production of a higher concentration of 
acetate.   
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Figure 5.25  Inclusion bodies from fermentations in 4 different medias refolded in buffer 2.  A) 
Absorbance at different wavelengths.  B) Intrinsic fluorescence and yield. 
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The use of intrinsic fluorescence as selection criteria for choosing high yielding 
conditions appears to be problematic for insulin.  Large variations in fluorescence 
appear to have only subtle effects in yield, as illustrated by the contrast in yields for 
proteins with close fluorescence values. Figure 5.26 shows a fluorescence value of 
between 10,500 and 35,000 appears to be desirable and could be used in future assays 
for selecting high yielding conditions for slower HPLC assays.   
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Figure 5.26  Yield as a function of relative fluorescence for insulin refolds.  Each point represents a 
duplicate (yield measurements) or triplicate (fluorescence measurements).  Cut-off lines at 10500 and 
35000 Fl.U. (– –). 
 
Table 5.7 summarises the optimal condition for each of the fermentation parameters 
investigated independently.  These variables resulted in inclusion bodies that refolded to 
give the highest yields of active refolded protein. 
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Table 5.7  Summarised optimal conditions for a high yield of active insulin 
 
Factor to control Optimum identified 
Induction time 4.5 h 
Feeding strategy Batch 
Media Glycerol complex media 
Refold buffer Rudolph 
5.3 Conclusions 
The automated microscale process sequence allows the study of multiple process 
variables in parallel.  Studies investigating the effect of induction time showed that the 
process sequence could be successfully used to investigate up to 5 different 
fermentation conditions in parallel on a single microwell plate, even while allowing for 
triplicates and a sacrificial well approach to sampling.  The number of variables 
investigated could be expanded further if differing downstream parameters were also 
developed and suitably integrated.   
 
Fermentation conditions have been demonstrated to effect inclusion body refolding 
yield.  The fermentation conditions investigated were previously linked to solubilising 
inclusion body expression and caused perturbations in yield.  For DHFR the inducer 
concentration was the most important fermentation variable for optimising the inclusion 
bodies formed during fermentation, increasing the refolding yield by a maximum of 
25%.  However, the maximum yield change caused by DHFR fermentation differences 
was small in comparison to IB washing and storage temperature, which had greater 
effects on the refolding yield of DHFR, increasing yields by 88% and 81% respectively.  
Refolding buffer also played an important role in increasing yield losses for DHFR, 
with buffer 1 and a 15 fold dilution factor resulted in the highest refold yields and could 
increase yields even for less desirable fermentation conditions.   
 
The sequence showed broader applicability as it was adapted for insulin fermentation 
and processing with minor adjustments.  Insulin displayed a greater sensitivity to 
changes in fermentation conditions as it showed clearer trends of the effect of 
fermentation conditions on refolding yield.  In particular, the choice of fermentation 
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media caused a doubling of refolding yield from 17 to 33%.  The optimal fermentation 
condition was shown to be batch fermentation in glycerol based complex media with 
induction at 4.5 hours is suggested for future experiments to maximise downstream 
refolding yield.  The choice of refolding buffer also showed an important role in 
maximising yield with buffer 2 giving the highest yields and acetic the lowest.  The 
intrinsic fluorescence assay was less sensitive to insulin refolding than observed for the 
previous proteins studied, showing its utility is protein specific.  However knowledge of 
target fluorescence could improve this if the intrinsic fluorescence of the correctly 
folded form of pro-insulin was known. 
 
This approach has clear advantages in terms of resources due to its scale, the use of 
automation and because of the speed due to the use of parallel experimentation.  
However uncontrolled microscale fermentation is vastly different to the industrial scale 
where cells experience a far greater process control (pH and dissolved oxygen tension) 
and substantial differences in terms of mixing and hydrodynamics.  Whether the 
findings of this chapter can be translated from microscale and used as a predictive tool 
for large scale manufacture is the subject of the next chapter.
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6 Translation of fermentation and refolding processes  
6.1 Introduction 
 
High cell density cultures of E. coli have a number of advantages in terms of high 
volumetric productivity, reduced production and investment costs and improved cell 
separation and product recovery downstream (Riesenberg et al., 1991).  However they 
also can have a number of drawbacks, as an example, the oxygen demand of an 
increased number of cells can lead to low soluble oxygen saturation (Riesenberg et al., 
1991).  Under anaerobic conditions, in the presence of few alternative electron 
acceptors, inhibitory metabolic by-products such as acetate, lactate, formate and ethanol 
are produced (Clark, 1989).  It has been shown that expression of a recombinant product 
in E. coli is higher at reduced growth rate for interferon α-1 (Riesenberg et al., 1990).  
Fed-batch cultivations are often used to allow control of the growth rate leading to 
lower acetate levels (Shiloach and Fass, 2005) and maintain dissolved oxygen 
concentration within a certain range, thus improving final product formation.  
 
Maintaining a sufficient oxygen supply is usually a challenge when cultivating cells at a 
high cell density (Riesenberg et al., 1991).  The oxygen transfer rate depends on the 
oxygen concentration difference, which provides the driving force, and on both the 
overall oxygen mass transfer coefficient (kL) and the specific gas-liquid surface area (a).   
 
OTR = kLa (CL
*
 - CL)        Equation 6.1 
 
Where CL
*
 is the equilibrium oxygen concentration (mol.L
-1
) and CL is the actual 
saturated oxygen concentration (mol.L
-1
).  In aerobic fermentations with plentiful 
nutrients, oxygen is the limiting factor for growth and consequently the volumetric 
oxygen mass transfer coefficient (kLa) can be used as scaling parameter (Ferreira-Torres 
et al., 2005; Micheletti et al., 2006).  The kLa is dependent on the fluid properties, 
system geometry, gas-liquid interfacial area and operating variables (Doig et al., 2005a).     
 
It has been demonstrated that the microwell process sequence can be used to investigate 
the effect of fermentation conditions on inclusion body refolding yield, but the degree to 
6  Translation of fermentation and refolding processes G. Ordidge 
 
213 
 
which this relates to the large scale has not yet been investigated.  Conventionally micro 
titre plates have been used for cell line selection and secondary metabolite screening 
(Duetz, 2007) instead of trying to mimic large scale fermentation conditions at the 
microscale.  Reproducing the environment and process control of a large scale 
fermenter remains challenging at the microscale and, as a result, differences in growth 
and product formation are often observed.  Several studies have addressed these 
concerns by developing modifications to microwell designs to provide pH control, 
mechanical agitation and air sparging systems that give higher kLas (Micheletti and Lye, 
2006). Additionally, new technologies are becoming commercially available, such as 
the BioLecter (Funke et al., 2010) and ambrTM for mammalian cell lines (Wen et al., 
2012), which allow parallel process control in high throughput systems.   
 
The aim of this chapter is to investigate how the microscale fermentation results 
compare with those obtained at the pilot scale using an industrially relevant protein.  It 
will also investigate whether kLa is an appropriate scaling parameter for this 
fermentation process and whether the large scale fermentation can be reproduced at the 
microwell in terms of yield and inclusion body quality.  Finally it will address relevance 
of the microscale sequence to the large scale and its use as a predictive tool to allow 
ranking of process variables.  The experimental approach was to first follow an existing 
fermentation protocol optimal for E. coli growth (provided by the collaborating 
company Fujifilm Diosynth Biotechnologies).  This was used to establish optimal 
fermentation performance at the 100 L scale.  The kLa was then determined in the 100 L 
fermenter and using correlations determined in the literature for microwells, 100 L 
fermentation conditions were arrived at that could then be scaled down to microwell 
based on kLa to the microwell.  The different fermentation scales were compared based 
on titre and refolding yield.  The reported scale invariance of the downstream refolding 
unit operation was also studied by comparing refold yields at different refolding scales. 
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6.2 Materials and methods 
 
The large scale fermentations and processing were conducted as described in 2.3.2, 
using the media described in Table 2.8.  Growth was monitored using OD, wet and dry 
cell weight measurements as described in 2.5.2.  The microscale fermentation and 
processing was carried out as detailed in 2.3.5 and OD measured using the sacrificial 
well technique.  The conditions for the fermentations are summarised in Table 6.1 for 
scale comparison.  The fermentation titre was determined using RP-HPLC as described 
in 2.5.9.1.1.1and 2.5.9.1.2. 
 
Table 6.1  Fermentation conditions 
 
 1 2 3 microwell 
Fill volume (L) 100 70 70 0.001 
Inoculum OD 6.46 6.73 8.65  
Impeller / shaking 
speed (rpm) 
250 (initial) 275 450 1000 
Feeding started (h) 9.65 13.23 N/A N/A 
Feed rate (g.L
-1
.h
-1
) 11 1.15* N/A N/A 
Induction OD 50 24.6 9.5  
Induction time (h) 10.65 16.85 6 6 
Fermentation length (h) 22 29 18.3 18 
*Average overall feed rate, initially started with 2 g.L-1h-1 but decreased continually until after 20h when it remained at 0.89 g.L-1h-1
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The refold conditions used for the 200 ml scale refolds are shown in Table 6.2.   
 
Table 6.2  Refold conditions for 200 ml dilution refolding.  Fermentation material 1: 100 L fed batch 
fermentation with cascade control with enriched oxygen, 3: 70 L batch fermentation at 475 rpm.  Refold 
buffer 1: 0.288 mM cystamine, 10% v/v hexylene glycol and 20 mM ethanolamine, 2: 10 mM Tris, 10 
mM glycine, 1 mM EDTA, 0.5 mM cysteine, 4.5 mM cystine. 
 
 Fermentation 
material 
Washing 
procedure 
Solubilisation 
concentration 
(g.L
-1
) 
Dilution 
factor 
Refold 
buffer 
Final protein 
concentration 
(g.L
-1
) 
1 1 Washed 1.5 18 1 0.08 
2 1 Washed 1.5 18 2 0.08 
3 1 Unwashed 1.5 18 1 0.08 
4 1 Unwashed 1.5 18 2 0.08 
5 3 Washed 1.5 18 1 0.08 
6 3 Washed 1.5 18 2 0.08 
7 3 Unwashed 1.5 18 1 0.08 
8 3 Unwashed 1.5 18 2 0.08 
9 1 Unwashed 10 10 1 1.00 
10 1 Unwashed 10 19 2 0.53 
11 1 Washed 10 17.2 1 0.58 
12 1 Washed 10 17.2 2 0.58 
13 1 Washed 10 18 1 0.56 
14 1 Washed 10 18 1 0.56 
15 1 Washed 10 18 2 0.56 
16 1 Unwashed 10 18 1 0.56 
17 1 Unwashed 10 18 2 0.56 
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6.3 Results and Discussion 
6.3.1 Volumetric mass transfer (kLa) determination 
The kLa was initially estimated for the microwell plate format using the correlation 
determined by Doig et al. (2005) for microwell plates, which has been shown to fit data 
sets besides their own to within ±30% (Hermann et al., 2003).  
      Equation 6.2 
This correlation was determined for deep round wells (DRW) while for  deep square 
wells the kLa has been estimated to be 30% higher than the corresponding values 
measured in the round geometry (Micheletti et al., 2006)  The square shape of the wells 
are thought to introduce a baffling effect which impacts on fluid mixing improving mass 
transfer processes (Duetz et al., 2000).  A maximum shaking speed of 1000 rpm resulted 
in fairly high kLa of between 210 to 370 h
-1
 for water and media respectively, as shown 
in Table 6.3.  This results largely from differences in the Bond number resulting from 
different wetting tensions determined by Doig et al. (2005).  One of the physical effects 
introduced by miniaturisation is the increased importance of the surface tension which 
opposes the liquid movement caused by the g-forces associated with orbital shaking, 
thus modifying the air-liquid surface area (Duetz, 2007).  
 
Table 6.3  KLa values determined with a fill volume of 1 ml and shaking speed of 1000 rpm using 
Equation 1. 
 
Microwell kLa (h
-1
) 
Water 210 
Media 370 
 
The determined values show similarity to previously predicted kLa values, Micheletti et 
al. (2006) calculated a value of 259.2 h
-1
 with media using the same correlation. 
Experimentally derived values for 96-well plates also show approximate agreement with 
the values calculated in this work using Eq 1.  Ferreira-Torres et al., (2005) obtained a 
kLa value of 198 h
-1
 for a fill volume of 0.5 ml, N = 1000 rpm and an identical shaking 
diameter of 3 mm.  The range of kLa values required for microbes growth is between 36 
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to 540 h
-1
 (Tribe et al., 1995), indicating that the microwell may be able to fulfil the 
oxygen requirement. 
 
The kLa was predicted for the 100 L fermenter using the correlation derived by (Linek et 
al., 2004) (Equation 6.2).  The equation was found to fit the experimentally obtained 
data by Linek et al., (2004) with a mean deviation of 4.7%.  It also fits the data of Alves 
et al., (2004) after minor modification with a mean deviation of 24.4%.   
        (3) 
This correlation predicted oxygen mass transfer values of between 96 to 169 h
-1
 
depending on impeller speed and working volume.  They suggest a good overlap with 
the range of values obtained at the microwell and that a mid-range impeller speed could 
potentially be used to mimic the microwell conditions. 
 
Table 6.4  KLa values determined with different fill volumes of a 146.5 L fermenter at different impeller 
speeds using Equation 2. 
 
Pilot scale fermenter rpm kLa (h
-1
) 
70 L 450 127 
 275 96 
100 L 700 169 
 
When the kLa was determined experimentally for the 146.5L fermenter using the static 
gassing out technique, the values were much higher than predicted by the correlation, as 
shown in Figure 6.1.  The overall trend of increasing kLa with faster impeller speeds 
agrees with current findings of kLa increasing with increasing power dissipated into the 
liquid.  Puthli et al., (2005) found that the kLa increased with increasing impeller speed 
for a triple impeller configuration.  This was attributed to the rapid breakage of air 
bubbles into smaller sized bubbles caused by the use of an higher power input per unit 
volume, enhancing the air-liquid interfacial area for oxygen mass transfer.   
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Figure 6.1  KLa determined in large scale fermenter with 70L of media and at varying impeller speeds.  
Points were fitted to an exponential growth curve with the equation y= (0.6542(e
(0.0018x)
-1)/0.0018)-
47.6714  
 
Table 6.5  Experimentally predicted kLa based on regression shown in Figure 6.1 
 
Impeller speed 
(rpm) 
kLa  
(h
-1
) 
100 24 
200 110 
300 213 
400 336 
450 406 
500 483 
 
However the kLa values obtained are much higher than those predicted by the equation.  
The kLa for an impeller speed of 450 rpm was determined experimentally as 372 h
-1
 in 
contrast to the 127 h
-1
 predicted from Equation 2, which could result for a number of 
reasons.  The correlation used was developed for a dual impeller system, whereas the 
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fermenter used in this work has a triple impeller system.  It has been reported that the 
number of impellers is immaterial and only the power dissipated in the fluid is 
important (Oldshue, 1966; Van’t Riet, 1979).  However Van’t Riet, (1979) asserted that 
confidence in this statement is problematic when fluctuations with differences of up to 
40% have been observed for mass transfer, which could be related to the low 
experimental accuracy.  Conversely (Puthli et al., 2005) found that a triple impeller 
system resulted in a higher kLa relative to a two impeller system, especially at higher 
gas flow rates of above 0.00002 m
3
s
-1 
(as used in this work).  They also found that kLa 
was highest for the triple impeller system even at similar levels of total power 
dissipation.  Therefore the third impeller could significantly contribute the increase of 
the kLa values, introducing large errors in the predicted kLa values.  Additionally the 
same value for bubble surface area was used in the correlation for the different impeller 
speeds due to the lack of available data or models predicting bubble surface area.  The 
bubble surface area would be expected to increase at faster impeller speeds.  Gas hold 
up also increases at higher impeller speeds (Gogate et al., 2000), allowing more time for 
oxygen transfer.  The bubble size also changes for different power dissipations, and 
consequently could be subject to change due to the extra third impeller, thereby 
introducing further error into the correlation.  
 
The microscale fermentation in traditional well plate format presents unavoidable 
limitations in terms of oxygen mass transfer, as aeration can solely be achieved by gas 
exchange at the surface of the liquid.  At the large scale, oxygen mass transfer is aided 
by the use of direct sparging of air or enriched oxygen and mixing via an impeller.  
Therefore an appropriate impeller speed for the large scale fermentation should be 
chosen based on the highest kLa achievable at the microscale to avoid oxygen limitation 
and realistically compare the two systems.  Based on the large scale experimentally 
derived kLa values, impeller speeds of 275 rpm and 450 rpm were selected.  An impeller 
speed of 275 rpm was shown to correspond to a kLa of approximately 200 h
-1
 and it was 
chosen to match the kLa of 210 h
-1
 estimated for the microwell plate format with water.  
An impeller speed of 450 rpm corresponds to a kLa of 372 h
-1 
which matches the kLa 
estimated for microwell plate format with media.  Ideally kLa should be maintained at a 
level where further increases in oxygen transfer do not result in higher yields as this 
would then provide a robust scaling factor.  For this reason fermentation were 
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conducted at both a high and low kLa values to establish the limitations of this scale-up 
approach. 
6.3.2 Fed batch 100L fermentation  
The initial fermentation condition chosen reflects the industry standard fermentation 
protocol for E. coli production with fed batch operation and enriched oxygen combined 
with cascade control to achieve a DOT of above 30%.  The growth curve obtained using 
these operating conditions is shown in Figure 6.2 and shows exponential growth 
between 4 and 15 hours.  The DOT also decreases significantly after 4 hours (Figure 
6.3) as the cells have grown substantially and therefore the oxygen demand is much 
greater.  Feeding was started at 10 hours after a DOT spike was observed indicating 
depletion of carbon resources (Figure 6.3).  The respiratory quotient (RQ) remains fairly 
constant throughout the fermentation, with the exception of the spikes observed around 
9 hours when it increases in value from 1 to 92.  This occurred at the same time around 
the time that gas blending started with enriched oxygen and results from the fermenter 
equipment failing to maintain a constant airflow rate.  The cells continue to grow for 15 
hours as shown by the dry cell weight and carbon dioxide evolution rate (CER), and 
after this point the cells enter the stationary phase.  The dry cell weight is approximately 
25% of the observed wet cell weight, as typically observed for E. coli (Bratbak and 
Dundas, 1984). 
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Figure 6.2  Growth profiles showing the optical density, wet and dry cell weight for 100 L fermentation 
with cascade control and enriched oxygen 
Batch time  
Figure 6.3  Fermentation trace of the dissolved oxygen (pO2), pH, respiratory quotient (RQ), and volume 
of acid, base and antifoam added. 
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6.3.3 Fed batch 70 L low kLa fermentation  
One of the aims of this chapter was to compare the large scale fermentation to the 
results obtained in the microwell plate format using a matched kLa approach.  Therefore, 
the fermentation had to operate within the constraints of the microwell system, with a 
constant low kLa, no oxygen enrichment and cascade control and consequently low 
oxygen availability at high ODs.  The fermentation protocol was adapted to allow a 
lower maximum oxygen uptake rate in fed batch mode, to limit growth initially because 
of the low availability of oxygen due to the reduced impeller speed.  In order to do this, 
the starting media contained less glycerol to ensure the cells grow to a lower cell density 
and then feeding was started to control growth at a lower rate so the cells can survive at 
low impeller speed with limited oxygen.  The knowledge gained from the previous 
fermentation was used to determine the point of the maximum OUR, which was around 
8 hours and corresponded to an OD of 20.  Therefore a media was used with only 15 
g.L
-1
 glycerol and 20 g.L
-1
 yeast, which would enable it to achieve an OD of 20.   
 
The OD, wet and dry cell weight profiles obtained in the 70 L fermenter are illustrated 
in Figure 6.4 and show the cells reached exponential growth after a lag phase 2 hours 
shorter than observed previously.  The cells reached an OD 4.8 A.U., higher than the 3.1 
A.U. for previous fermentation in the equivalent time frame.  A faster growth rate was 
not expected due to the lower initial carbon concentration, and can be attributed to the 
higher inoculum OD and the dynamic conditions of the fermenter.  The 70 L 
fermentation had more turbulent mixing (Re=132,000 for 70 L fermentation and 
Re=120,000 for 100 L fermentation) during the initial fermentation period before 
cascade control started, which may have resulted in faster growth.  Figure 6.5 shows the 
dissolved oxygen concentration, pH profile, stirrer speed, airflow rate and inlet oxygen 
concentration for the 70 L fermentation.  The DOT decreased to below 2% after 4 hours 
and no DOT spike occurs as previously observed at 9 hours is observed and therefore 
there is no exhaustion of the carbon source after establishment of exponential growth.    
Under a DOT of close to zero, cells are extremely oxygen limited and will grow 
anaerobically producing high concentrations of acetic acid.  The amount of base 
required to maintain a constant pH increases after 4 hours to neutralise the acidity 
generated by the production of acetic acid.  This accumulated acetic acid could then be 
used as a carbon source between 8 and 12 hours, thus explaining the lack of carbon 
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deprivation, and the decrease in acetate levels from 0.35 to 0.04 g.L
-1
 from 8 to 16.6 
hours.  Feeding was started at 13.2 hours at a reduced rate of 2 g.L
-1
.h
-1 
to limit growth.  
Initially no increase was observed in growth rate after 1 hour of continuous feeding and 
the feed was terminated after 45 minutes.  A DOT spike was then observed at 14.7 
hours, showing the cells were carbon source limited and feeding was then started again 
at a rate of 4 g.L
-1
 (lower than what was used in the previous experiment in order to 
maintain a lower growth rate).  The feeding rate was continually decreased throughout 
the fermentation in an attempt to maintain a higher DOT value.  Induction occurred at 
16.9 hours and cells continued to grow steadily reaching a final OD of 34.4 A.U. and a 
dry cell weight of 12.4 g.L
-1
.  
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Figure 6.4  Growth profiles showing the optical density, wet and dry cell weight for 70 L fermentation 
with a Reynolds number of 132,000. 
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Batch time  
Figure 6.5  Fermentation traces of 1) dissolved oxygen (pO2), pH, inlet oxygen concentration, stirrer 
speed and airflow rate.  2) Volume of acid, base and antifoam added.  3) respiratory quotient (RQ), 
carbon dioxide evolution rate (CER) and oxygen uptake rate (OUR). 
 
The aim of this chapter was to conduct the large scale process in a manner that 
reproduced the oxygen limitations present in microwell plate format.  The fermentation 
results obtained demonstrate that cells growing in the microwell geometry at this kLa 
would be severely oxygen limited after just 4 hours of fermentation.  Anaerobic growth 
generates increasing amounts of acetate which is then utilised by the cells as a carbon 
source.   Acetate also inhibits growth and has been reported to reduce recombinant 
protein production (Jensen and Carlsen, 1990; Luli and Strohl, 1990). The production of 
acetic acid also has the knock-on effect of altering the pH of media, and in the 
microwell with no pH control this could have detrimental effects.  The media used also 
has been known to precipitate which could affect the supply of nutrients to cells, 
downstream recovery and purification (Shiloach and Fass, 2005).  
6.3.4 Batch 70 L high kLa fermentation 
Due to the oxygen limitations observed when running the 70L fermentation at N = 275 
rpm, a large scale fermentation was conducted at a higher impeller speed N = 450 rpm.  
An impeller speed of 450 rpm corresponds to the highest kLa predicted for the 
microwell geometry.  The growth profiles for OD, wet and dry cell weight are shown in 
Figure 6.6.  The cells initially grew slower than previously observed, reaching an OD of 
2 A.U. after 4 hours.  Cells start to grow exponentially at approximately 5 hours, but 3 
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hours later OD and wet cell weight measurements show growth slows again (Figure 
6.6).  This change in growth rate is also demonstrated by the OUR and CER data, which 
are shown in Figure 6.7 B).  A drop of OUR and CER at approximately 8 hours is 
observed indicating cell death and a corresponding rise in available dissolved oxygen is 
observed after 9 hours as shown in Figure 6.7 A).  After 10 hours, the OUR and CER 
start increasing again reaching the same levels as previously observed after 11 hours, as 
cells start to grow.  The oscillations between growth and stationary phase appear 
dependent on the concentration of dissolved oxygen available; showing that even at this 
higher kLa value growth is oxygen limited.  The maximum oxygen uptake rate was 
found to be 123 mM.L
-1
.h
-1
, which is significantly lower than 200 mM.L
-1
.h
-1 
obtained 
for the 100 L fermentation with cascade control and enriched oxygen levels.   
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Figure 6.6  Growth profiles showing the optical density, wet and dry cell weight for 70 L fermentation 
with a Reynolds number of 215,000. 
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Figure 6.7  Fermentation traces of A) inlet oxygen concentration, stirrer speed, dissolved oxygen (pO2), 
pH and airflow rate.  B) respiratory quotient (RQ), carbon dioxide evolution rate (CER) and oxygen 
uptake rate (OUR). 
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6.3.5 Experimental kLa determination at the microscale 
After the large scale fermentations were conducted at 275 and 450 rpm, kLa was 
measured directly in the microwell.  The experimentally derived values were found to 
be significantly lower than those predicted by the correlation (Eq 1) and lower than 
either of the kLa at which the large scale fermentations were performed. Figure 6.8 
shows that kLa increases with increasing shaking speeds from 16 to 46 h
-1
. The trend 
observed in microplate geometry is similar to that obtained at the large scale .  Results 
obtained in this work are also in agreement with the findings of (Doig et al., 2005a), 
where an increase in shaking speed resulted in a non-linear increase in kLa for 96 DRW 
plates and 3mm shaking diameter.  Hermann et al. (2003) also found that kLa increases 
when shaking speeds are increased in a similar system.   
 
Experiments were conducted to elucidate the relationship between kLa and fill volume 
Higher kLa were obtained at decreasing fill volumes as illustrated in Figure 6.9, which 
shows kLa values between 70 and 107 h
-1
 for different fill volumes.  The values 
obtained fall within the ranges of previously determined kLa values in microwell plates 
of 60 to 200 h
-1 
(Duetz et al., 2000; Duetz W.A. and Witholt B., 2001; Hermann et al., 
2003; Duetz and Witholt, 2004; Doig et al., 2005a).  Decreasing the fill volume from 
1.0 ml to 0.6 ml increases kLa from approximately 70 h
-1
 to 105 h
-1
.  Ferreira-Torres 
(2008) reported the kLa changing from 51 h
-1
 to 102 h
-1
 under the same operating 
conditions but different fermentation media.  The maximum oxygen transfer rate is 
reported to increase with decreasing fill volume as it is related to the mass transfer area, 
which is a function of shaking volume and diameter (Hermann et al., 2003). 
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Figure 6.8  Measured kLa values in a 96 DSW plate as a function of shaking speed with a shaking 
diameter of 3 mm and fermentation media, plus additions and no antifoam.  Error bars are shown for an 
average of 3 measurements per data point 
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Figure 6.9  Measured kLa values in a 96 DSW plate as a function of fill volume for fermentation batch 
media and 0.02% antifoam (PPG).  Error bars are shown for an average of 3 measurements per data point. 
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The kLa experiments in microwell plate format highlighted the oxygen limitations present in 
this geometry and posed some difficulties in finding similar kLa values for the microwell 
and the 70L bioreactor scale.  It can be speculated that there is an upper limit to the 
applicability of the matched kLa approach.  The scaling factor in this work is 70,000 and 
to the best of our knowledge no successful scale-up approaches have been demonstrated 
between shaken and stirred system at similar scale ratios.  The results obtained at the 
highest kLa tested in this work in stirred bioreactor geometry showed that cells were 
oxygen limited and therefore it is likely that cells experience similar oxygen limitations 
in the microwell plate format where kLa is lower than either values tested at large scale.  
A smaller fill volume could be used to achieve a slightly higher kLa in the microwell 
system.  Ferreira-Torres (2008) obtained a kLa of 158 h
-1
, obtained at a fill volume of 
0.2 ml and shaking speed N = 1000 rpm in the same system.  However a higher kLa 
value of 195 h
-1
 was obtained in the 70 L bioreactor at an impeller speed of 275 rpm and 
oxygen availability was limited with cells reaching a low final DCW of 12 g.L
-1
.  
Therefore even near the maximum oxygen transfer conditions of the microwell system, 
cells are still oxygen limited and therefore this is not an ideal condition for scale-up.  A 
fill volume of 0.2 ml introduces additional problems as evaporation is an issue over the 
course of an 18 hour long fermentation.  The microwell plate fermentations were 
conducted with no lid to aid oxygen transfer via surface aeration.  Volume losses from 
evaporation may result in inaccuracies in OD measurements making comparison 
between scales rather challenging.  In addition minimum volume requirements are set 
by the subsequent process step and the use of sacrificial well approach.  Consequently a 
compromise is needed between volume requirements and achievement of the minimum 
oxygen transfer levels in the well.  Therefore large scale datum was compared to the 
yields achieved from a reproducible and accurate microwell fermentation procedure 
with identical media and inoculums preparation. 
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6.3.6 Batch microwell fermentation  
The growth profile of the batch microwell fermentation is shown in Figure 6.10.  The 
microwell fermentation displays different growth characteristics to the larger scale, 
reaching a much lower final OD.  After a short lag phase the cells enter exponential 
phase.  After 6 hours of fermentation the cells enter stationary phase and continue to 
grow at a much slower rate.  This is probably a consequence of the induction carried out 
at 6 hours, which results in a change in metabolism and stresses to the cells.   
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Figure 6.10  Growth profile showing the optical density of the microscale batch fermentation with a fill 
volume of 1 ml and a shaking speed of 1000 rpm. 
 
The final OD achieved in the microwell geometry is 17 A.U., less than 50% of the 
lowest OD reached at large scale in this work (Table 6.6), confirming that at this kLa the 
cells experience oxygen limitations that reduce the growth rate.  There could also be 
other growth limiting factors at the microscale, a lack of pH control could result in 
unfavourable conditions.  The fermentation pH is an important factor for cell growth 
and product formation as it effects membrane permeability, cell morphology and 
enzyme activity (Elmahdi et al., 2003).  Whilst the microwell growth data shows a 
lower number of cells was achieved, cells reached a similar level of productivity as the 
product titre shows it yields the same amount of product (1.4 g.L
-1
) as the 100L 
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fermentation process where oxygen limitations did not occur (Table 6.6).  Although the 
oxygen transfer rate may be limited at the microwell, it could provide the oxygen 
required for product expression and metabolism but insufficient for rapid growth and 
hence result in similar cell productivities.  The results shown in Table 6.6 also 
demonstrate the importance of an early induction time as the fermentation conducted at 
a kLa of 195 h
-1 
(higher
 
than the microwell) produces no product probably as a result of 
the different feeding and induction strategy employed. 
 
Table 6.6  Comparison of growth characteristics and titre for the fermentation conditions studied. 
 
Fermentation Condition Final OD 
(A.U.) 
Dry Cell Weight 
(g.L
-1
) 
Product titre  
(g.L
-1
) 
100 L cascade control, enriched O2 87.6 29.7 1.40 
70 L 275 rpm 34.4 12.4 0 
70 L 450 rpm 44.8 18.0 0.74 
Microwell 16.9  1.42
*
 
*measured on a different HPLC column and system 
6.3.7 Scalability of refolding 
Refolds were conducted at different scales (4.5 L, 200 ml and 300 μl) in order to 
compare pilot scale and microscale yields.  The refolding yields obtained at different 
scales are shown in Figure 6.11 for buffer 1 (0.288 mM cystamine, 10% v/v hexylene 
glycol and 20 mM ethanolamine) and buffer 2 (10 mM Tris, 10 mM glycine, 1 mM 
EDTA, 0.5 mM cysteine, 4.5 mM cystine).  Washed inclusion bodies refold gave 
similar yields in buffer 1 for 300 μl, 200 ml and 4.5 L scales resulting in yields of 15, 12 
and 14 % respectively, demonstrating scale invariance.  Results for refolding in a 
different buffer (buffer 2) agree with this finding, as the yield difference is only 4% for 
the microlitre and millilitre scale.  This shows that microscale refolding is capable of 
predicting large scale refolding yield and can be a good substitute for time consuming 
and resource intensive pilot scale refolds.   
 
Unwashed inclusion bodies from the same large scale fermentations show a slightly 
larger yield difference of 5%, with a yield of 5% for millilitre scale and 10% for 
microlitre scale.  Therefore the yield at the microlitre scale is almost double that found 
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at the millilitre scale and this could be due to the different solubilisation procedures 
used.  The time allowed for solubilisation at the microscale is 4 times longer, which 
could result in a larger concentration of reduced insulin for refolding at the microscale 
and consequently a higher yield.  Previous attempts to use a shorter solubilisation 
procedure identical to the lab scale at the microscale resulted in aggregation during 
refolding due to the presence of insoluble IB particles in the denatured protein.  This 
appears to be a significant problem, in particular, for the unwashed inclusion bodies 
where the largest yield difference exists.  This suggests unwashed inclusion bodies are 
potentially more difficult to solubilise at the microscale.  The mixing mechanism used 
for solubilisation at the microscale is shaking as opposed to direct stirring with a 
magnetic bead at the lab scale.  Shaking is less efficient that magnetic stirrer bars which 
are capable of achieving greater speeds and shear rates.  The solubilisation procedure 
has a significant impact on the refolding yield, and at large scale the solubilisation 
procedure lasts 1 hour instead of four hours at the microwell.  However if the refold 
yield is assessed as a function of the concentration of solubilised IBs present in the 
denatured material, yields appear much higher as shown in Figure 6.12, with the refold 
at 4.5 L clearly outperforming the yield at other scales.  The solubilisation procedure 
was less efficient at the largest scale and hence the fully denatured insulin available for 
refolding was lower.  When this difference was taken into account the yield achieved is 
higher than previously thought.  The refolding yield is also higher at lower 
concentrations of protein (Clark, 2001).  Therefore in order to aid future comparisons 
between scales, the solubilisation step needs to be optimised first or material taken 
directly from large scale solubilisation for use at the microscale. 
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Figure 6.11 Refolding washed and unwashed inclusion bodies from the first fermentation in buffer 1 and 
2 at different scales. 
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Figure 6.12  Refolding washed and unwashed inclusion bodies from the first fermentation in buffer 1 and 
2 at different scales, with yield determined from concentration of fully solubilised protein as tested by 
HPLC method 
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6.3.8 Effect of oxygen limitation on IB refolding yield 
The effect of the fermentation process conditions on refolding yield was assessed using 
material from fermentations at 100 L and 70 L at the higher kLa values tested, refolded 
at the microscale.  Higher refolding yields were obtained with IB material from the 100 
L fermentation than for the 70 L (with a constant impeller speed and no oxygen 
enrichment), thus indicating that fermentation conditions impact refolding yield for 
insulin, as previously found for DHFR.  Figure 6.13 shows the refold yield of washed 
IBs from the 100 L fermentation (where DOT was maintained at 30%) and the 70 L 
fermentation (where DOT was close to zero for a large majority of the time).  IB 
material from the 70 L fermentation with lower oxygen levels achieves a refold yield of 
7% compared with 33% for the 100 L fermentation, when refolded in buffer 2.  Refolding 
in buffer 1 results in higher yields of 20 and 38% for 70 L and 100 L fermentations 
respectively, showing this to be superior buffer for refolding insulin and capable of majorly 
improving refolding yield for suboptimal fermentation conditions.  Therefore the 
fermentations show a significant refolding yield difference under the same refold 
conditions, therefore showing that the low oxygen and more stressful fermentation 
conditions impacts the refold yield and consequently must result in a change in the quality 
of the inclusion bodies.  During the 70 L fermentation at the higher kLa oxygen is severely 
limited after 5.5 hours and increases above 30% for only 4 hours of the remaining 8.5 hours 
when cell growth is stationary (Figure 6.7).  Whilst this fermentation is a more extreme 
example of oxygen limitation than would be observed during a production process, its 
shows that even after IB washing the IBs retain properties intrinsic to them that affect the 
refolding success.  There is ample evidence to show oxygen availability has numerous 
negative effects on E. coli.  Under anaerobic conditions and high concentrations of acetate, 
cells are probably under increased stress, altering metabolism and expression.  E. coli is 
capable of switching metabolic mode to the most energetically favourable system for the 
current environment, depending on the availability of oxygen and electron acceptors (Spiro 
and Guest, 1991).  It has been estimated that the availability of oxygen influences the 
expression of 200 genes in E. coli (Unden et al., 1995).  Oxygen limitation during the 
growth phase has been shown to decrease growth rate and biomass yield (Li et al., 1992), 
however its effect on the expression of heterologous protein is not well understood.  There 
have been contradicting reports on this effect that suggest oxygen limitation can modulate 
the expression of recombinant proteins positively or negatively depending on the host-
vector and expression system (Bhattacharya and Dubey, 1997; Qoronfleh, 1999).  For 
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example, Li et al. (1992) discovered anaerobic growth results in a decrease in plasmid 
content in all strains and an increase in β-galactosidase specific activity in two of the strains 
tested (although volumetrically the activity was lower because of the decreased biomass 
compared with aerobic fermentation).  In addition to the direct effects of low oxygen on 
metabolism and expression, acetate is produced due to either a fast growth rate (oxygen 
consumption rate limitations) or a low dissolved oxygen concentration (Eiteman and 
Altman, 2006b).  Acetate is a weak acid and can diffuse across the plasma membrane and 
release a proton in the cytoplasm (Lasko et al., 2000).  This lowers the transmembrane 
proton gradient and cytoplasmic pH, thus reducing cellular energy supply and 
simultaneously resulting in toxic intracellular conditions (Axe and Bailey, 2004). 
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Figure 6.13  The effect of fermentation conditions on yield after refolding at the microscale washed 
inclusion bodies in two different buffers.  F1: Fermentation with cascade control and enriched oxygen and 
a maximum impeller speed of 700 rpm.  F3: Fermentation at the high kLa matched condition, with a 
constant impeller speed of 450 rpm.  Buffer 1 0.288 mM cystamine, 10% v/v hexylene glycol, 20 mM 
ethanolamine, pH 10.5. Buffer 2 10 mM Tris, 10 mM glycine, 1 mM EDTA, 0.5 mM cysteine, 4.5 mM 
cystine, pH 10.5. 
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6.3.9 Microscale fermentation and refold system for large scale 
yield predictions 
The yields obtained at different refold scales have been shown to be similar for the same 
fermentation material, with small differences caused by the differing solubilisation 
procedure between scales.  Therefore microscale refolding can be used as a tool for 
screening many refold conditions using large scale fermentation material, which will 
allow the rapid analysis of multiple refold conditions in parallel early on in process 
development.  However given that the fermentation conditions effect inclusion body 
quality and consequently refold yield, it is important to investigate whether the 
microscale fermentation and process as whole can be used for the prediction of the 
effect of process variables on yield given the differences between microscale 
fermentation and large scale fermentation.  
 
Figure 6.14 illustrates the maximum yields obtained when refolding at the microscale 
IB material from the microscale fermentation and large scale fermentations (100 L and 
70 L).  The results are contrary to expectations as, based on the kLa, the conditions 
experienced in the microwell are more similar to the 70 L fermentation.  The microscale 
process has a yield of 64 % whereas the 70 L fermentation shows a much lower 
maximum yield of 38 %.  The maximum microscale refold yield obtained for material 
from the microscale fermentation and process of 64 % are similar to the 65 % yield of 
the 100 L fermentation.  Therefore the microscale process sequence can attain similar 
yields to standard large scale fermentation conditions and processing when the same 
solubilisation procedure is used. The microscale process has definite promise for use 
early on in process development to estimate large scale yield from either large scale 
material (as shown in Section 6.3.7) or material from the microscale fermentation and 
process, and identify scaling issues.  The fermentation conditions experienced in the 
microwell may have been more favourable than those in the 70 L fermentation with a 
slightly higher kLa value because final OD at the microscale is 62 % lower (Table 6.6) 
and consequently the demand for oxygen is lower.   
 
The maximum yields achievable for different fermentation and process scales illustrated 
in Figure 6.14 are not under the same refold condition, but show different optimal refold 
buffers.  Microscale IB material refolds optimally in buffer 2, which has shown to be 
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optimal for proinsulin by Winter et al., (2002) at lab scale.  IB material from the large scale 
fermentations shows optimal yields when refolding in buffer 1.  Buffer 1 contains hexylene 
glycol, which has been shown to improve refolding of activin-A from inclusion bodies 
when 5% hexylene glycol is present (Ejima et al., 2006).  Hexylene glycol can stabilise the 
native form of proteins by preferential exclusion (Seefeldt et al., 2008).  It also contains 
cystamine, a reducing agent which with break interchain disulphide bonds promoting the 
disulphide shuffling to form the correct pairings of the 3 disulphide bonds in insulin 
(Rudolph and Lilie, 1996).  The pH of both the buffers is alkaline, a mild alkaline pH has 
been shown to be optimal for disulphide bond disruption as it proceeds through nucleophilic 
attack by the thiolate anion (Vallejo and Rinas, 2004).    Figure 6.14 shows that it is 
possible to achieve high yields from microscale fermentation material and it could be used 
to predict potential yields at the large scale.  IB material that has experienced different 
fermentation conditions appears to interact with refold buffers differently depending on the 
components and properties of the buffer.  Consequently the optimal buffer is different, 
reflecting a difference in the inclusion body material and the optimal buffer required to 
guide it through its folding pathway to achieve an optimal yield.   
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Figure 6.14  Maximum yields obtained from refolding at the microscale IB material from the 
fermentations.  Maximum conditions for each of the fermentation conditions are as follows, F1: washed 
IB, buffer 1, 0.1 g.L
-1
.  F3: washed IB, buffer 1, 0.15 g.L
-1
. Microscale fermentation: unwashed IB in 
buffer 2. 
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6.3.10 The effect of refold buffer on purity of refold 
In order to investigate how the refold buffer influences yield further, the purity of the 
active refolded protein formed in relation to the total contaminants content was studied.  
The purity of the refold is a function of both fermentation contaminants and the 
different refold species present (such as intermediates and misfolded protein species), 
which may be eluted at different times from the column.  A higher purity refold offers a 
distinct advantage for further downstream processing steps as it would reduce the 
impurities load on following chromatography steps.  Figure 6.15 shows the purity of 
washed and unwashed IB material from 100 L (F1) and 70 L (F3) fermentations and 
refolded in buffer 1 or 2.  The washing of the inclusion bodies appears to dictate the 
refold purity depending on the source of fermentation material.  The purity is highest for 
the 100 L fermentation (F1) washed IBs refolded in buffer 2, which has a purity of 62 
%.  The refold purity for the 100 L fermentation is higher in both buffers when the IBs 
are washed, whereas the refold purity for the 70 L fermentation (F3) is higher in both 
buffers when the IBs are unwashed.  This is unexpected as washing to remove 
contaminants from the surface of the inclusion body should improve the purity of the 
refold.  However this suggest contaminants are beneficial for the refolding of 70 L 
fermentation material, perhaps resulting in less off path partially folded protein 
intermediates.  The contaminants appear detrimental to the refolding of 100 L 
fermentation material.  This could be because the contaminant profile is different 
between these two different fermentation conditions.  
 
The buffer chosen drastically impacts the purity of the refold. Unwashed material 
refolds with a lower purity in buffer 2 in comparison with buffer 1, decreasing the 
purity from 60 to 45% and 46 to 23% for 70 L (F3) and 100 L fermentation (F1) 
respectively.  Therefore for suboptimal fermentation conditions, such as the low oxygen 
experienced for the 70 L fermentation (F3), the purity is optimised by using unwashed 
the inclusion bodies refolded in buffer 2.  However for the washed material the 
relationship with buffer is more complex as the optimal buffer is different for the 
different fermentations.  The washing procedure causes a change in the IB material from 
the 100 L fermentation (F1), resulting in buffer 2 becoming more favourable for purity 
of the refold.  This indicates that contaminants play a role in the interactions between 
folding protein and buffer choice.  In order to choose the right refold buffer to maximise 
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purity, the fermentation condition and washing of the inclusion body must be 
considered as these two factors interact to determine refold purity. 
 
Figure 6.16 illustrates the relationship between yield and purity, showing that yields of 
above 90% have purities greater than 40%.  There is one noticeable exception, where 
the yield is 85% but the purity is 23%, but this might not reflect a truly high yielding 
condition as the same starting material achieved a yield of up to 150% (under a different 
refold condition).  Achieving an accurate assessment of the protein titre in a inclusion 
body slurry by RP-HPLC is challenging because of the granular and viscous nature of 
the inclusion body slurry, which can result in inaccurate estimates. In general, the 
highest yielding refold conditions are the highest in terms of purity, as there is a large 
concentration of active product present that consists of the largest proportion of protein 
present. 
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Figure 6.15  Purity of active protein in 200 ml refolds for the different large scale fermentations, with 
different IB washing regimes and refold buffers.  Refolds used material solubilised at a concentration of 
1.5 g.L
-1
 and an 18 fold dilution factor.  F1: Fermentation with cascade control and enriched oxygen and a 
maximum impeller speed of 700 rpm.  F3: Fermentation at the high kLa matched condition, with a 
constant impeller speed of 450 rpm.   
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Figure 6.16  Yield as a function of purity for refolds at the 200 ml scale with varying refold conditions 
(IB washing, buffer, dilution factor, final protein concentration).  
6.3.11 Effect of different refold conditions on insulin 
 
The large scale fermentation material was refolded at the lab scale to investigate the 
effect of different refold conditions on insulin.  The IB material from the 70 L 
fermentation at the higher kLa which was refolded at the 200 ml scale is collectively 
shown in Figure 6.17.  It shows the highest yielding condition is from washed IB 
material from the first fermentation, diluted 18 fold in buffer 2 to give a low final 
protein concentration of 0.08 g.L
-1
.  This shows that fermentation with cascade control 
and enriched oxygen ultimately produces the highest yielding product.  The second 
highest yielding condition was unwashed IB material from the 70 L fermentation 
refolded in buffer 2 and the same dilution factor and protein concentration.  This 
indicates that poor yielding fermentations that experience oxygen deprivation can still 
be productive and high yields obtained if a different strategy is adopted downstream.  
As previously observed unwashed inclusion bodies can result in high yields under some 
conditions (Section 5.2.1.1) as lipid contaminants may aid folding.  Ultimately however 
a fermentation condition with no oxygen or carbon limitations and pH control results in 
6  Translation of fermentation and refolding processes G. Ordidge 
 
242 
 
the highest yielding condition as the quality of inclusion bodies is improved and hence 
the refold yield and purity is higher.   
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Figure 6.17  The refolding yield of IB material from the first fermentation (cascade control and enriched 
oxygen) and the high kLa fermentation.  For details of each refolding condition see Table 6.2. 
6.4 Conclusions 
This chapter has demonstrated that the microscale fermentation is capable of producing 
a similar product titre to pilot scale fermention (100 L).  However, it was not possible to 
use a matched kLa approach due to the oxygen limitations observed during the 
microwell fermentation and the oxygen requirements of the strain used.  A fixed kLa 
does not work as a scaling parameter for high cell density cell culture unless the oxygen 
transfer capacity present is in excess of that required for the final OD.  Currently oxygen 
limitations in the microwell hamper the ability to reach the ODs observed at the 100 L 
scale.  This demonstrates that the oxygen conditions experienced in the microwell 
geometry are significantly different from normal operational limits at the 70 or 100 L 
scale.  The 70 L fermentation at higher kLa values than the microwell resulted in oxygen 
limitation and for the lower kLa tested no product expression, showing a minimum 
requirement of oxygen transfer for product expression.  The microwell fermentation 
must experience longer periods of oxygen limitation as the kLa is lower than both of the 
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70 L fermentations.  This could be overcome by the use of miniature bioreactors at the 
microscale, which would allow increased oxygen transfer through sparging and/or 
impeller driven mixing.   
 
The microscale refold is able to produce similar yields of refolded protein as larger scale 
refolds (200 ml and 4.5 L).  Dilution refolding is reported to be scale invariant 
(Middelberg, 2002), and as such microscale refolding could provide a high throughput 
method for analysing refold conditions during process development.  However, 
differences were observed between refold yields at the pilot and lab scale when 
efficiency of solubilisation step was taken into account.  Achieving high degrees of IB 
solubilisation is challenging at all scales, particularly for unwashed inclusion bodies, 
and may give varying results depending on the degree of solubilisation of the inclusion 
bodies.  In order to aid future scale comparisons, the solubilisation step must first be 
optimised to provide equivalent protein concentrations at the different scales.   
 
The previous chapter has demonstrated that inclusion body quality is affected by the 
fermentation conditions.  This is supported by evidence in this chapter, which has 
shown the differences in growth profiles and oxygen availability between microwell and 
large scale fermentations alter IB quality and concurrently refolding yields.  Refolding 
experiments at the microscale demonstrate material from the microscale process 
sequence achieves comparable yields to pilot scale IB material refolded at the same 
scale (when using the same solubilisation procedure).  The optimal refolding condition 
was different for the microscale and pilot scale material due to the varying inclusion 
body quality resulting from their different fermentation source.  However it 
demonstrates high yields can be achieved with the microscale process sequence and that 
with further development it may be possible to use the microscale process sequence as a 
predictive tool.  Optimisation of the solubilisation step in future would allow better 
scale-up of the refold step.  Additionally, the use of a miniature bioreactor for 
microscale fermentation would allow control of the key process parameters, pH and 
dissolved oxygen, and provide better mixing and oxygen transfer capabilities.  This in 
turn would provide processing conditions similar to large scale fermentation and 
consequently IBs which have product quality properties that are equivalent to the large 
scale.  This is necessary if the results at the microscale are to have relevance for large 
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scale process development and enable the process sequence to be used in studies for 
QbD purposes.   
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7 Conclusive remarks and future recommendations 
7.1 Automated, high throughput assays for IB yield 
determination 
 
A novel microscale methodology with a hierarchy of assays to evaluate protein 
refolding was clearly established in this chapter.  The translation of the refold process 
and related assays to a robotic platform demonstrated approximately equal errors to 
manual operation, with automation having additional advantages in terms of consistency 
and speed.  The hierarchy of assays developed in this work was used to explore a wider 
range of lysozyme refold conditions, showing relative fluorescence was a good 
predictor of yield once aggregating conditions have been screened out by an absorbance 
assay. In conclusion, the automated microscale refolding process described would allow 
the rapid evaluation of a large number of conditions to optimise protein refolding to 
achieve higher product yields from inclusion bodies.  Measurement of particulate 
formation by absorbance scattering provides an initial filter to eliminate aggregating 
conditions, and intrinsic fluorescence spectroscopy identifies conditions that produce 
protein with the most native-like tertiary structure. Assays to directly measure native 
protein yields, which are typically available at lower throughput or at higher costs, 
could then be used to validate fewer samples and alleviate the analytical bottleneck.  
The hierarchical orthogonal assays enables the analysis of refold conditions on a much 
shorter time scale by selecting only the most promising conditions for characterisation 
by resource intensive analytical methods such as RP-HPLC.  An optimal relative 
fluorescence range could be used to select 29% of the samples from the conditions 
tested, which also gave the highest activities values (83-113%).   The assays were 
demonstrated to be generically applicable to IB proteins sourced from fermentation 
material in the form of DHFR.  In this case an intrinsic fluorescence boundary of 
between 5110-7610 captured 75% of the data points with a high activity of over 
10 ΔOD.min-1.mg-1.   
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7.2 Developing an automated, whole bioprocess for IB 
production at the microscale  
 
The development of an automated linked bioprocess sequence showed it was possible to 
develop a whole bioprocess at the microscale that required very little manual 
intervention with the exception of offline cell lysis.  This has numerous advantages over 
manual operations as reproducibility is improved between experiments due to the 
reduction in error and improvement in precision and accuracy of the liquid handling.  
Improvements in productivity were also obtained from the increased speed of automated 
manipulations and walk away operation.  Growth of DHFR expressing E. coli in 
microwells reached comparable optical densities as the 20 L scale.  Higher levels of 
clarification were achieved at the microscale during the cell harvest step due to the 
higher centrifugal forces achievable in a microcentrifuge.  However this also posed 
challenges as the more compacted pellet was harder to resuspend, resulting in cell 
losses.  Adaptive focused acoustics was demonstrated to be the best method for high 
throughput lysis, although the method efficiency is lower than what is achievable by 
conventional sonication.  This was shown by the application of a recently developed 
flow cytometry technique for measuring inclusion bodies during processing, which was 
used to study cell lysis.  However the resulting inclusion body pellet from AFA lysis 
showed a similar contaminant profile to large scale inclusion body harvest.   
7.3 The effect of fermentation conditions on refolding 
 
The results shown in Chapter 5 show that fermentation conditions have a significant 
impact on IB refolding quality and yields.  For DHFR IBs, inducer concentration and 
time were important variables for maximising yields.  Doubling the IPTG concentration 
from 0.125 mM to 0.25 mM resulted in a 24 % increase in yield of active protein from 
unwashed inclusion bodies.   However yield differences between conditions were much 
smaller for washed inclusion bodies, highlighting the importance of certain 
contaminants that aid refolding or effect IB quality.  An earlier induction time of 3 
hours resulted in a 10% increase in yield over later induction, but resulted in the 
accumulation of lower concentrations of protein and therefore a later induction time was 
considered more economical.  Inclusion bodies are often frozen after harvest as it 
provides an ideal point at which to decouple the process.  The storage temperature 
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showed little effect for microscale fermentation material stored over a few months, but 
material from larger scale fermentations stored at -20°C over a period of several years 
refolded to give higher yield of active protein.  The sequence demonstrated its broad 
applicability by its adaption to insulin IB production and refolding.  The bioprocess 
sequence was used to study the effect of induction time, feeding strategy and media.  A 
glycerol carbon source results in a higher yield of 33% instead of 18% obtained for the 
worst fermentation media condition (terrific broth) at equal protein concentration.  This 
demonstrates a significant difference in IB quality, which is additional to the almost 
three times higher fermentation titre for glycerol based media.  The optimal conditions 
were shown to be induction at 4.5 hours (mid exponential phase) and batch operation, 
possibly as the feeding rate was too high for fed-batch.  In conclusion the sequence 
showed it could be used as a tool to investigate the effects of fermentation conditions on 
yield in order to select optimal fermentation conditions for both insulin and DHFR 
inclusion body production.  It also showed that variations in fermentation condition 
caused changes in inclusion body quality as shown by the varying refold yields at 
equivalent conditions, as well as titre differences.   
7.4 Scale up of fermentation and refolding processes 
 
The microscale fermentation is capable of producing a high titre of product equivalent 
to the large scale.  However it was not possible to match the kLa and hence the oxygen 
transfer capabilities of the large scale.  Consequently the fermentation in the microwell 
format was shown to be oxygen limited, which had corresponding implications for the 
inclusion body quality produced.  The refolding step did not show scale invariance, 
although this could result from the difficulties of achieving reproducible solubilisation 
of inclusion body material between scales rather than differences in the engineering 
environment.  The microscale bioprocess sequence was able to attain equally high final 
yield of active protein as large scale material refolded at the same scale.  However this 
was under a different refold condition from the large scale optimal condition because of 
difference in inclusion body quality and its interactions with refolding buffer.  It can be 
therefore concluded that the automated microscale bioprocess has the potential for 
predicting yield, identifying scaling issues and for investigating the interactions between 
different unit operations. 
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7.5 Future recommendations 
7.5.1 Assay development 
The next stage for the development of the automated hierarchical refold assays would 
be to automate the analysis of the results through further programming.  The existing 
data analysis was a bottleneck in the high throughput process.  Additionally, using a 
randomised plate layout results in time consuming data analysis to match the high 
yielding wells to the conditions used, so automated analysis will allow faster 
recognition of critical refolding parameters.  When there is no fast activity assay 
available analysing the yield using HPLC assays also contributes significantly to the 
length of the sequence.  The RP-HPLC assay used for insulin in this work was 57 
minutes.  Ultimately, combining the automated refold and hierarchical assays with new 
UPLC methods could enable an even faster analytical method for identifying active 
protein, shorter lag times and increase robotic platform productivity further.   
7.5.2 Sequence development 
The automated linked bioprocess sequence could be developed further to incorporate 
unit operations after inclusion body refolding.  The next unit operation to add would be 
purification, which could be performed using existing technologies such as Atolls 
MediaScout
®
 Robocolumns that are compatible with the robotic platform used.  The 
other challenge surrounding the current bioprocess is that it does not act as a direct 
large-scale mimic.  Further development is required of each unit operation to match the 
conditions observed at the large scale, for example the cell debris profile after lysis, 
which will impact upon yields in the following unit operation.   
7.5.3 Applications of the whole bioprocess approach 
The whole bioprocess approach could be used to investigate a number of further 
fermentation variables that have been demonstrated to have an effect on inclusion body 
formation.  For example, the whole bioprocess approach could be used as a host 
screening tool to explore the role of stronger promoters and high plasmid copy numbers 
in inclusion body formation.  Alternatively, it could also be used to screen a wider scope 
of refolding conditions such as other additives, redox reagents, pHs and buffering 
systems.   
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7.5.4 Scaling-up  
The most significant improvement to the process would be the addition of fermentation 
control through the use of micro-bioreactors.  This would allow online pH and DOT 
monitoring and control, along with direct sparging and/or impeller driven mixing to 
achieve higher oxygen transfer rates.  This would provide an engineering environment 
more akin to the large scale in terms oxygen transfer and mixing.  Consequently higher 
kLa values will be achievable, which will allow kLa to be used as a scaling parameter for 
high cell density E. coli fermentation.  The online measurement of pH and DOT and the 
introduction of control loops will allow improved control of fermentation variables 
within the same operating parameters as the large scale.  This would lead to more 
meaningful results and this methodology could be used alongside DOE to map critical 
process parameters in fermentation.  The results could then be translated to the larger 
scale, allowing improved process development.  Additionally, the resulting inclusion 
bodies from controlled microscale fermentation will have quality attributes that are 
more similar to larger scale fermentation products, enabling better predictions of 
refolding yields during early refold screening studies.  The final results chapter also 
showed that the solubilisation step needs to be optimised further to give similar 
efficiencies to large scale solubilisation to allow direct comparisons between refolding 
scales.   
 
Regulatory bodies increasingly require Quality by Design (QbD) principles to be 
followed for the approval of a new biological drug product (Rathore and Winkle, 2009).  
This requires a detailed understanding of both the product and the process, in order to 
evaluate the impact of the process on the product’s key quality attributes and 
consequently its clinical properties. This involves a large investment of resources at the 
research and development stage as intensive research is required to map the design 
space of a chain of unit operations in a process.  This is an area where high throughput 
microscale technologies will become increasingly important as it facilitates parallel 
experimentation of multiple process variables at the small scale and hence allows the 
cost effective implementation of QbD.  The sequence developed could be used to 
investigate critical process parameters that effect the critical quality attributes of the 
product during fermentation and refolding.  However for the microscale results to be 
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meaningful, they need to be scaleable or predictive of the large scale, which may require 
increased process control during fermentation.   
7.6 Overall conclusions 
 
The main findings are summarised below in relation to each of the thesis objectives 
described in Chapter 1. 
 
1. An automated microwell-based dilution refolding system was demonstrated with 
automated hierarchical generic assays to allow the analysis and selection of high 
yielding conditions.  The hierarchical generic assay methodology is a novel 
approach for optimising refolding conditions at high throughput, using two non-
invasive functionally independent assays to select optimal refold conditions, 
which can be applied to different protein products.   
2. An automated bioprocess was developed for the production, processing and 
refolding of inclusion bodies.  This was the first time (to the author’s 
knowledge) an automated sequence of unit operations has been applied to 
inclusion body refolding. 
3. A whole bioprocess approach was used to study the effect of fermentation 
conditions on IB refolding yields.  It demonstrated the importance of inclusion 
body washing, fermentation media and inclusion body storage to maximising 
refold yields.  This allowed the optimisation of processing variables at the 
microscale whilst minimising resource requirements.  The addition of 
fermentation control at the microscale and further development of the sequence 
could allow in the future the identification of critical processing parameters and 
the mapping of the design space required for Quality by Design.   
4. Validation of the fermentation and refolding step identified scaling issues.  
Oxygen was limited during microwell fermentation and consequently kLa did 
not provide a valid scaling parameter, illustrating the challenges associated with 
scaling up to manufacturing scale.  High fermentation titres and refold yields 
could be achieved at the microscale.  However the optimal conditions for 
refolding at large scale did not directly translate to the microscale due to 
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differences in solubilisation efficiency, showing the complexities involved in 
scaling up.    
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9 Appendix 
9.1 Appendix for Chapter 3 
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Figure 9.1 Absorbance of denatured and native protein in different buffers and at different 
concentrations 
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Figure .9.2 Fluorescence intensity fluctuations with temperature  
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9.2 Appendix for Chapter 4 
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Figure 9.3 Calibration Curve for conversion between dry cell weight and OD.  Best fit line: 
y=0.394x+0.32 
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Figure 9.4 Calibration curve for conversion between wet cell weight and OD.  Best fit line: y=2.620x 
+10.566 
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Figure 9.5  Relative fluorescence of unstained inclusion bodies determined using flow cytometry. 
 
Figure 9.6  Relative fluorescence of stained inclusion bodies determined using flow cytometry. 
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SYTOX Green f luoresence
 
Figure 9.7  Relative fluorescence of unstained whole cells determined using flow cytometry. 
SYTOX Green f luoresence
 
Figure 9.8  Relative fluorescence of stained whole cells determined using flow cytometry. 
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9.2.1 Plasmid Information 
 
murine DHFR pQE-40 
 
Molecular Weight 24.5 kDa 
Isoelectric Point 9.2 
Charge at pH 7.0 7.2 
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9.3 Appendix for Chapter 5 
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Figure 9.9  Dry cell weight calibration curve 
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Figure 9.10  Inclusion bodies from fermentations in 4 different medias refolded in buffer 3.  A) 
Absorbance at different wavelengths.  B) Intrinsic fluorescence and yield. 
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9.4 Appendix for Chapter 6 
9.4.1 Estimating kLas 
When: 
 
Probe response time is negligible.  Therefore the rate of change in dissolved oxygen 
concentration is equal to the rate of oxygen transfer from gas to liquid 
 
Where CL  = actual oxygen concentration 
            C
* 
 = maximum oxygen concentration 
            kLa  = oxygen mass transfer coefficient 
 t = time 
Integration gives: 
 
Therefore a plot of ln(C
*
 - CL) versus time has a gradient equal to kLa.  The gradient of 
the linear slope (in this case between 20 to 70% DOT) was taken. 
9.4.2 Acetic acid determination 
9.4.2.1 Reaction Sequence 
 (AK)  
1) Acetic acid  + ATP  ––––––––––––––> acetyl-phosphate + ADP 
                                                       (PTA) 
2) Acetyl-phosphate  +  CoA ––––––––––––––> acetyl-CoA +  Pi 
(PK) 
3) ADP  +  PEP    ––––––––––––––> pyruvate  +  ATP 
(D-LDH) 
4) Pyruvate  +  NADH  ––––––––––––––>  NAD+  + D-lactic acid 
 
9.4.2.2 Calculation  
c = V  x  MW       x    ΔAacetic acid        [g/L] 
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   ϵ  x d x v 
V = final volume [ml] 
MW = molecular weight of acetic acid [g/mol] 
ϵ = extinction coefficient of NADH at 340 nm [l x mol-1 x cm-1] 
d = light path [cm] 
v = sample volume [ml]  
 
c = 2.66 x 60.05       x    ΔAacetic acid        [g/L] 
  6300 x 1 x 0.10 
c = 0.2535    x    ΔAacetic acid        [g/L] 
9.4.3 Fermentation data 
 
Figure 6.9.11  Fermentation trace of the stirrer speed, dissolved oxygen (pO2), oxygen uptake rate 
(OUR), carbon evolution rate (CER), oxygen saturation in air inlet (Inlet_O2) and airflow rate (AIRFL) 
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Figure 6.9.12 A summary of the yield and purity results of the 200 ml refold conditions detailed in Table 
X. 
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Figure 6.9.13 A summary of the yield of the microscale refolds of the large scale fermentation material 
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Figure 6.9.14  DOT profiles for different shaking speeds of 800, 700, 600 and 500 rpm  
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Batch timeBatch time (h)
 
Figure 6.9.15  The acid, base and antifoam additions of the higher kLa fermentation 
 
 
 
